
<html lang="en"     class="pb-page"  data-request-id="2e9c7dcd-83cb-48af-bea7-3b8eade42fc9"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/jm0612968;website:website:acspubs;issue:issue:10.1021/jmcmar.2007.50.issue-6;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of (R)-9-Ethyl-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-a]isoindol- 6(2H)-one, a Selective, Orally Active Agonist of the 5-HT2C Receptor" /></meta><meta name="dc.Creator" content="Dean A.  Wacker,*" /></meta><meta name="dc.Creator" content="Jeffrey G.  Varnes," /></meta><meta name="dc.Creator" content="Sarah E.  Malmstrom," /></meta><meta name="dc.Creator" content="Xueying  Cao," /></meta><meta name="dc.Creator" content="Chen-Pin  Hung," /></meta><meta name="dc.Creator" content="Thao  Ung," /></meta><meta name="dc.Creator" content="Ginger  Wu," /></meta><meta name="dc.Creator" content="Ge  Zhang," /></meta><meta name="dc.Creator" content="Eva  Zuvich," /></meta><meta name="dc.Creator" content="Michael A.  Thomas," /></meta><meta name="dc.Creator" content="William J.  Keim," /></meta><meta name="dc.Creator" content="Mary Jane  Cullen," /></meta><meta name="dc.Creator" content="Kenneth W.  Rohrbach," /></meta><meta name="dc.Creator" content="Qinling  Qu," /></meta><meta name="dc.Creator" content="Rangaraj  Narayanan," /></meta><meta name="dc.Creator" content="Karen  Rossi," /></meta><meta name="dc.Creator" content="Evan  Janovitz," /></meta><meta name="dc.Creator" content="Lois  Lehman-McKeeman," /></meta><meta name="dc.Creator" content="Mary F.  Malley," /></meta><meta name="dc.Creator" content="James  Devenny," /></meta><meta name="dc.Creator" content="Mary Ann  Pelleymounter," /></meta><meta name="dc.Creator" content="Keith J.  Miller, and" /></meta><meta name="dc.Creator" content="Jeffrey A.  Robl" /></meta><meta name="dc.Description" content="Robust pharmaceutical treatment of obesity has been limited by the undesirable side-effect profile of currently marketed therapies. This paper describes the synthesis and optimization of a new clas..." /></meta><meta name="Description" content="Robust pharmaceutical treatment of obesity has been limited by the undesirable side-effect profile of currently marketed therapies. This paper describes the synthesis and optimization of a new clas..." /></meta><meta name="dc.Publisher" content=" American Chemical Society " /></meta><meta name="dc.Date" scheme="WTN8601" content="February 23, 2007" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm0612968" /></meta><meta name="dc.Identifier" scheme="crossover-key" content="JMCMAr-50-6-1365" /></meta><meta name="dc.Identifier" scheme="pii" content="S0022-2623(06)01296-9" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright Â© 2007 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm0612968" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm0612968" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm0612968" /></link>
        
    
    

<title>Discovery of (R)-9-Ethyl-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-a]isoindol- 6(2H)-one, a Selective, Orally Active Agonist of the 5-HT2C Receptor | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm0612968" /></meta><meta property="og:title" content="Discovery of (R)-9-Ethyl-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-a]isoindol- 6(2H)-one, a Selective, Orally Active Agonist of the 5-HT2C Receptor" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-6/jm0612968/production/images/large/jm0612968n00001.jpeg" /></meta><meta property="og:description" content=" Robust pharmaceutical treatment of obesity has been limited by the undesirable side-effect profile of currently marketed therapies. This paper describes the synthesis and optimization of a new class of pyrazinoisoindolone-containing, selective 5-HT2C agonists as antiobesity agents. Key to optimization of the pyrazinoisoindolone core was the identification of the appropriate substitution pattern and functional groups which led to the discovery of (R)-9-ethyl-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-a]isoindol-6(2H)-one (58), a 5-HT2C agonist with &gt;300-fold functional selectivity over 5-HT2B and &gt;70-fold functional selectivity over 5-HT2A. Oral dosing of 58 reduced food intake in an acute rat feeding model, which could be completely reversed by a selective 5-HT2C antagonist and caused a reduction in body weight gain in a 4-day rat model.  " /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm0612968"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm0612968">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm0612968&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm0612968&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm0612968&amp;href=/doi/10.1021/jm0612968" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2007</span><span class="cit-fg-volume">, 50</span><span class="cit-fg-issue">, 6</span><span class="cit-fg-pageRange">, 1365-1379</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/50/6" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm061290i" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm061131z" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of (<i>R</i>)-9-Ethyl-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-<i>a</i>]isoindol- 6(2<i>H</i>)-one, a Selective, Orally Active Agonist of the 5-HT<sub>2C</sub> Receptor</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dean+A.++Wacker">Dean A. Wacker</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jeffrey+G.++Varnes">Jeffrey G. Varnes</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sarah+E.++Malmstrom">Sarah E. Malmstrom</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xueying++Cao">Xueying Cao</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chen-Pin++Hung">Chen-Pin Hung</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thao++Ung">Thao Ung</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ginger++Wu">Ginger Wu</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ge++Zhang">Ge Zhang</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Eva++Zuvich">Eva Zuvich</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+A.++Thomas">Michael A. Thomas</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=William+J.++Keim">William J. Keim</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mary+Jane++Cullen">Mary Jane Cullen</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kenneth+W.++Rohrbach">Kenneth W. Rohrbach</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Qinling++Qu">Qinling Qu</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rangaraj++Narayanan">Rangaraj Narayanan</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Karen++Rossi">Karen Rossi</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Evan++Janovitz">Evan Janovitz</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lois++Lehman-McKeeman">Lois Lehman-McKeeman</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mary+F.++Malley">Mary F. Malley</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=James++Devenny">James Devenny</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mary+Ann++Pelleymounter">Mary Ann Pelleymounter</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Keith+J.++Miller">Keith J. Miller</a></span></span></li><span class="comma-separator">,Â andÂ </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jeffrey+A.++Robl">Jeffrey A. Robl</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info"><span class="aff-text">Departments of Discovery Chemistry, Metabolic Diseases, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Pharmaceutical Research Institute, P.O. Box 5400, Princeton, New Jersey 08543-5400 </span></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="JMCMAr" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm0612968&amp;href=/doi/10.1021%2Fjm0612968" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2007</span></span><span class="cit-volume">, 50</span><span class="cit-issue">, 6</span><span class="cit-pageRange">, 1365â1379</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 23, 2007</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>7 November 2006</li><li><span class="item_label"><b>Published</b> online</span>23 February 2007</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 1 March 2007</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm0612968" title="DOI URL">https://doi.org/10.1021/jm0612968</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2007 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1365%26pageCount%3D15%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DDean%2BA.%2BWacker%252C%2BJeffrey%2BG.%2BVarnes%252C%2BSarah%2BE.%2BMalmstrom%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D50%26issueNum%3D6%26contentID%3Djm0612968%26title%3DDiscovery%2Bof%2B%2528R%2529-9-Ethyl-1%252C3%252C4%252C10b-tetrahydro-7-trifluoromethylpyrazino%255B2%252C1-a%255Disoindol-%2B6%25282H%2529-one%252C%2Ba%2BSelective%252C%2BOrally%2BActive%2BAgonist%2Bof%2Bthe%2B5-HT2C%2BReceptor%26numPages%3D15%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1379%26publicationDate%3DMarch%2B2007">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm0612968"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2109</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">26</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm0612968" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of (R)-9-Ethyl-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-a]isoindol- 6(2H)-one, a Selective, Orally Active Agonist of the 5-HT2C Receptor&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Dean&quot;,&quot;last_name&quot;:&quot;A. Wacker&quot;},{&quot;first_name&quot;:&quot;Jeffrey&quot;,&quot;last_name&quot;:&quot;G. Varnes&quot;},{&quot;first_name&quot;:&quot;Sarah&quot;,&quot;last_name&quot;:&quot;E. Malmstrom&quot;},{&quot;first_name&quot;:&quot;Xueying&quot;,&quot;last_name&quot;:&quot;Cao&quot;},{&quot;first_name&quot;:&quot;Chen-Pin&quot;,&quot;last_name&quot;:&quot;Hung&quot;},{&quot;first_name&quot;:&quot;Thao&quot;,&quot;last_name&quot;:&quot;Ung&quot;},{&quot;first_name&quot;:&quot;Ginger&quot;,&quot;last_name&quot;:&quot;Wu&quot;},{&quot;first_name&quot;:&quot;Ge&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Eva&quot;,&quot;last_name&quot;:&quot;Zuvich&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;A. Thomas&quot;},{&quot;first_name&quot;:&quot;William&quot;,&quot;last_name&quot;:&quot;J. Keim&quot;},{&quot;first_name&quot;:&quot;Mary&quot;,&quot;last_name&quot;:&quot;Jane Cullen&quot;},{&quot;first_name&quot;:&quot;Kenneth&quot;,&quot;last_name&quot;:&quot;W. Rohrbach&quot;},{&quot;first_name&quot;:&quot;Qinling&quot;,&quot;last_name&quot;:&quot;Qu&quot;},{&quot;first_name&quot;:&quot;Rangaraj&quot;,&quot;last_name&quot;:&quot;Narayanan&quot;},{&quot;first_name&quot;:&quot;Karen&quot;,&quot;last_name&quot;:&quot;Rossi&quot;},{&quot;first_name&quot;:&quot;Evan&quot;,&quot;last_name&quot;:&quot;Janovitz&quot;},{&quot;first_name&quot;:&quot;Lois&quot;,&quot;last_name&quot;:&quot;Lehman-McKeeman&quot;},{&quot;first_name&quot;:&quot;Mary&quot;,&quot;last_name&quot;:&quot;F. Malley&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;Devenny&quot;},{&quot;first_name&quot;:&quot;Mary&quot;,&quot;last_name&quot;:&quot;Ann Pelleymounter&quot;},{&quot;first_name&quot;:&quot;Keith&quot;,&quot;last_name&quot;:&quot;J. Miller&quot;},{&quot;first_name&quot;:&quot;Jeffrey&quot;,&quot;last_name&quot;:&quot;A. Robl&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2007&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;23&quot;,&quot;issue&quot;:&quot;6&quot;,&quot;volume&quot;:&quot;50&quot;,&quot;pages&quot;:&quot;1365-1379&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm0612968&quot;},&quot;abstract&quot;:&quot;Robust pharmaceutical treatment of obesity has been limited by the undesirable side-effect profile of currently marketed therapies. This paper describes the synthesis and optimization of a new class of pyrazinoisoindolone-containing, selective 5-HT2C agonists as antiobesity agents. Key to optimization of the pyrazinoisoindolone core was the identification of the appropriate substitution pattern and functional groups which led to the discovery of (R)-9-ethyl-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-a]isoindol-6(2H)-one (58), a 5-HT2C agonist with &gt;300-fold functional selectivity over 5-HT2B and &gt;70-fold functional selectivity over 5-HT2A. Oral dosing of 58 reduced food intake in an acute rat feeding model, which could be completely reversed by a selective 5-HT2C antagonist and caused a reduction in body weight gain in a 4-day rat model.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm0612968&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm0612968" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm0612968&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm0612968" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm0612968&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm0612968" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm0612968&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm0612968&amp;href=/doi/10.1021/jm0612968" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm0612968" /></input><a href="/doi/pdf/10.1021/jm0612968" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (191 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm0612968&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm0612968%26sid%3Dliteratum%253Aachs%26pmid%3D17315987%26genre%3Darticle%26aulast%3DWacker%26date%3D2007%26atitle%3DDiscovery%2Bof%2B%2528R%2529-9-Ethyl-1%252C3%252C4%252C10b-tetrahydro-7-trifluoromethylpyrazino%255B2%252C1-a%255Disoindol-%2B6%25282H%2529-one%252C%2Ba%2BSelective%252C%2BOrally%2BActive%2BAgonist%2Bof%2Bthe%2B5-HT2C%2BReceptor%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D50%26issue%3D6%26spage%3D1365%26epage%3D1379%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">Â»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291719" title="Redox reactions">Redox reactions</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a>,</li><li><a href="/action/doSearch?ConceptID=291803" title="Obesity">Obesity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/50/6" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-6/jm0612968/production/images/medium/jm0612968n00001.gif" alt="" id="_i2" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-6/jm0612968/production/images/large/jm0612968n00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0612968&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Robust pharmaceutical treatment of obesity has been limited by the undesirable side-effect profile of currently marketed therapies. This paper describes the synthesis and optimization of a new class of pyrazinoisoindolone-containing, selective 5-HT<sub>2C</sub> agonists as antiobesity agents. Key to optimization of the pyrazinoisoindolone core was the identification of the appropriate substitution pattern and functional groups which led to the discovery of (<i>R</i>)-9-ethyl-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-<i>a</i>]isoindol-6(2<i>H</i>)-one (<b>58</b>), a 5-HT<sub>2C</sub> agonist with >300-fold functional selectivity over 5-HT<sub>2B</sub> and >70-fold functional selectivity over 5-HT<sub>2A</sub>. Oral dosing of <b>58</b> reduced food intake in an acute rat feeding model, which could be completely reversed by a selective 5-HT<sub>2C</sub> antagonist and caused a reduction in body weight gain in a 4-day rat model. </p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec fnGroup"><div class="fnGroupItem" id="jm0612968AF1"><span><h4><span class="NLM_fn-symbol">*</span></h4></span><span><p class="last"> âTo whom correspondence should be addressed. Phone:â 609-818-5381. Fax:â 609-818-3331. E-mail:â <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="b6d2d3d7d898c1d7d5ddd3c4f6d4dbc598d5d9db98">[emailÂ protected]</a></p></span></div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51055" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51055" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Obesity is recognized as a major global public health issue. In the U.S., greater than 66% of the adult population are considered overweight with a body-mass index (BMI) of >25, and 32% are classified as obese with a BMI > 30.<sup><a onclick="showRef(event, 'jm0612968b00001'); return false;" href="javascript:void(0);" class="ref jm0612968b00001">1</a></sup> Furthermore, obesity rates are climbing every year, and, if this trend continues, obesity will overtake smoking as the leading cause of preventable deaths in the U.S. The issue is not limited to the U.S. or developed countries, as studies indicate that obesity rates are rising in every part of the world.<sup><a onclick="showRef(event, 'jm0612968b00002'); return false;" href="javascript:void(0);" class="ref jm0612968b00002">2</a></sup> The increasing prevalence of obesity is seen across all age groups, and the rate of morbid obesity is increasing at an even faster rate than obesity. </div><div class="NLM_p">Obesity negatively affects both the physical and psychological health of patients. The prevalence of serious, chronic health problems such as coronary heart disease, hypertension, stroke, diabetes, arthritis, and some cancers have been correlated to the severity of obesity.<sup><a onclick="showRef(event, 'jm0612968b00003'); return false;" href="javascript:void(0);" class="ref jm0612968b00003">3</a></sup> For example, it has been estimated that controlling obesity would reduce the incidence of hypertension by 48% in Caucasians and 28% in African Americans.<sup><a onclick="showRef(event, 'jm0612968b00004'); return false;" href="javascript:void(0);" class="ref jm0612968b00004">4</a></sup> Also, evidence from numerous studies indicate that a causal relationship exists between obesity and reduced self-esteem and a lower quality of life, especially in children.<sup><a onclick="showRef(event, 'jm0612968b00005'); return false;" href="javascript:void(0);" class="ref jm0612968b00005">5</a></sup> Given the widespread nature of this disease, there is an increasing importance in finding new treatments for obesity. </div><div class="NLM_p">Historically, antiobesity pharmacotherapy has focused on modulation of neurotransmitter receptor activity. The elevation of monoaminergic neurotransmitter levels by inhibition of reuptake mechanisms, stimulation of release mechanisms, or direct activation of the neurotransmitter receptors has provided several antiobesity drugs such as sibutramine, phentermine, and dexfenfluramine. However, these drugs have had limited success because of several undesirable side effects presumably arising from a lack of receptor selectivity, such as valvular hypertrophy, pulmonary hypertension, and abuse potential. To overcome these issues, more recent research has focused on the selective regulation of the neurotransmitter receptors and, specifically, serotonin receptors. </div><div class="NLM_p">Several serotonin receptors have been implicated in the regulation of appetite, however, a growing body of evidence implicates 5-HT<sub>2C</sub> as a primary contributor. In preclinical models, the nonselective 5-HT<sub>2B/2C</sub> agonist <i>m</i>-chlorophenylpiperazine (mCPP) reduces food intake in rats.<sup><a onclick="showRef(event, 'jm0612968b00006'); return false;" href="javascript:void(0);" class="ref jm0612968b00006">6</a></sup> This effect is attenuated by the selective 5-HT<sub>2C</sub> antagonist SB-242086<sup><a onclick="showRef(event, 'jm0612968b00007'); return false;" href="javascript:void(0);" class="ref jm0612968b00007">7</a></sup> and is absent in 5-HT<sub>2C</sub> receptor knock-out mice.<sup><a onclick="showRef(event, 'jm0612968b00008'); return false;" href="javascript:void(0);" class="ref jm0612968b00008">8</a></sup> In clinical settings, mCPP reduces appetite and body weight of both normal and obese human subjects.<sup><a onclick="showRef(event, 'jm0612968b00009'); return false;" href="javascript:void(0);" class="ref jm0612968b00009">9</a></sup> In light of these results, our efforts have focused on discovering new structural motifs with potent 5-HT<sub>2C</sub> agonist activity. The challenge has been to identify compounds<sup><a onclick="showRef(event, 'jm0612968b00010'); return false;" href="javascript:void(0);" class="ref jm0612968b00010">10</a></sup> that are also selective over the homologous 5-HT<sub>2A</sub> receptor, to eliminate the unwanted side-effect of hallucinogenesis, and 5-HT<sub>2B</sub> receptor, to reduce the possibility of valvular hypertrophy.<sup><a onclick="showRef(event, 'jm0612968b00011'); return false;" href="javascript:void(0);" class="ref jm0612968b00011">11</a></sup></div><div class="NLM_p">A series of tetracyclic indolines, exemplified by <b>1 </b>(Figure 1<a data-tab="pane-pcw-Figures" href="#jm0612968f00001" id="" class=" internalNav"></a>), were reported by Bristol-Myers Squibb to be potent and selective 5-HT<sub>2C</sub> agonists.<sup><a onclick="showRef(event, 'jm0612968b00012'); return false;" href="javascript:void(0);" class="ref jm0612968b00012">12</a></sup> Selected compounds from the series exhibited excellent sustained efficacy in in vivo models out to 14 weeks in duration. Unfortunately, the tetracyclic indolines had unwanted toxicities believed to be associated with the amphiphilic nature of the molecules, such as parietal cell necrosis. This toxicity has been observed with multiple 5-HT<sub>2C</sub> agonist structural motifs.<sup><a onclick="showRef(event, 'jm0612968b00013'); return false;" href="javascript:void(0);" class="ref jm0612968b00013">13</a></sup> To overcome these issues, we have focused on retaining the three-dimensional orientation of the basic amine in relation to the core phenyl ring, while reducing the size and more evenly distributing the polarity of the molecule. The pyrazinoisoindolone core structure <b>2</b> offered the <a name="jm005000601366" id="jm005000601366"></a> potential to accomplish these goals. A puckered shape is retained at the piperazine ring fusion, while a polar amide is centrally located in the structure. This paper reports the optimization of the pyrazinoisoindolone core and identification of (<i>R</i>)-9-ethyl-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-<i>a</i>]isoindol-6(2<i>H</i>)-one (<b>58</b>), a potent and selective orally bioavailable 5HT<sub>2C</sub> agonist. <div id="_i4"><figure id="jm0612968f00001" data-index="1" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-6/jm0612968/production/images/medium/jm0612968f00001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-6/jm0612968/production/images/large/jm0612968f00001.jpeg" id="_i5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 1 Published and proposed 5-HT<sub>2C</sub> agonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-6/jm0612968/production/images/large/jm0612968f00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0612968&amp;id=jm0612968f00001"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p"><b>Chemistry.</b> Two general synthetic routes, based on the work of Welch,<sup><a onclick="showRef(event, 'jm0612968b00014'); return false;" href="javascript:void(0);" class="ref jm0612968b00014">14</a></sup> were developed for the synthesis of the pyrazinoisoindolone core structures (Schemes 1<a data-tab="pane-pcw-Figures" href="#jm0612968h00001" id="" class=" internalNav"></a><a data-tab="pane-pcw-Figures" href="#jm0612968h00002" id="" class=" internalNav"></a> and 2). The first route began with readily available benzoic acids <b>3</b>, which were converted to the corresponding diethyl amides <b>4</b> with oxalyl chloride and diethylamine in excellent yield. Benzamides <b>4</b> were then deprotonated with <i>sec</i>-butyllithium and TMEDA, and the resulting anions were quenched with DMF to provide intermediates <b>5</b>. Isobenzofurans <b>6</b> were formed by refluxing <b>5</b> with 6 M aq HCl overnight. Utilizing the procedures of Welch,<sup>14</sup><b>6</b> was reacted with sodium cyanide and <i>N</i>-Cbz-ethylenediamine hydrochloride to produce compounds <b>7</b>. The cyanoisoindolones <b>7</b> were cyclized in the presence of palladium on carbon and hydrogen to yield final products <b>8</b>. To obtain the chiral products, compounds <b>8</b> were reacted with di-<i>tert</i>-butyl dicarbonate and the resulting <i>N</i>-Boc carbamates were separated by chiral HPLC. Deprotection with 12 M HCl afforded the chiral final products <b>9</b>. Derivatives of the 7-CF<sub>3</sub>-substituted pyrazinoisoindolone core were synthesized by reacting <b>8</b> with concd H<sub>2</sub>SO<sub>4</sub> and <i>N</i>-bromosuccinimide to yield intermediate bromide <b>10</b>. Alkylation of <b>10</b> under Suzuki or Stille conditions, followed by enantiomeric resolution by chiral HPLC and subsequent deprotection with 12 M HCl, afforded final alkyl products <b>11</b>. Absolute configuration was determined by X-ray crystallography.<sup><a onclick="showRef(event, 'jm0612968b00015'); return false;" href="javascript:void(0);" class="ref jm0612968b00015">15</a></sup><div id="_i6"><figure id="jm0612968h00001" data-index="2" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-6/jm0612968/production/images/medium/jm0612968h00001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-6/jm0612968/production/images/large/jm0612968h00001.jpeg" id="_i7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 1.â Synthesis of Pyrazinoisoindolones (Method A)<i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup>âReagents:â (a) (1) Oxalyl chloride, 0.1 equiv of DMF, CH<sub>2</sub>Cl<sub>2</sub>, (2) 2.2 equiv of diethylamine, CH<sub>2</sub>Cl<sub>2</sub>; (b) (1) <i>s</i>-BuLi, TMEDA, THF, â78 Â°C, 15 min, then DMF, â78 Â°C to rt, 1 h; (c) 6 M aq HCl, reflux, 16 h; (d) NaOAc, NaCN, <i>N</i>-Cbz-ethylenediamine hydrochloride, 2:1 EtOH:AcOH; (e) 60 psi H<sub>2</sub>, 10% Pd/C, concd HCl, MeOH; (f) (1) Boc<sub>2</sub>O, CH<sub>2</sub>Cl<sub>2</sub>, (2) chiral separation, (3) 12 M HCl; (g) (1) NBS, concd H<sub>2</sub>SO<sub>4</sub>, (2) Boc<sub>2</sub>O, Na<sub>2</sub>CO<sub>3</sub>, THF; (h) (1) R<sub>9</sub>-B(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, DME, H<sub>2</sub>O, reflux or R<sub>9</sub>-Sn(<i>n</i>-Bu)<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, Tol, reflux<sub>,</sub> (2) 12 M HCl.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-6/jm0612968/production/images/large/jm0612968h00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0612968&amp;id=jm0612968h00001"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="jm0612968h00002" data-index="3" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-6/jm0612968/production/images/medium/jm0612968h00002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-6/jm0612968/production/images/large/jm0612968h00002.jpeg" id="_i8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 2.â Alternative Synthesis of Pyrazinoisoindolones (Method B)<i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup>âReagents:â (a) NaOAc, NaCN, 2,2-diethoxyethylamine, 2:1 EtOH:AcOH; (b) 1 atm H<sub>2</sub>, Raney Ni, EtOH; (c) (1) 12 M HCl, (2) NaBH(OAc)<sub>3</sub>, MeOH, ClCH<sub>2</sub>CH<sub>2</sub>Cl, (3) Boc<sub>2</sub>O, Na<sub>2</sub>CO<sub>3</sub>, EtOAc; (d) 12 M HCl. </p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-6/jm0612968/production/images/large/jm0612968h00002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0612968&amp;id=jm0612968h00002"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">Alternatively, when the starting benzoic acids had substituents that were sensitive to hydrogenation conditions with palladium on carbon, a slightly modified synthetic scheme was used relying on a Raney nickel-catalyzed reduction (Scheme 2). Isobenzofurans <b>6</b> were treated with sodium cyanide and 2,2-diethoxyethylamine to provide nitriles <b>12</b> in good yield. The cyano group of <b>12</b> was reduced with Raney nickel and hydrogen to yield intermediates <b>13</b>. Treatment of <b>13</b> with 12 M HCl for 30 min and then reaction with NaBH(OAc)<sub>3</sub> gave the cyclized products which were protected with di-<i>tert</i>-butyl dicarbonate to facilitate purification and chiral separation if desired. The final products <b>9</b> were obtained by removal of the protecting group with 12 M HCl. </div><div class="NLM_p last">Compounds with alkyl substitutuents at C1 of the pyrazinoisoindolone core were synthesized from isobenzofuran <b>6a</b> (Scheme 3<a data-tab="pane-pcw-Figures" href="#jm0612968h00003" id="" class=" internalNav"></a>). Treatment of <b>6a</b> with <i>N</i>-Boc-ethylenediamine hydrochloride and NaBH(OAc)<sub>3</sub> yielded isoindolone <b>14</b>. Intermediate <b>14</b> was deprotonated with <i>sec</i>-butyllithium, and the resulting anion was then quenched with the desired aldehyde. Alcohols <b>15</b> were then oxidized to the corresponding ketones <b>16</b> under DessâMartin conditions. Intermediates <b>16</b> were cyclized to the corresponding enamines with 12 M HCl and protected with di-<i>tert</i>-butyl dicarbonate and DMAP to yield <b>17</b>. This protection was necessary for optimal reduction of the enamines in the next step. The final products <b>18</b> were then synthesized by reduction of <b>17</b> with palladium on carbon and <a name="jm005000601367" id="jm005000601367"></a> hydrogen followed by chiral HPLC resolution and deprotection with 12 M HCl. <div id="_i9"><figure id="jm0612968h00003" data-index="4" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-6/jm0612968/production/images/medium/jm0612968h00003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-6/jm0612968/production/images/large/jm0612968h00003.jpeg" id="_i10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 3.â Synthesis of 1-Substituted Pyrazinoisoindolone Core<i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup>âReagents:â (a) NaBH(OAc)<sub>3</sub>, <i>N</i>-Boc-ethylenediamine hydrochloride, AcOH, ClCH<sub>2</sub>CH<sub>2</sub>Cl; (b) (1) <i>s</i>-BuLi, THF, â78 Â°C, 15 min, (2) RCOH, â78 Â°C â 0 Â°C, 5 min; (c) DessâMartin periodinane, CH<sub>2</sub>Cl<sub>2</sub>; (d) (1) 12 M aq HCl, Et<sub>2</sub>O, (2) Boc<sub>2</sub>O, 2 equiv of DMAP; (e) (1) 60 psi H<sub>2</sub>, 10% Pd/C, MeOH, (2) chiral separation; (f) 12 M HCl.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-6/jm0612968/production/images/large/jm0612968h00003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0612968&amp;id=jm0612968h00003"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00701" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00701" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p"><b>Lead Identification and Optimization.</b> Our initial operating assumption was that the core structure of an agonist needed to have some functional preference for 5-HT<sub>2C</sub> over 5-HT<sub>2B</sub> and 5-HT<sub>2A</sub> if we were to achieve our desired selectivity profile. The goal of our research was to design a 5-HT<sub>2C</sub> agonist with a <i>K</i><sub>i</sub> and EC<sub>50</sub> of less than 25 nM and greater than 100-fold functional selectivity over the 5-HT<sub>2B</sub> and 5-HT<sub>2A</sub> receptors. When we tested the unsubstituted, racemic pyrazinoisoindolone core (<b>19</b>),<sup>14</sup> we were very encouraged by the preliminary binding and functional assay results (Table 1<a class="ref showTableEvent internalNav" data-ID="jm0612968t00001" href="#jm0612968t00001"></a>). Although not extremely potent, compound <b>19</b> was >9-fold functionally selective for 5-HT<sub>2C</sub> over 5-HT<sub>2B</sub> and >14-fold over 5-HT<sub>2A</sub>. <div class="NLM_table-wrap" id="jm0612968t00001"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 1.â In Vitro Activity of the Pyrazinoisoindolone Core<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-6/jm0612968/production/images/medium/jm0612968u00001a.gif" alt="" id="_i12" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">â</td><td class="colsep2 rowsep2">chirality</td><td class="colsep2 rowsep2">R7</td><td class="colsep2 rowsep2">5-HT<sub>2C</sub><i>K</i><sub>i</sub>,ânM<i><sup>a</sup></i><sup></sup></td><td class="colsep2 rowsep2">5-HT<sub>2B</sub><i>K</i><sub>i</sub>,ânM<i><sup>a</sup></i><sup></sup></td><td class="colsep2 rowsep2">5-HT<sub>2A</sub><i>K</i><sub>i</sub>,ânM<i><sup>a</sup></i><sup></sup></td><td class="colsep2 rowsep2">5-HT<sub>2C</sub> EC<sub>50</sub>,ânM<i><sup>a</sup></i><sup>,</sup><i><sup>â</sup></i><sup></sup><i><sup>b</sup></i><sup></sup></td><td class="colsep2 rowsep2">5-HT<sub>2B</sub> EC<sub>50</sub>,ânM<i><sup>a</sup></i><sup>,</sup><i><sup>âb</sup></i><sup></sup></td><td class="colsep2 rowsep2">5-HT<sub>2A</sub> EC<sub>50</sub>,ânM<i><sup>a</sup></i><sup>,</sup><i><sup>b</sup></i><sup></sup></td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>19</b></td><td class="colsep2 rowsep2"><i>rac</i></td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">630âÂ±â130 </td><td class="colsep2 rowsep2">4540âÂ±â220 </td><td class="colsep2 rowsep2">8540âÂ±â250 </td><td class="colsep2 rowsep2">1500âÂ±â30 </td><td class="colsep2 rowsep2">>10000 </td><td class="colsep2 rowsep2">>10000 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>20</b></td><td class="colsep2 rowsep2"><i>rac</i></td><td class="colsep2 rowsep2">CF<sub>3</sub></td><td class="colsep2 rowsep2">19âÂ±â10 </td><td class="colsep2 rowsep2">249âÂ±â87 </td><td class="colsep2 rowsep2">110âÂ±â2 </td><td class="colsep2 rowsep2">24âÂ±â11 </td><td class="colsep2 rowsep2">192âÂ±â6 </td><td class="colsep2 rowsep2">131âÂ±â17 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>21</b></td><td class="colsep2 rowsep2"><i>rac</i></td><td class="colsep2 rowsep2">OMe </td><td class="colsep2 rowsep2">133âÂ±â62 </td><td class="colsep2 rowsep2">192âÂ±â26 </td><td class="colsep2 rowsep2">3280âÂ±â410 </td><td class="colsep2 rowsep2">136âÂ±â46 </td><td class="colsep2 rowsep2">207âÂ±â29 </td><td class="colsep2 rowsep2">>10000 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>22</b></td><td class="colsep2 rowsep2"><i>rac</i></td><td class="colsep2 rowsep2">OCF<sub>3</sub></td><td class="colsep2 rowsep2">20âÂ±â7 </td><td class="colsep2 rowsep2">550âÂ±â300 </td><td class="colsep2 rowsep2">67âÂ±â4 </td><td class="colsep2 rowsep2">26âÂ±â7 </td><td class="colsep2 rowsep2">498âÂ±â31 </td><td class="colsep2 rowsep2">87âÂ±â14 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>23</b></td><td class="colsep2 rowsep2"><i>rac</i></td><td class="colsep2 rowsep2">F </td><td class="colsep2 rowsep2">1030âÂ±â350 </td><td class="colsep2 rowsep2">3690âÂ±â400 </td><td class="colsep2 rowsep2">>10000 </td><td class="colsep2 rowsep2">1730âÂ±â57 </td><td class="colsep2 rowsep2">>10000 </td><td class="colsep2 rowsep2">>10000 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>24</b></td><td class="colsep2 rowsep2"><i>rac</i></td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">31âÂ±â20 </td><td class="colsep2 rowsep2">309âÂ±â79 </td><td class="colsep2 rowsep2">586âÂ±â36 </td><td class="colsep2 rowsep2">37âÂ±â2 </td><td class="colsep2 rowsep2">501âÂ±â29 </td><td class="colsep2 rowsep2">1780âÂ±â140 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>25</b></td><td class="colsep2 rowsep2"><i>rac</i></td><td class="colsep2 rowsep2">CN </td><td class="colsep2 rowsep2">300âÂ±â100 </td><td class="colsep2 rowsep2">3930âÂ±â270 </td><td class="colsep2 rowsep2">>10000 </td><td class="colsep2 rowsep2">281âÂ±â35 </td><td class="colsep2 rowsep2">>10000 </td><td class="colsep2 rowsep2">>10000 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>26</b></td><td class="colsep2 rowsep2"><i>rac</i></td><td class="colsep2 rowsep2">SMe </td><td class="colsep2 rowsep2">40âÂ±â12 </td><td class="colsep2 rowsep2">84âÂ±â6 </td><td class="colsep2 rowsep2">216âÂ±â78 </td><td class="colsep2 rowsep2">42âÂ±â15 </td><td class="colsep2 rowsep2">87âÂ±â32 </td><td class="colsep2 rowsep2">111âÂ±â10 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>27</b></td><td class="colsep2 rowsep2"><i>rac</i></td><td class="colsep2 rowsep2">OH </td><td class="colsep2 rowsep2">980âÂ±â520 </td><td class="colsep2 rowsep2">3740âÂ±â490 </td><td class="colsep2 rowsep2">1670âÂ±â320 </td><td class="colsep2 rowsep2">514âÂ±â26 </td><td class="colsep2 rowsep2">>10000 </td><td class="colsep2 rowsep2">>10000 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>28</b></td><td class="colsep2 rowsep2"><i>rac</i></td><td class="colsep2 rowsep2">OiPr </td><td class="colsep2 rowsep2">115âÂ±â48 </td><td class="colsep2 rowsep2">1600âÂ±â500 </td><td class="colsep2 rowsep2">250âÂ±â100 </td><td class="colsep2 rowsep2">107âÂ±â28 </td><td class="colsep2 rowsep2">825âÂ±â49 </td><td class="colsep2 rowsep2">449âÂ±â69 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>29</b></td><td class="colsep2 rowsep2"><i>R</i></td><td class="colsep2 rowsep2">CF<sub>3</sub></td><td class="colsep2 rowsep2">7âÂ±â1 </td><td class="colsep2 rowsep2">74âÂ±â10 </td><td class="colsep2 rowsep2">59âÂ±â5 </td><td class="colsep2 rowsep2">7âÂ±â2 </td><td class="colsep2 rowsep2">180âÂ±â26 </td><td class="colsep2 rowsep2">176âÂ±â38 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>30</b></td><td class="colsep2 rowsep2"><i>S</i></td><td class="colsep2 rowsep2">CF<sub>3</sub></td><td class="colsep2 rowsep2">1100âÂ±â330 </td><td class="colsep2 rowsep2">3430âÂ±â620 </td><td class="colsep2 rowsep2">>10000 </td><td class="colsep2 rowsep2">1840âÂ±â100 </td><td class="colsep2 rowsep2">>10000 </td><td class="colsep2 rowsep2">>10000</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup>â<i>K</i><sub>i</sub> and EC<sub>50</sub> values were calculated from doseâresponse curves. Positive control was mCPP which gave 5-HT<sub>2C</sub><i>K</i><sub>i</sub> = 17 Â± 2 nM, EC<sub>50</sub> = 15 Â± 4 nM; 5-HT<sub>2B</sub><i>K</i><sub>i</sub> = 24 Â± 1 nM, EC<sub>50</sub> = 287 Â± 94 nM; 5-HT<sub>2A</sub><i>K</i><sub>i</sub> = 48 Â± 4 nM, EC<sub>50</sub> = 290 Â± 110 nM.<i><sup>b</sup></i><sup></sup>âIntrinsic activity for all compounds = 1 as compared to serotonin at 3 Î¼M unless noted in parentheses.</p></div></div></div><div class="NLM_p">In order to increase the potency and selectivity of the pyrazinoisoindolone core, our efforts focused on substituting the 7-position, which, according to our modeling efforts, was analogous to the lower ring of the tetracyclic indoline core previously described. Incorporation of the nonpolar electron-withdrawing CF<sub>3</sub> group (<b>20</b>) provided a compound with a â¼30-fold increase in potency and similar selectivity as compared to <b>19</b>. However, not all electron-withdrawing groups provided a large potency increase when compared to the unsubstituted core. The fluoro group (<b>23</b>) reduced potency, and the cyano functionality (<b>25</b>) provided little potency advantage. Electron-donating groups also provided mixed results. While the hydroxyl moiety (<b>27</b>) decreased potency, the methoxy substituent (<b>21</b>) provided a modest â¼4-fold increase in potency. Large improvements in both binding and function were obtained with the trifluoromethoxy (<b>22</b>) and methylthiol (<b>26</b>) functionalities when compared to <b>19</b>. The greater potency obtained with <b>22</b> and <b>26</b> is most likely due to the reduced electron-donating ability of these functional groups when compared to that of a methoxy group rather than any hydrophobic contribution. This is supported by compound <b>28</b>, which is roughly equipotent with <b>21</b>, despite the added methyl groups. To evaluate the potential potency and selectivity differences between enantiomers, all racemic compounds were separated into their enantiomerically pure components. As exemplified by the CF<sub>3</sub> analogs (<b>29</b> and <b>30</b>), the <i>R</i>-enantiomers in all cases proved to be significantly more potent than the <i>S</i>-enantiomers. The selectivity differences between the enantiomers could not be meaningfully addressed due to the low potency of the S-configured compounds. As a result, all further optimization studies utilized the <i>R</i>-enantiomeric configuration. This initial exploration of the pyrazinoisoindolone <a name="jm005000601368" id="jm005000601368"></a> core provided a very potent compound (<b>29</b>); however, further efforts were needed to achieve the desired functional selectivity. </div><div class="NLM_p">To increase the selectivity of compound <b>29</b>, a variety of substitution patterns were investigated. The modification of the piperazine ring by alkylation of the amino group (<b>31</b>) or alpha to the nitrogen at C3 (<b>32</b><b>â</b><b>34</b>) dramatically reduced the binding and functional potency at all three of the serotonin receptor subtypes (Table 2<a class="ref showTableEvent internalNav" data-ID="jm0612968t00002" href="#jm0612968t00002"></a>). In contrast, substitution of C4 with alkyl groups (<b>35</b><b>â</b><b>37</b>) provided very potent 5-HT<sub>2C</sub> compounds, however, functional selectivity versus 5-HT<sub>2A</sub> and 5-HT<sub>2B</sub> was lost. Substitution at C1 with a methyl group (<b>38</b>) also provided a potent 5-HT<sub>2C</sub> compound, but again selectivity over 5-HT<sub>2A</sub> and 5-HT<sub>2B</sub> was dramatically reduced. Additionally, any further increase in steric bulk at C1, as exemplified by compound <b>39</b>, decreased both 5-HT<sub>2C</sub> binding and functional potency. <div class="NLM_table-wrap" id="jm0612968t00002"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 2.â In Vitro Activity of Substituted Piperazine Ring Analogs<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-6/jm0612968/production/images/medium/jm0612968u00002a.gif" alt="" id="_i13" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">Â </td><td class="colsep2 rowsep2">R1</td><td class="colsep2 rowsep2">R2</td><td class="colsep2 rowsep2">R3</td><td class="colsep2 rowsep2">R4</td><td class="colsep2 rowsep2">5-HT<sub>2C</sub><i>K</i><sub>i</sub>,ânM<i><sup>a</sup></i><sup></sup></td><td class="colsep2 rowsep2">5-HT<sub>2B</sub><i>K</i><sub>i</sub>,ânM<i><sup>a</sup></i><sup></sup></td><td class="colsep2 rowsep2">5-HT<sub>2A</sub><i>K</i><sub>i</sub>,ânM<i><sup>a</sup></i><sup></sup></td><td class="colsep2 rowsep2">5-HT<sub>2C</sub> EC<sub>50</sub>,ânM<i><sup>a</sup></i><sup>,</sup><i><sup>b</sup></i><sup></sup></td><td class="colsep2 rowsep2">5-HT<sub>2B</sub> EC<sub>50</sub>,ânM<i><sup>a</sup></i><sup>,</sup><i><sup>b</sup></i><sup></sup></td><td class="colsep2 rowsep2">5-HT<sub>2A</sub> EC<sub>50</sub>,ânM<i><sup>a</sup></i><sup>,</sup><i><sup>b</sup></i><sup></sup></td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>31</b></td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">Me </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">430âÂ±â200 </td><td class="colsep2 rowsep2">1580âÂ±â230 </td><td class="colsep2 rowsep2">4120âÂ±â100 </td><td class="colsep2 rowsep2">296âÂ±â68 </td><td class="colsep2 rowsep2">417âÂ±â35 </td><td class="colsep2 rowsep2">994âÂ±â8 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>32</b></td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">Me,âMe </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">1450âÂ±â61 </td><td class="colsep2 rowsep2">3190âÂ±â390 </td><td class="colsep2 rowsep2">>10000 </td><td class="colsep2 rowsep2">1580âÂ±â250 </td><td class="colsep2 rowsep2">>10000 </td><td class="colsep2 rowsep2">>10000 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>33</b></td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2"><i>S</i>-Me </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">369âÂ±â236 </td><td class="colsep2 rowsep2">3010âÂ±â580 </td><td class="colsep2 rowsep2">>10000 </td><td class="colsep2 rowsep2">478âÂ±â87 </td><td class="colsep2 rowsep2">>10000 </td><td class="colsep2 rowsep2">>10000 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>34</b></td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2"><i>R</i>-Me </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">321âÂ±â211 </td><td class="colsep2 rowsep2">2350âÂ±â870 </td><td class="colsep2 rowsep2">>10000 </td><td class="colsep2 rowsep2">>10000 </td><td class="colsep2 rowsep2">>10000 </td><td class="colsep2 rowsep2">>10000 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>35</b></td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2"><i>R</i>-Me </td><td class="colsep2 rowsep2">74âÂ±â24 </td><td class="colsep2 rowsep2">116âÂ±â16 </td><td class="colsep2 rowsep2">360âÂ±â180 </td><td class="colsep2 rowsep2">82âÂ±â26 </td><td class="colsep2 rowsep2">100âÂ±â19 </td><td class="colsep2 rowsep2">370âÂ±â62 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>36</b></td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2"><i>S</i>-Me </td><td class="colsep2 rowsep2">22âÂ±â14 </td><td class="colsep2 rowsep2">29âÂ±â13 </td><td class="colsep2 rowsep2">117âÂ±â10 </td><td class="colsep2 rowsep2">18âÂ±â9 </td><td class="colsep2 rowsep2">40âÂ±â10 </td><td class="colsep2 rowsep2">91âÂ±â2 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>37</b></td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2"><i>S</i>-iâPr </td><td class="colsep2 rowsep2">13âÂ±â3 </td><td class="colsep2 rowsep2">7âÂ±â1 </td><td class="colsep2 rowsep2">38âÂ±â19 </td><td class="colsep2 rowsep2">10âÂ±â7 </td><td class="colsep2 rowsep2">14âÂ±â5 </td><td class="colsep2 rowsep2">56âÂ±â10 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>38</b></td><td class="colsep2 rowsep2"><i>S</i>-Me </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">29âÂ±â8 </td><td class="colsep2 rowsep2">24âÂ±â1 </td><td class="colsep2 rowsep2">122âÂ±â25 </td><td class="colsep2 rowsep2">28âÂ±â8 </td><td class="colsep2 rowsep2">22âÂ±â6 </td><td class="colsep2 rowsep2">78âÂ±â16 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>39</b></td><td class="colsep2 rowsep2"><i>S</i>-Et </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">335âÂ±â7 </td><td class="colsep2 rowsep2">235âÂ±â32 </td><td class="colsep2 rowsep2">91âÂ±â25 </td><td class="colsep2 rowsep2">480âÂ±â94 </td><td class="colsep2 rowsep2">293âÂ±â36 </td><td class="colsep2 rowsep2">126âÂ±â28</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup>â<i>K</i><sub>i</sub> and EC<sub>50</sub> values were calculated from doseâresponse curves. Positive control was mCPP which gave 5-HT<sub>2C</sub><i>K</i><sub>i</sub> = 17 Â± 2 nM, EC<sub>50</sub> = 15 Â± 4 nM; 5-HT<sub>2B</sub><i>K</i><sub>i</sub> = 24 Â± 1 nM, EC<sub>50</sub> = 287 Â± 94 nM; 5-HT<sub>2A</sub><i>K</i><sub>i</sub> = 48 Â± 4 nM, EC<sub>50</sub> = 290 Â± 110 nM.<i><sup>b</sup></i><sup></sup>âIntrinsic activity for all compounds = 1 as compared to serotonin at 3 Î¼M unless noted in parentheses.</p></div></div></div><div class="NLM_p">Similar results were obtained when the substitution pattern of the aryl ring was investigated (Table 3<a class="ref showTableEvent internalNav" data-ID="jm0612968t00003" href="#jm0612968t00003"></a>). Compounds were either dramatically less potent, as seen with the 7,10-disubstituted compounds <b>40</b><b>â</b><b>42</b> and <b>44</b>, or very potent but with little to no selectivity over 5-HT<sub>2A</sub> and 5-HT<sub>2B</sub>, e.g. 7,8-disubstituted <b>45</b><b>â</b><b>47</b> and 8,9-disubstituted <b>49</b>. An exception was compound <b>43</b>, which was both functionally potent and selective for 5-HT<sub>2C</sub> but lacked the desired receptor binding affinity. The most intriguing results from this work were obtained from 7,9-disubstituted compounds <b>50</b> and <b>51</b>. Although <b>50</b> and <b>51</b> were not extremely potent 5-HT<sub>2C</sub> agonists, the compounds had >100-fold functional selectivity for 5-HT<sub>2C</sub> over 5-HT<sub>2A</sub> and 5-HT<sub>2B</sub>. This substitution pattern provided the desired selectivity profile and suggested additional modification of the substituents would provide selective 5-HT<sub>2C</sub> compounds with better potency to test in our in vivo models. <div class="NLM_table-wrap" id="jm0612968t00003"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 3.â In Vitro Activity of Phenyl Ring Analogs<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-6/jm0612968/production/images/medium/jm0612968u00003a.gif" alt="" id="_i14" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">Â </td><td class="colsep2 rowsep2">R7</td><td class="colsep2 rowsep2">R8</td><td class="colsep2 rowsep2">R9</td><td class="colsep2 rowsep2">R10</td><td class="colsep2 rowsep2">5-HT<sub>2C</sub><i>K</i><sub>i</sub>,ânM<i><sup>a</sup></i><sup></sup></td><td class="colsep2 rowsep2">5-HT<sub>2B</sub><i>K</i><sub>i</sub>,ânM<i><sup>a</sup></i><sup></sup></td><td class="colsep2 rowsep2">5-HT<sub>2A</sub><i>K</i><sub>i</sub>,ânM<i><sup>a</sup></i><sup></sup></td><td class="colsep2 rowsep2">5-HT<sub>2C</sub> EC<sub>50</sub>,ânM<i><sup>a</sup></i><sup>,</sup><i><sup>b</sup></i><sup></sup></td><td class="colsep2 rowsep2">5-HT<sub>2B</sub> EC<sub>50</sub>,ânM<i><sup>a</sup></i><sup>,</sup><i><sup>b</sup></i><sup></sup></td><td class="colsep2 rowsep2">5-HT<sub>2A</sub> EC<sub>50</sub>,ânM<i><sup>a</sup></i><sup>,</sup><i><sup>b</sup></i><sup></sup></td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>40</b></td><td class="colsep2 rowsep2">OMe </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">5060âÂ±â780 </td><td class="colsep2 rowsep2">>10000 </td><td class="colsep2 rowsep2">>10000 </td><td class="colsep2 rowsep2">NT </td><td class="colsep2 rowsep2">NT </td><td class="colsep2 rowsep2">NT </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>41</b></td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">Me </td><td class="colsep2 rowsep2">927âÂ±â11 </td><td class="colsep2 rowsep2">730âÂ±â170 </td><td class="colsep2 rowsep2">4010âÂ±â740 </td><td class="colsep2 rowsep2">54âÂ±â12 </td><td class="colsep2 rowsep2">290âÂ±â51 </td><td class="colsep2 rowsep2">>3000 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>42</b></td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">Et </td><td class="colsep2 rowsep2">425âÂ±â41 </td><td class="colsep2 rowsep2">547âÂ±â170 </td><td class="colsep2 rowsep2">2420âÂ±â130 </td><td class="colsep2 rowsep2">46âÂ±â21 </td><td class="colsep2 rowsep2">274âÂ±â51 </td><td class="colsep2 rowsep2">3280âÂ±â640 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>43</b></td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">OMe </td><td class="colsep2 rowsep2">59âÂ±â42 </td><td class="colsep2 rowsep2">1420âÂ±â610 </td><td class="colsep2 rowsep2">86âÂ±â1 </td><td class="colsep2 rowsep2">5âÂ±â1 </td><td class="colsep2 rowsep2">>1000 </td><td class="colsep2 rowsep2">220âÂ±â120 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>44</b></td><td class="colsep2 rowsep2">CF<sub>3</sub></td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">1084âÂ±â43 </td><td class="colsep2 rowsep2">4030âÂ±â680 </td><td class="colsep2 rowsep2">1473âÂ±â61 </td><td class="colsep2 rowsep2">35âÂ±â4 </td><td class="colsep2 rowsep2">>1000 </td><td class="colsep2 rowsep2">>3000 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>45</b></td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">107âÂ±â5 </td><td class="colsep2 rowsep2">70âÂ±â11 </td><td class="colsep2 rowsep2">383âÂ±â37 </td><td class="colsep2 rowsep2">20âÂ±â5 </td><td class="colsep2 rowsep2">57âÂ±â16 </td><td class="colsep2 rowsep2">>1000 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>46</b></td><td class="colsep2 rowsep2">OMe </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">176âÂ±â15 </td><td class="colsep2 rowsep2">86âÂ±â15 </td><td class="colsep2 rowsep2">813âÂ±â69 </td><td class="colsep2 rowsep2">12âÂ±â1 </td><td class="colsep2 rowsep2">28âÂ±â3 </td><td class="colsep2 rowsep2">872âÂ±â74 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>47</b></td><td class="colsep2 rowsep2">OMe </td><td class="colsep2 rowsep2">Et </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">37âÂ±â15 </td><td class="colsep2 rowsep2">18âÂ±â3 </td><td class="colsep2 rowsep2">43âÂ±â6 </td><td class="colsep2 rowsep2">1.4âÂ±â0.5 </td><td class="colsep2 rowsep2">8âÂ±â1 </td><td class="colsep2 rowsep2">123âÂ±â22 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>48</b></td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">OMe </td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">2330âÂ±â780 </td><td class="colsep2 rowsep2">471âÂ±â92 </td><td class="colsep2 rowsep2">1780âÂ±â180 </td><td class="colsep2 rowsep2">246âÂ±â84 </td><td class="colsep2 rowsep2">>1000 </td><td class="colsep2 rowsep2">>1000 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>49</b></td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">OMe </td><td class="colsep2 rowsep2">Et </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">36âÂ±â14 </td><td class="colsep2 rowsep2">75âÂ±â1 </td><td class="colsep2 rowsep2">589âÂ±â55 </td><td class="colsep2 rowsep2">17âÂ±â3 </td><td class="colsep2 rowsep2">33âÂ±â7 </td><td class="colsep2 rowsep2">374âÂ±â47 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>50</b></td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">OMe </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">209âÂ±â88 </td><td class="colsep2 rowsep2">890âÂ±â140 </td><td class="colsep2 rowsep2">4500âÂ±â380 </td><td class="colsep2 rowsep2">86âÂ±â44 </td><td class="colsep2 rowsep2">>10000 </td><td class="colsep2 rowsep2">>10000 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>51</b></td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">Et </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">124âÂ±â1 </td><td class="colsep2 rowsep2">248âÂ±â82 </td><td class="colsep2 rowsep2">4960âÂ±â510 </td><td class="colsep2 rowsep2">49âÂ±â13 </td><td class="colsep2 rowsep2">>10000 </td><td class="colsep2 rowsep2">>10000</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup>â<i>K</i><sub>i</sub> and EC<sub>50</sub> values were calculated from doseâresponse curves. Positive control was mCPP which gave 5-HT<sub>2C</sub><i>K</i><sub>i</sub> = 17 Â± 2 nM, EC<sub>50</sub> = 15 Â± 4 nM; 5-HT<sub>2B</sub><i>K</i><sub>i</sub> = 24 Â± 1 nM, EC<sub>50</sub> = 287 Â± 94 nM; 5-HT<sub>2A</sub><i>K</i><sub>i</sub> = 48 Â± 4 nM, EC<sub>50</sub> = 290 Â± 110 nM.<i><sup>b</sup></i><sup></sup>âIntrinsic activity for all compounds = 1 as compared to serotonin at 3 Î¼M unless noted in parentheses.</p></div></div></div><div class="NLM_p">Due to the desirable combination of potency and selectivity imparted by the trifluoromethyl group, investigation of the 7,9-disubstituted pyrazinoisoindolone analogs focused on compounds with this moiety at C7 (Table 4<a class="ref showTableEvent internalNav" data-ID="jm0612968t00004" href="#jm0612968t00004"></a>). Diversification of C9 with a wide variety of functional groups was investigated. A number of these groups, such as halogens (<b>52</b>) and polar functionalities (<b>53</b>, <b>54</b>), dramatically decreased binding potency compared to <b>29</b>. Methoxy and ethoxy analogs <b>55</b> and <b>56</b>, respectively, did afford a comparative improvement in both binding and functional potency at 5-HT<sub>2C</sub>, but neither compound met our criteria for 5-HT<sub>2C</sub> potency. However, a simple methyl group at C9 provided a very potent 5-HT<sub>2C</sub> agonist that was 27- and 47-fold functionally selective over 5-HT<sub>2A</sub> and 5-HT<sub>2B,</sub><a name="jm005000601369" id="jm005000601369"></a> respectively. Encouraged by this result, we increased the steric bulk of the alkyl chain at C9. The structureâactivity relationship was extremely narrow with respect to 5-HT<sub>2C</sub> potency and selectivity over 5-HT<sub>2B</sub> and 5-HT<sub>2A</sub>. Increasing the size of the C9 substituent resulted in a decease in 5-HT<sub>2C</sub> potency; the propyl <b>59</b>, butyl <b>60</b>, and isopropyl <b>61</b> compounds no longer exhibited robust 5-HT<sub>2C</sub> functional efficacy but in turn had excellent functional selectivity. In contrast, the ethyl substituent (<b>58</b>) provided the desired 5-HT<sub>2C</sub> binding and functional potency and was >300-fold functionally selective over 5-HT<sub>2B</sub> and 73-fold selective over 5-HT<sub>2A</sub>. Interestingly, <b>58</b> was also the first compound from the series that exhibited partial agonism at both 5-HT<sub>2B</sub> and 5-HT<sub>2A</sub>. To further optimize the potency and selectivity of this molecule, the steric size of the ethyl group was attenuated by replacement with a vinyl (<b>62</b>) or an acetylene (<b>63</b>) functionality, but these substitutions only reduced 5-HT<sub>2C</sub> potency. Cyclopropyl <b>64</b> and 1-methylcyclopropyl <b>65</b> were also investigated and had good 5-HT<sub>2C</sub> potency and selectivity profiles. While <b>58</b>, <b>64</b>, and <b>65</b> were viable candidates for in vivo experiments, we opted to focus on <b>58</b> due to its better overall potency profile. <div class="NLM_table-wrap" id="jm0612968t00004"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 4.â In Vitro Activity of 7,9-Disubstituted Phenyl Analogs<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-6/jm0612968/production/images/medium/jm0612968u00004a.gif" alt="" id="_i15" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">Â </td><td class="colsep2 rowsep2">R9</td><td class="colsep2 rowsep2">5-HT<sub>2C</sub><i>K</i><sub>i</sub>,ânM<i><sup>a</sup></i><sup></sup></td><td class="colsep2 rowsep2">5-HT<sub>2B</sub><i>K</i><sub>i</sub>,ânM<i><sup>a</sup></i><sup></sup></td><td class="colsep2 rowsep2">5-HT<sub>2A</sub><i>K</i><sub>i</sub>,ânM<i><sup>a</sup></i><sup></sup></td><td class="colsep2 rowsep2">5-HT<sub>2C</sub> EC<sub>50</sub>,ânM<i><sup>a</sup></i><sup>,</sup><i><sup>b</sup></i><sup></sup></td><td class="colsep2 rowsep2">5-HT<sub>2B</sub> EC<sub>50</sub>,ânM<i><sup>a</sup></i><sup>,</sup><i><sup>b</sup></i><sup></sup></td><td class="colsep2 rowsep2">5-HT<sub>2A</sub> EC<sub>50</sub>,ânM<i><sup>a</sup></i><sup>,</sup><i><sup>b</sup></i><sup></sup></td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>52</b></td><td class="colsep2 rowsep2">Cl </td><td class="colsep2 rowsep2">900âÂ±â260 </td><td class="colsep2 rowsep2">>10000 </td><td class="colsep2 rowsep2">1040âÂ±â120 </td><td class="colsep2 rowsep2">NT </td><td class="colsep2 rowsep2">NT </td><td class="colsep2 rowsep2">NT </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>53</b></td><td class="colsep2 rowsep2">Ac </td><td class="colsep2 rowsep2">1610âÂ±â27 </td><td class="colsep2 rowsep2">>10000 </td><td class="colsep2 rowsep2">5200âÂ±â800 </td><td class="colsep2 rowsep2">NT </td><td class="colsep2 rowsep2">NT </td><td class="colsep2 rowsep2">NT </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>54</b></td><td class="colsep2 rowsep2">CH<sub>2</sub>OH </td><td class="colsep2 rowsep2">460âÂ±â210 </td><td class="colsep2 rowsep2">470âÂ±â290 </td><td class="colsep2 rowsep2">3050âÂ±â890 </td><td class="colsep2 rowsep2">NT </td><td class="colsep2 rowsep2">NT </td><td class="colsep2 rowsep2">NT </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>55</b></td><td class="colsep2 rowsep2">OMe </td><td class="colsep2 rowsep2">40âÂ±â4 </td><td class="colsep2 rowsep2">1090âÂ±â220 </td><td class="colsep2 rowsep2">1400âÂ±â170 </td><td class="colsep2 rowsep2">11âÂ±â2 </td><td class="colsep2 rowsep2">175âÂ±â27 </td><td class="colsep2 rowsep2">289âÂ±â22 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>56</b></td><td class="colsep2 rowsep2">OEt </td><td class="colsep2 rowsep2">158âÂ±â51 </td><td class="colsep2 rowsep2">1300âÂ±â460 </td><td class="colsep2 rowsep2">3820âÂ±â59 </td><td class="colsep2 rowsep2">63âÂ±â10 </td><td class="colsep2 rowsep2">>10000 </td><td class="colsep2 rowsep2">>10000 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>57</b></td><td class="colsep2 rowsep2">Me </td><td class="colsep2 rowsep2">9âÂ±â3 </td><td class="colsep2 rowsep2">336âÂ±â85 </td><td class="colsep2 rowsep2">560âÂ±â130 </td><td class="colsep2 rowsep2">6âÂ±â4 </td><td class="colsep2 rowsep2">282âÂ±â62 </td><td class="colsep2 rowsep2">167âÂ±â41 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>58</b></td><td class="colsep2 rowsep2">Et </td><td class="colsep2 rowsep2">20âÂ±â6 </td><td class="colsep2 rowsep2">153âÂ±â42 </td><td class="colsep2 rowsep2">431âÂ±â41 </td><td class="colsep2 rowsep2">16âÂ±â4 </td><td class="colsep2 rowsep2">4926âÂ±â498â(0.5) </td><td class="colsep2 rowsep2">1170âÂ±â200â(0.5) </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>59</b></td><td class="colsep2 rowsep2">Pr </td><td class="colsep2 rowsep2">48âÂ±â1 </td><td class="colsep2 rowsep2">380âÂ±â130 </td><td class="colsep2 rowsep2">1070âÂ±â130 </td><td class="colsep2 rowsep2">94âÂ±â4 </td><td class="colsep2 rowsep2">>10000 </td><td class="colsep2 rowsep2">>10000 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>60</b></td><td class="colsep2 rowsep2">Bu </td><td class="colsep2 rowsep2">57âÂ±â13 </td><td class="colsep2 rowsep2">220âÂ±â120 </td><td class="colsep2 rowsep2">627âÂ±â66 </td><td class="colsep2 rowsep2">363âÂ±â13 </td><td class="colsep2 rowsep2">>10000 </td><td class="colsep2 rowsep2">>10000 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>61</b></td><td class="colsep2 rowsep2"><i>i</i>-Pr </td><td class="colsep2 rowsep2">51âÂ±â9 </td><td class="colsep2 rowsep2">190âÂ±â100 </td><td class="colsep2 rowsep2">2620âÂ±â410 </td><td class="colsep2 rowsep2">72âÂ±â28 </td><td class="colsep2 rowsep2">>10000 </td><td class="colsep2 rowsep2">>10000 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>62</b></td><td class="colsep2 rowsep2">CH<sub>2</sub>CH </td><td class="colsep2 rowsep2">43âÂ±â16 </td><td class="colsep2 rowsep2">648âÂ±â270 </td><td class="colsep2 rowsep2">829âÂ±â52 </td><td class="colsep2 rowsep2">43âÂ±â21 </td><td class="colsep2 rowsep2">1610âÂ±â520 </td><td class="colsep2 rowsep2">1620âÂ±â83 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>63</b></td><td class="colsep2 rowsep2">HCC </td><td class="colsep2 rowsep2">332âÂ±â61 </td><td class="colsep2 rowsep2">2099âÂ±â710 </td><td class="colsep2 rowsep2">6560âÂ±â200 </td><td class="colsep2 rowsep2">NT </td><td class="colsep2 rowsep2">NT </td><td class="colsep2 rowsep2">NT </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>64</b></td><td class="colsep2 rowsep2"><i>c</i>-Pr </td><td class="colsep2 rowsep2">35âÂ±â3 </td><td class="colsep2 rowsep2">209âÂ±â84 </td><td class="colsep2 rowsep2">579âÂ±â94 </td><td class="colsep2 rowsep2">14âÂ±â6 </td><td class="colsep2 rowsep2">2980âÂ±â260 </td><td class="colsep2 rowsep2">513âÂ±â240 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>65</b></td><td class="colsep2 rowsep2">1-Me-<i>c</i>-Pr </td><td class="colsep2 rowsep2">34âÂ±â3 </td><td class="colsep2 rowsep2">29âÂ±â7 </td><td class="colsep2 rowsep2">2310âÂ±â89 </td><td class="colsep2 rowsep2">54âÂ±â17 </td><td class="colsep2 rowsep2">>10000 </td><td class="colsep2 rowsep2">>10000</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup>â<i>K</i><sub>i</sub> and EC<sub>50</sub> values were calculated from doseâresponse curves. Positive control was mCPP which gave 5-HT<sub>2C</sub><i>K</i><sub>i</sub> = 17 Â± 2 nM, EC<sub>50</sub> = 15 Â± 4 nM; 5-HT<sub>2B</sub><i>K</i><sub>i</sub> = 24 Â± 1 nM, EC<sub>50</sub> = 287 Â± 94 nM; 5-HT<sub>2A</sub><i>K</i><sub>i</sub> = 48 Â± 4 nM, EC<sub>50</sub> = 290 Â± 110 nM.<i><sup>b</sup></i><sup></sup>âIntrinsic activity for all compounds = 1 as compared to serotonin at 3 Î¼M unless noted in parentheses.</p></div></div></div><div class="NLM_p"><b>Pharmacokinetics and Metabolism of 58.</b> A summary of the pharmacokinetic characteristics of <b>58</b> are detailed in Table 5<a class="ref showTableEvent internalNav" data-ID="jm0612968t00005" href="#jm0612968t00005"></a>. In SpragueâDawley rats, <b>58</b> had a moderate systemic clearance with a relatively high volume of distribution and a brain-to-plasma concentration ratio slightly above 1 when measured at 2, 4, 8, and 24 h postdose. The absorption parameters were excellent, with a high Caco-2 value, rapid absorption in vivo<i>,</i> as seen by the short <i>T</i><sub>max</sub>, and good oral bioavailability. Free fraction in rat and human serum was 17%. Compound <b>58</b> modestly inhibited the cytochrome P-450 3A4 isoform with an IC<sub>50</sub> of 8.7 Î¼M, while all other isoforms tested had IC<sub>50</sub>s over 40 Î¼M. <div class="NLM_table-wrap" id="jm0612968t00005"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 5.â Single Dose Plasma Pharmacokinetic Parameters of <b>58</b> in Male SpragueâDawley Rats</p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">doseâiv/poâ(mg/kg)</td><td class="colsep2 rowsep2">4.4/8.8 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">poâ<i>T</i><sub>max</sub>â(h) </td><td class="colsep2 rowsep2">0.7âÂ±â0.3 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">poâ<i>C</i><sub>max</sub>â(nM) </td><td class="colsep2 rowsep2">4050âÂ±â910 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">poâ<i>T</i><sub>1/2</sub>â(h) </td><td class="colsep2 rowsep2">1.6âÂ±â0.2 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">poâAUC<sub>tot</sub>â(nM*h) </td><td class="colsep2 rowsep2">11000âÂ±â1100 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">poâ<i>F</i>% </td><td class="colsep2 rowsep2">77 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">ivâClâ(mL/min/kg) </td><td class="colsep2 rowsep2">37.4âÂ±â6.9 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">ivâ<i>V</i><sub>ss</sub>â(L/kg) </td><td class="colsep2 rowsep2">4.8âÂ±â0.6 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">Caco-2â(nm/s) </td><td class="colsep2 rowsep2">212 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">proteinâbindingâ(%âbound) </td><td class="colsep2 rowsep2">83</td></tr></tbody></table></div></div></div><div class="NLM_p"><b>In Vivo Pharmacology.</b> The in vivo efficacy of <b>58</b> was tested in an acute food intake model in SpragueâDawley rats (Figure 2<a data-tab="pane-pcw-Figures" href="#jm0612968f00002" id="" class=" internalNav"></a>). In this 20 h operant feeding model, 250 g rats were dosed orally with compound 1 h prior to onset of the dark cycle and food availability. Compound <b>58</b> caused a dose-dependent reduction in food pellet consumption, with a statistically significant 32% reduction at 10 mg/kg and 41% at 30 mg/kg. During the experiment, water consumption and locomotor activity were within normal ranges and no overt physical or behavior abnormalities were observed. A reversal experiment was conducted to confirm that the observed food intake reduction was mediated by the 5-HT<sub>2C</sub> receptor (Figure 3<a data-tab="pane-pcw-Figures" href="#jm0612968f00003" id="" class=" internalNav"></a>). In the same operant feeding model, <b>58</b> was coadminstered with SB-243213, a selective 5-HT<sub>2C</sub> antagonist.<sup><a onclick="showRef(event, 'jm0612968b00016'); return false;" href="javascript:void(0);" class="ref jm0612968b00016">16</a></sup> The 5-HT<sub>2C</sub> antagonist caused a complete reversal in the food intake in a dose-dependent manner, indicating that 5-HT<sub>2C</sub> receptor activation was the mechanism that mediated food reduction by <b>58</b>. <div id="_i16"><figure id="jm0612968f00002" data-index="5" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-6/jm0612968/production/images/medium/jm0612968f00002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-6/jm0612968/production/images/large/jm0612968f00002.jpeg" id="_i17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 2 20-h rat operant feeding model with compound <b>58</b>. Values indicate percent reduction in consumed pellets from vehicle dosed animals.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-6/jm0612968/production/images/large/jm0612968f00002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0612968&amp;id=jm0612968f00002"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="jm0612968f00003" data-index="6" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-6/jm0612968/production/images/medium/jm0612968f00003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-6/jm0612968/production/images/large/jm0612968f00003.jpeg" id="_i18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 3 Antagonist reversal in the 20-h rat operant feeding model. </p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-6/jm0612968/production/images/large/jm0612968f00003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0612968&amp;id=jm0612968f00003"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">The ability of <b>58</b> to cause body weight reduction was tested by subchronic administration to lean SpragueâDawley rats fed <a name="jm005000601370" id="jm005000601370"></a> ad libitum on a choice diet consisting of standard rat chow and a highly palatable high fat chow (Figure 4<a data-tab="pane-pcw-Figures" href="#jm0612968f00004" id="" class=" internalNav"></a>). The compound was administered orally once daily 1 h prior to onset of the dark cycle for 4 days. Compound <b>58</b> reduced the body weight increase of the rats in a dose-dependent manner with a statistically significant reduction seen as early as day 2 at the 30 mg/kg dose. The overall reduction in body weight over control at day 4 at 30 mg/kg was 6%. <div id="_i19"><figure id="jm0612968f00004" data-index="7" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-6/jm0612968/production/images/medium/jm0612968f00004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-6/jm0612968/production/images/large/jm0612968f00004.jpeg" id="_i20" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 4 4-Day rat weight loss model with compound <b>58</b>. Values indicate percent reduction in weight gain from vehicle dosed animals. </p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-6/jm0612968/production/images/large/jm0612968f00004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0612968&amp;id=jm0612968f00004"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p last">The compelling results from the feeding models encouraged us to evaluate compound <b>58</b> for gastric parietal cell necrosis to determine if this previously observed toxicity had been circumvented. Compound <b>58</b> was dosed orally to mice at doses up to 300 mg/kg. After 24 h the stomachs were evaluated for lesions by histopathological analysis, and no effects were observed. </div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51770" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51770" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Pyrazinoisoindolones were identified as a new class of 5-HT<sub>2C</sub> agonists for the treatment of obesity. SAR studies found that 7,9-disubstitution of the aromatic ring presented the best balance between potency and selectivity, especially over 5-HT<sub>2B</sub>. After surveying a wide variety of functional groups at both positions, <b>58</b> proved to have the best overall characteristics for advancement. In an acute feeding model, oral dosing of the compound produced a statistically significant reduction in food intake in a dose-dependent manner. The effect was reversed with a selective 5-HT<sub>2C</sub> antagonist, indicating a 5-HT<sub>2C</sub> mechanism-based reduction in food intake. In a 4-day model, oral dosing of <b>58</b> caused a robust reduction in body weight gain by young rats, and no overt physical or behavioral abnormalities were seen in any of the in vivo models. On the basis of its efficacy and selectivity profile, compound <b>58</b> was selected for further evaluation for the treatment of obesity, the results of which will be disclosed in the future. </div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04034" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04034" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p"><b>Chemistry.</b> All nonaqueous reactions were carried out under an argon or nitrogen atmosphere at room temperature, unless otherwise noted. All reagents and solvents were purchased from commercial sources and were used without further purification or distillation, unless otherwise stated. Analytical thin-layer chromatography (TLC) was performed on EM Science silica gel 60 F<sub>254</sub> (0.25 mm). Compounds were visualized by UV light and/or stained with either iodine or cerium molybdate followed by heating. Flash column chromatography was performed on EM Science silica gel 60 (particle size of 40â63 Î¼m). Radial chromatography was performed on a Harrison Research Chromatotron. Radial silica gel plates of 1, 2, 4, or 8 mm thickness were obtained from Analtech Research. Analytical high-pressure liquid chromatography (HPLC) and LC-MS analyses were conducted using Shimadzu LC-10AS pumps and a SPD-10AV UVâvis detector set at 220 nm with the MS detection performed with a Micromass Platform LC spectrometer. NMR (<sup>1</sup>H and <sup>13</sup>C) spectra were recorded on JEOL 400 MHz spectrometer and calibrated using an internal reference. Elemental analyses were performed by Robertson Microlit Laboratories, and the results obtained are within Â±0.4% of the theoretical values. </div><div class="NLM_p"><b>General Procedure A for the Synthesis of Pyrazino[2,1-</b><b><i>a</i></b><b>]isoindol-6(2</b><b><i>H</i></b><b>)-ones. Preparation </b><b>of (</b>Â±<b>)-1,3,4,10b-Tetrahydro-7-trifluoromethylpyrazino[2,1-</b><b><i>a</i></b><b>]isoindol-6(2</b><b><i>H</i></b><b>)-one </b><b>Hydrochloric Acid Salt (20). Step A.</b> To a stirring solution of 2-trifluoromethylbenzoic acid (3.6 g, 18.9 mmol) in dry CH<sub>2</sub>Cl<sub>2</sub> (150 mL) with DMF (0.5 mL) was added a 2 M solution of oxalyl chloride in CH<sub>2</sub>Cl<sub>2</sub> (17.5 mL) dropwise over 30 min. The reaction was stirred for 2 h and then concentrated <i>in vacuo</i> to a white solid. The solid was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (150 mL), and diethylamine (3.2 g, 43.8 mmol) was added. The reaction was stirred for 16 h and then concentrated <i>in vacuo</i> to a yellow solid. The solid was purified by radial chromatography (SiO<sub>2</sub>, 1:5, EtOAc:hexanes) to yield 4.3 g (93%) of <i>N,N</i>-diethyl-2-trifluoromethylbenzamide as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.68 (d, <i>J</i> = 7.9 Hz, 1 H), 7.57 (t, <i>J</i> = 7.5 Hz, 1 H), 7.48 (t, <i>J</i> = 7.7 Hz, 1 H), 7.32 (d, <i>J</i> = 7.5 Hz, 1 H), 3.81â3.90 (m, 1 H), 3.21â3.30 (m, 1 H), 3.07 (ddd, <i>J</i> = 19.0, 14.2, 7.3 Hz, 2 H), 1.22 (t, <i>J</i> = 7.3 Hz, 3 H), 1.03 (t, <i>J</i> = 7.0 Hz, 3 H). MS (ESI) 246.2 (M + H). </div><div class="NLM_p"><b>Step B.</b> To a stirring solution of <i>N,N</i>-diethyl-2-trifluoromethylbenzamide (2260 mg, 9.2 mmol) and <i>N,N,N</i><i>â</i>,Nâ-tetramethylethylenediamine (1410 mg) in dry THF (20 mL) at â78 Â°C was added 0.93 M <i>sec</i>-butyllithium in hexanes (10.2 mL) dropwise. The reaction was stirred for 30 min and then DMF (2.0 mL) was added. The reaction was stirred for 1 h and then quenched with 1 M HCl (15 mL). The reaction was extracted with EtOAc (3 Ã 15 mL). The organic layers were combined, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated <i>in vacuo</i> to a yellow oil. The oil was purified by radial chromatography (SiO<sub>2</sub>, 1:4, EtOAc:hexanes) to yield 2213 mg (88%) of <i>N,N</i>-diethyl-2-carboxaldehyde-6-trifluoromethylbenzamide as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 10.06 (s, 1 H), 8.16 (d, <i>J</i> = 7.9 Hz, 1 H), 7.92 (d, <i>J</i> = 7.9 Hz, 1 H), 7.66 (t, <i>J</i> = 7.9 Hz, 1 H), 3.85 (dq, <i>J</i> = 7.0, 6.9 Hz, 1 H), 3.43 (dq, <i>J</i> = 7.0, 6.9 Hz, 1 H), 3.02â3.13 (m, 2 H), 1.28 (t, <i>J</i> = 7.0 Hz, 3 H), 1.01 (t, <i>J</i> = 7.3 Hz, 3 H). MS (ESI) 274.2 (M + H). </div><div class="NLM_p"><b>Step C.</b> A stirring solution of <i>N,N</i>-diethyl-2-carboxaldehyde-6-trifluoromethylbenzamide (1378 mg, 5.3 mmol) in 6 M HCl (70 mL) was heated to 100 Â°C and stirred for 12 h. The reaction was cooled to room temperature and extracted with EtOAc (3 Ã 70 mL). The organic layers were combined, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated <i>in vacuo</i> to a brown oil. The oil was purified by flash column chromatography (SiO<sub>2</sub>, 20â50% EtOAc in hexanes) to provide 3-hydroxy-7-trifluoromethyl-3<i>H</i>-isobenzofuran-1-one as an off-white solid (1365 mg, 99%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.88â7.93 (m, 1 H), 7.84â7.87 (m, 2 H), 6.64 (s, 1 H), 3.97 (s, 1 H). MS (ESI) 201.2 (M â OH). </div><div class="NLM_p"><b>Step D</b>. The 3-hydroxy-7-trifluoromethyl-3<i>H</i>-isobenzofuran-1-one (1365 mg, 5.0 mmol) from Step C was added to a stirring <a name="jm005000601371" id="jm005000601371"></a> solution of 1-(benzyloxycarbonylamino)-2-aminoethane hydrochloride (1156 mg, 5.0 mmol) and sodium acetate (411 mg, 5.0 mmol) in ethanol (13.5 mL) and acetic acid (6.5 mL), followed by sodium cyanide (245 mg, 5.0 mmol). The reaction was stirred overnight and then concentrated <i>in vacuo</i> to a yellow solid. The solid was partitioned between water (10 mL) and EtOAc (10 mL). The organic layer was separated and the aqueous layer was extracted with EtOAc (3 Ã 10 mL). The organic layers were combined, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated <i>in vacuo</i> to a yellow oil. The oil was purified by radial chromatography (SiO<sub>2</sub>, 1:3, EtOAc:hexanes) to yield 1331 mg (66%) of (Â±)-2-[2-[(benzyloxycarbonyl)amino]ethyl]-1-carbonitrile-1,3-dihydro-4-trifluoromethyl-isoindol-3(1<i>H</i>)-one as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.89 (d, <i>J</i> = 7.5 Hz, 1 H), 7.77â7.85 (m, 2 H), 7.16â7.24 (m, 5 H), 5.76 (s, 1 H), 5.09 (s, 1 H), 4.89 (s, 2 H), 4.25 (ddd, <i>J</i> = 14.6, 10.4, 3.9 Hz, 1 H), 3.70â3.81 (m, 1 H) 3.47(dt, <i>J</i> = 14.5, 3.5 Hz, 1 H), 3.33â3.42 (m, 1 H). MS (ESI) 404.3 (M + H). </div><div class="NLM_p"><b>Step E.</b> A stirring solution of (Â±)-2-[2-[(benzyloxycarbonyl)amino]ethyl]-1-carbonitrile-1,3-dihydro-4-trifluoromethylisoindol-3(1<i>H</i>)-one (1331 mg, 3.3 mmol) and 10% palladium on carbon (440 mg) in EtOH (9 mL) and HCl (1 mL) was placed under 80 psi of hydrogen. The reaction was stirred for 96 h. The reaction was filtered and the filtrate was concentrated <i>in vacuo</i> to yield a white solid. The solid was partioned between 1 M aq NaOH (10 mL) and EtOAc (10 mL). The organic layer was separated and the aqueous layer was extracted with EtOAc (3 Ã 10 mL). The organic layers were combined, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated <i>in vacuo</i> to a pale yellow oil. The oil was purified by radial chromatography (SiO<sub>2</sub>, 98:2, CH<sub>2</sub>Cl<sub>2</sub>:MeOH with NH<sub>4</sub>OH) to yield 432 mg of the product as a colorless oil. The oil was treated with 1.0 N HCl in ether, dried <i>in vacuo</i>, and lyophilized from water to give <b>20</b> as a white solid (493 mg, 51%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´ 7.90â7.97 (m, 2 H), 7.85 (t, <i>J</i> = 7.5 Hz, 1 H), 4.92 (dd, <i>J</i> = 12.1, 4.2 Hz, 1 H), 4.52â4.60 (m, 1 H), 4.11â4.15 (m, 1H), 3.46â3.57 (m, 2H), 3.01â3.12 (m, 1 H), 2.83 (t, <i>J</i> = 12.1 Hz, 1 H). MS (ESI) 257.3 (M â Cl). Anal. (C<sub>12</sub>H<sub>11</sub>F<sub>3</sub>N<sub>2</sub>OÂ·HClÂ·1.3H<sub>2</sub>O), C, H, N. </div><div class="NLM_p"><b>(</b>Â±<b>)-7-Methoxy-1,3,4,10b-tetrahydropyrazino[2,1-</b><b><i>a</i></b><b>]isoindol-6(2</b><b><i>H</i></b><b>)-one Hydrochloric Acid </b><b>Salt (21).</b> Prepared according to General Procedure A with substitution of 2-methoxybenzoic acid for 2-trifluoromethoxybenzoic acid at Step A. <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) Î´ 7.57 (t, <i>J</i> = 7.9 Hz, 1 H), 7.11 (d, <i>J</i> = 7.5 Hz, 1 H), 7.05 (d, <i>J</i> = 8.4 Hz, 1 H), 4.76â4.79 (m, 1 H), 4.38 (dd, <i>J</i> = 14.7, 4.2 Hz, 1 H), 4.01 (dd, <i>J</i> = 12.7, 3.9 Hz, 1 H), 3.85 (s, 3 H), 3.54 (dd, <i>J</i> = 12.7, 3.5 Hz, 1 H), 3.40â3.49 (m, 1 H), 3.01 (dt, <i>J</i> = 12.6, 4.6 Hz, 1 H), 2.74 (t, <i>J</i> = 12.30 Hz, 1 H). MS (ESI) 219.3 (M â Cl). Anal. (C<sub>12</sub>H<sub>14</sub>N<sub>2</sub>O<sub>2</sub>Â·HClÂ·0.4H<sub>2</sub>O), C, H, N. </div><div class="NLM_p"><b>(</b>Â±<b>)-1,3,4,10b-Tetrahydro-7-trifluoromethoxypyrazino[2,1-</b><b><i>a</i></b><b>]isoindol-6(2</b><b><i>H</i></b><b>)-one (22)</b>. Prepared according to General Procedure A with substitution of 2-trifluoromethoxybenzoic acid for 2-trifluoromethylbenzoic acid at Step A. This sample was not treated with 1.0 N HCl or lyophilized from water. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´ 7.46 (t, <i>J</i> = 7.9 Hz, 1 H), 7.26 (d, <i>J</i> = 7.5 Hz, 1 H), 7.18â7.23 (m, 1 H), 4.33 (dd, <i>J</i> = 10.8, 4.2 Hz, 1 H), 4.25â4.30 (m, 1 H), 3.53 (dd, <i>J</i> = 12.1, 4.2 Hz, 1 H), 2.99â3.08 (m, 2 H), 2.47â2.56 (m, 1 H), 2.22 (t, <i>J</i> = 11.4 Hz, 1 H). MS (ESI) 273 (M + H). Anal. (C<sub>12</sub>H<sub>11</sub>F<sub>3</sub>N<sub>2</sub>O<sub>2</sub> Â· 0.35 CH<sub>2</sub>Cl<sub>2</sub>), C, H, N. </div><div class="NLM_p"><b>(</b>Â±<b>)-7-Fluoro-1,3,4,10b-tetrahydropyrazino[2,1-</b><b><i>a</i></b><b>]isoindol-6(2</b><b><i>H</i></b><b>)-one Trifluoroacetic Acid </b><b>Salt (23).</b> Prepared according to General Procedure A with substitution of 2-fluorobenzoic acid for 2-trifluoromethylbenzoic acid at Step A. Final purification was accomplished by reverse phase high performance liquid chromatography (C<sub>18</sub>, 20â100% CH<sub>3</sub>CN/H<sub>2</sub>O w/0.05% TFA). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>CN) Î´ 7.63 (dt, <i>J</i> = 7.9, 4.8 Hz, 1 H) 7.41 (d, <i>J</i> = 7.5 Hz, 1 H) 7.22 (t, <i>J</i> = 9.0 Hz, 1 H) 4.98 (dd, <i>J</i> = 11.7, 3.7 Hz, 1 H) 4.34â4.41 (m, 1 H) 3.98 (dd, <i>J</i> = 12.3, 3.9 Hz, 1 H) 3.45â3.56 (m, 2 H) 2.87â2.96 (m, 1 H) 2.66 (t, <i>J</i> = 12.1 Hz, 1 H). MS (ESI) 207.2 (M â CF<sub>3</sub>CO<sub>2</sub>). Anal. (C<sub>11</sub>H<sub>11</sub>FN<sub>2</sub>OÂ·2.2C<sub>2</sub>HF<sub>3</sub>O<sub>2</sub>Â·0.5CH<sub>3</sub>CN), C, H, N. </div><div class="NLM_p"><b>General Procedure B for the Synthesis of Pyrazino[2,1-</b><b><i>a</i></b><b>]isoindol-6(2</b><b><i>H</i></b><b>)-one Hydrochloric </b><b>Acid Salts. Preparation of </b><b>(</b>Â±<b>)-7-Chloro-1,3,4,10b-tetrahydropyrazino[2,1-</b><b><i>a</i></b><b>]isoindol-6(2</b><b><i>H</i></b><b>)-one Hydrochloric Acid Salt </b><b>(24).</b><b>Step A.</b> To (Â±)-1-carbonitrile-2-(2,2-diethoxyethyl)-1,3-dihydro-4-chloro-isoindol-3(1<i>H</i>)-one (1.0 g, 3.25 mmol) [prepared according to General Procedure A, Steps AâD, using aminoacetaldehyde diethyl acetal] in ethanol (30 mL) was added Raney 2400 Nickel (1 mL; slurry in water). The mixture was degassed and the reaction vessel was fitted with a hydrogen balloon. After 4 h, the mixture was filtered (with a water wash), concentrated <i>in vacuo</i>, and purified by radial chromatography (SiO<sub>2</sub>, 2% ammonium hydroxide in 4% methanol in dichloromethane) to give (Â±)-1-(aminomethyl)-2-(2,2-diethoxyethyl)-1,3-dihydro-4-chloroisoindol-3(1<i>H</i>)-one as a yellow oil (640 mg, 63%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) 7.47 (t, <i>J</i> = 7.5 Hz, 1 H), 7.40 (d, <i>J</i> = 7.9 Hz, 1 H), 7.34 (d, <i>J</i> = 7.5 Hz, 1 H), 4.81 (t, <i>J</i> = 5.1 Hz, 1 H), 4.63â4.68 (m, 1 H), 3.90 (dd, <i>J</i> = 14.3, 4.6 Hz, 1 H), 3.71â3.81 (m, 2 H), 3.51â3.63 (m, 2 H), 3.31â3.38 (m, 2 H), 3.15â3.21 (m, 1 H), 1.22 (t, <i>J</i> = 7.0 Hz, 3 H), 1.17 (t, <i>J</i> = 7.0 Hz, 3 H). MS (ESI) 267.3, 269.2 (M + H). </div><div class="NLM_p"><b>Step B.</b> To (Â±)-1-(aminomethyl)-2-(2,2-diethoxyethyl)-1,3-dihydro-4-chloroisoindol-3(1<i>H</i>)-one (200 mg, 0.65 mmol) was added concentrated aqueous HCl (5 mL, 12N). The resulting mixture was stirred for 30 min before being concentrated <i>in vacuo</i>. The resulting residue was concentrated from toluene and treated with 1,2-dichloroethane (5 mL). To this yellow mixture were added sodium triacetoxyborohydride (270 mg, 1.3 mmol) and methanol (0.5 mL), and the resulting mixture was stirred for 1 h before being quenched with aqueous HCl (5 mL, 1N). The mixture was then basified with sodium carbonate, diluted with EtOAc (6 mL), and treated with excess di-<i>tert</i>-butyl dicarbonate (400 mg). After 1 h, the reaction was extracted with EtOAc (Ã3). The combined organic layers were dried over sodium sulfate, filtered, and concentrated <i>in vacuo</i>. The resulting yellow residue was purified by radial chromatography (SiO<sub>2</sub>, 30â50% EtOAc in hexanes) to give (Â±)-<i>N</i>-(<i>tert</i>-butoxycarbonyl)-7-chloro-1,3,4,10b-tetrahydropyrazino[2,1-<i>a</i>]isoindol-6(2<i>H</i>)-one as a white solid (87 mg, 63%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.40â7.48 (m, 2 H), 7.33 (d, <i>J</i> = 7.0 Hz, 1 H), 4.72 (s, 1 H), 4.34â4.42 (m, 2 H), 4.17 (s, 1 H), 3.07â3.17 (m, 1 H), 2.74 (s, 1 H), 2.32 (s, 1 H), 1.48â1.54 (m, 9 H). MS (ESI) 323.3, 325.3 (M + H). </div><div class="NLM_p"><b>Step C.</b> To (Â±)-<i>N</i>-(<i>tert</i>-butoxycarbonyl)-1,3,4,10b-tetrahydro-7-chloropyrazino[2,1-<i>a</i>]isoindol-6(2<i>H</i>)-one (15 mg, 0.05 mmol) was added concentrated HCl (1 mL). After 15 min, the resulting solution was concentrated <i>in vacuo</i>, diluted with water, and lyophilized to give <b>24</b> as an off-white solid (12 mg, 100%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´ 7.60â7.65 (m, 2 H), 7.51â7.57 (m, 1 H), 4.85â4.88 (m, 1 H), 4.53 (d, <i>J</i> = 14.5 Hz, 1 H), 4.08 (dd, <i>J</i> = 12.1, 3.7 Hz, 1 H), 3.46â3.57 (m, 2 H), 3.00â3.10 (m, 1 H), 2.80 (t, <i>J</i> = 11.9 Hz, 1 H). MS (ESI) 223.2, 225.2 (M â Cl). Anal. (C<sub>11</sub>H<sub>12</sub>Cl<sub>2</sub>N<sub>2</sub>OÂ·1.15HClÂ·0.5H<sub>2</sub>O), C, H, N. </div><div class="NLM_p"><b>(</b>Â±<b>)-7-Methylthio-1,3,4,10b-tetrahydropyrazino[2,1-</b><b><i>a</i></b><b>]isoindol-6(2</b><b><i>H</i></b><b>)-one Hydrochloric Acid </b><b>Salt (26).</b> Prepared according to General Procedure B with the substitution of 2-(methylthio)benzoic acid for 2-chlorobenzoic acid in step A. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´ 7.59 (t, <i>J</i> = 7.5 Hz, 1 H), 7.33â7.40 (m, 2 H), 4.81 (dd, <i>J</i> = 11.9, 3.9 Hz, 1 H), 4.50 (dd, <i>J</i> = 14.5, 3.9 Hz, 1 H), 4.03 (dd, <i>J</i> = 12.1, 3.7 Hz, 1 H), 3.34â3.55 (m, 2 H), 3.41 (d, <i>J</i> = 3.5 Hz, 1 H), 3.02 (dt, <i>J</i> = 12.4, 4.2 Hz, 1 H), 2.76 (t, <i>J</i> = 12.1 Hz, 1 H), 2.50 (s, 3 H). MS (ESI) 235.2 (M â Cl). Anal. (C<sub>12</sub>H<sub>14</sub>N<sub>2</sub>OSÂ·1.7HClÂ·H<sub>2</sub>O), C, H, N. </div><div class="NLM_p"><b>(</b>Â±<b>)-7-Nitrile-1,3,4,10b-tetrahydropyrazino[2,1-</b><b><i>a</i></b><b>]isoindol-6(2</b><b><i>H</i></b><b>)-one Hydrochloric Acid Salt </b><b>(25).</b> To <i>N</i>-(<i>tert</i>-butoxycarbonyl)-(Â±)-7-chloro-1,3,4,10b-tetrahydropyrazino[2,1-<i>a</i>]isoindol-6(2<i>H</i>)-one (25 mg, 0.08 mmol) in a round-bottom flask were added zinc cyanide (5 mg, 0.05 mmol), tris(dibenzylideneacetone)dipalladium(0) (1.4 mg, 0.002 mmol), and 1,1â-bis(diphenylphosphino)ferrocene (1.7 mg, 0.003 mmol). To these reagents was added <i>N</i>, <i>N</i>-dimethylacetamide (1 mL), and the resulting mixture was degassed. The reaction was then subjected to microwave conditions (130 Â°C, 30 min; 300 W). The reaction was then cooled, and additional zinc cyanide (0.05 mmol), tris(dibenzylideneacetone)dipalladium(0) (0.002 mmol), and 1,1â-bis(diphenylphosphino)ferrocene (0.003 <a name="jm005000601372" id="jm005000601372"></a> mmol) were added. The reaction was again subjected to microwave conditions (160 Â°C, 60 min; 300 W). The resulting black mixture was then subjected to microwave conditions for a final time (220 Â°C, 60 min; 300 W) before being cooled and diluted with tetrahydrofuran (2 mL) and treated with excess di-<i>tert</i>-butyl dicarbonate. After 1 h, the reaction was diluted with EtOAc, and the mixture was washed with saturated aq ammonium hydroxide and brine. The organic layer was then dried over sodium sulfate, filtered, and concentrated <i>in vacuo</i>. The resulting residue was purified by radial chromatography (SiO<sub>2</sub>, 30â50% EtOAc in hexanes) to give a clear residue. To the clear residue was added concentrated aqueous HCl (1 mL). After 1 min, the solution was concentrated <i>in vacuo</i>, diluted with water, and lyophilized to yield 25 as a white residue (1.0 mg, 18%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´ 7.98 (t, <i>J</i> = 7.3 Hz, 2 H), 7.85 (t, <i>J</i> = 7.7 Hz, 1 H), 4.90â4.96 (m, 1 H), 4.57 (d, <i>J</i> = 14.5 Hz, 1 H), 4.13 (dd, <i>J</i> = 12.3, 3.5 Hz, 1 H), 3.48â3.60 (m, 2 H), 3.03â3.13 (m, 1 H), 2.85 (t, <i>J</i> = 12.1 Hz, 1 H). MS (ESI) 214.3 (M â Cl). Anal. (C<sub>12</sub>H<sub>11</sub>N<sub>2</sub>O<sub>2</sub>Â·HClÂ·0.5H<sub>2</sub>O), C, H, N. </div><div class="NLM_p"><b>(</b>Â±<b>)-7-Hydroxy-1,3,4,10b-tetrahydropyrazino[2,1-</b><b><i>a</i></b><b>]isoindol-6(2</b><b><i>H</i></b><b>)-one Hydrochloric Acid </b><b>Salt (27). Step A.</b> To a solution of (Â±)-7-methoxy-1,3,4,10b-tetrahydropyrazino[2,1-<i>a</i>]isoindol-6(2<i>H</i>)-one (1.7 g, 0.008 mmol) prepared according General Procedure A (substituting 2-methoxybenzoic acid for 2-trifluoromethylbenzoic acid at Step A) in tetrahydrofuran (20 mL) was added di-<i>tert</i>-butyl dicarbonate (2.5 g, 0.012 mmol). After 2 h, the solution was concentrated and purified by flash column chromatography (SiO<sub>2</sub>, 50â100% EtOAc in hexanes) to give <i>N</i>-(<i>tert</i>-butoxycarbonyl)-(Â±)-7-methoxy-1,3,4,10b-tetrahydropyrazino[2,1-<i>a</i>]isoindol-6(2<i>H</i>)-one as a white solid (2.4 g, quant). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.47 (app. t, <i>J</i> = 8.4, 7.5 Hz, 1H), 7.00 (d, <i>J</i> = 7.5 Hz, 1 H), 6.93 (d, <i>J</i> = 8.4 Hz, 1 H), 4.63â4.74 (m, 1H), 4.32â4.40 (m, 2 H), 4.11 (s, 1 H), 3.96 (s, 3 H), 3.09 (dt, <i>J</i> = 12.6, 3.3 Hz, 1 H), 2.65â2.76 (m, 1 H), 2.31 (s, 1 H), 1.50 (s, 9 H). MS (ESI) 319.3 (M + H). </div><div class="NLM_p"><b>Step B.</b> To a solution of <i>N</i>-(<i>tert</i>-butoxycarbonyl)-(Â±)-7-methoxy-1,3,4,10b-tetrahydropyrazino[2,1-<i>a</i>]isoindol-6(2<i>H</i>)-one (100 mg, 0.31 mmol) in dichloromethane (3 mL) at â78 Â°C was added dropwise boron tribromide (0.79 mL, 0.79 mmol; 1.0 M in CH<sub>2</sub>Cl<sub>2</sub>). After 5 min, the reaction was warmed to 0 Â°C and an additional 0.2 mL of boron tribromide (1.0 M in CH<sub>2</sub>Cl<sub>2</sub>) was added. After 2 h, the yellow mixture was cooled to â78 Â°C and quenched with water. The reaction was warmed to room temperature and stirred for 14 h. The mixture was then concentrated <i>in vacuo</i> and quenched again with aq HCl (3 M), and the resulting yellow solution was concentrated <i>in vacuo</i> to dryness. The residue was diluted with tetrahydrofuran (10 mL) and saturated aqueous sodium bicarbonate (1 mL). Di-<i>tert</i>-butyl dicarbonate (69 mg, 0.31 mmol) was added, and the mixture was stirred for 1 h. The reaction was then diluted with EtOAc, and the layers were separated. The organic layer was then dried over sodium sulfate, fitered, and concentrated <i>in vacuo</i>. The resulting residue was purified by radial chromatography (SiO<sub>2</sub>, 20% EtOAc in hexanes) to give an off-white solid. To the solid was added 12 N aq HCl (1 mL). After 5 min, the solution was concentrated <i>in vacuo</i>, diluted with water, and lyophilized to give <b>27</b> as an off-white solid (8 mg, 42%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´ 7.45â7.51 (m, 1 H), 7.08 (d, <i>J</i> = 7.5 Hz, 1 H), 6.91 (d, <i>J</i> = 8.4 Hz, 1 H), 4.80 (dd, <i>J</i> = 11.9, 3.9 Hz, 1 H), 4.49 (dd, <i>J</i> = 14.3, 4.2 Hz, 1 H), 4.01 (dd, <i>J</i> = 12.3, 3.9 Hz, 1 H), 3.49â3.54 (m, 1 H), 3.40â3.49 (m, 1 H), 3.03 (dt, <i>J</i> = 12.4, 4.2 Hz, 1 H), 2.76 (t, <i>J</i> = 11.9 Hz, 1 H). MS (ESI) 205.2 (M â Cl). Anal. (C<sub>11</sub>H<sub>12</sub>N<sub>2</sub>O<sub>2</sub>Â·HClÂ·1.1H<sub>2</sub>O), C, H, N. </div><div class="NLM_p"><b>(</b>Â±<b>)-7-Isopropoxy-1,3,4,10b-tetrahydropyrazino[2,1-</b><b><i>a</i></b><b>]isoindol-6(2</b><b><i>H</i></b><b>)-one Hydrochloric Acid </b><b>Salt (28).</b> To a stirring solution of <i>N,N</i>-dimethylformamide (1.5 mL), <i>N</i>-(<i>tert</i>-butoxycarbonyl)-(Â±)-7-hydroxy-1,3,4,10b-tetrahydropyrazino[2,1-<i>a</i>]isoindol-6 (2<i>H</i>)-one (25 mg, 0.083 mmol), and anhydrous potassium carbonate (34 mg, 0.25 mmol) was added 2-iodopropane (0.012 mL, 0.125 mmol). The mixture was warmed to 80 Â°C and stirred for 12 h. The reaction was cooled, diluted with EtOAc, and washed with 50% saturated aqueous sodium chloride. The organic layer was then dried over sodium sulfate, filtered, and concentrated <i>in </i><i>vacuo</i>. The resulting residue was purified by radial chromatography (SiO<sub>2</sub>, 30% EtOAc in hexanes) to afford a clear residue. To the residue was added concentrated aqueous HCl (1 mL). After 5 min, the solution was concentrated <i>in vacuo</i>, diluted with water, and lyophilized to give <b>28</b> as a white solid (4 mg, 18%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´ 7.55â7.62 (m, 1 H), 7.12â7.18 (m, 2 H), 4.74â4.84 (m, 2 H), 4.51 (dd, <i>J</i> = 14.5, 3.9 Hz, 1 H), 4.02 (dd, <i>J</i> = 12.3, 3.9 Hz, 1 H), 3.52 (dd, <i>J</i> = 12.5, 3.3 Hz, 1 H), 3.38â3.47 (m, 1 H), 3.01 (dt, <i>J</i> = 12.6, 4.2 Hz, 1 H), 2.69â2.77 (m, 1 H), 1.35â1.41 (m, 6 H). MS (ESI) 247.3 (M â Cl). Anal. (C<sub>14</sub>H<sub>18</sub>N<sub>2</sub>O<sub>2</sub>Â·HClÂ·1.7 H<sub>2</sub>O), C, H, N. </div><div class="NLM_p"><b>General Procedure for the Preparation of Chiral Pyrazino[2,1-</b><b><i>a</i></b><b>]isoindol-6(2</b><b><i>H</i></b><b>)-one </b><b>Hydrochloric Acid Salts. </b><b>(</b><b><i>R</i></b><b>)-1,3,4,10b-Tetrahydro-7-trifluoromethylpyrazino[2,1-</b><b><i>a</i></b><b>]isoindol-6(2</b><b><i>H</i></b><b>)-one Hydrochloric </b><b>Acid Salt (29). Step A.</b> To a stirring solution of (Â±)-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-<i>a</i>]isoindol-6(2<i>H</i>)-one (432 mg, 1.1 mmol) in dry CH<sub>2</sub>Cl<sub>2</sub> (10 mL) was added di-<i>tert</i>-butyl dicarbonate (383 mg, 1.8 mmol). The reaction was stirred for 4 h and then concentrated <i>in vacuo</i> to a white solid. The solid was purified by radial chromatography (SiO<sub>2</sub>, 1:10, EtOAc:hexanes). The compound was then separated by chiral HPLC (Chiracell OD column with 80% heptane with 0.1% diethylamine and 20% 1:1 MeOH:EtOH with 0.1% diethylamine) to yield 181 mg of <i>N</i>-(<i>tert</i>-butoxycarbonyl)-(<i>R</i>)-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-<i>a</i>]isoindol-6(2<i>H</i>)-one and 217 mg of the <i>N</i>-(<i>tert</i>-butoxycarbonyl)-(<i>S</i>)-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-<i>a</i>]isoindol-6(2<i>H</i>)-one as white solids. <i>R</i> enantiomer:â Enantiomeric excess >99:1 based on chiral HPLC. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.77â7.82 (m, 1 H), 7.64â7.68 (m, 2 H), 4.79 (s, 1 H), 4.46 (dd, <i>J</i> = 11.0, 4.4 Hz, 1 H), 4.40 (dd, <i>J</i> = 13.6, 3.5 Hz, 1 H), 4.20 (s, 1 H), 3.11â3.20 (m, 1 H), 2.72â2.84 (m, 1 H), 2.36 (s, 1 H), 1.51 (s, 9 H). MS (ESI) 357.3 (M + H); <i>S</i> enantiomer:â Enantiomeric excess >99:1 based on chiral HPLC. NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.77â7.82 (m, 1 H), 7.64â7.68 (m, 2 H), 4.79 (s, 1 H), 4.46 (dd, <i>J</i> = 11.0, 4.4 Hz, 1 H), 4.40 (dd, <i>J</i> = 13.6, 3.5 Hz, 1 H), 4.20 (s, 1 H), 3.11â3.20 (m, 1 H), 2.72â2.84 (m, 1 H), 2.36 (s, 1 H), 1.51 (s, 9 H). MS (ESI) 357.3 (M + H). </div><div class="NLM_p"><b>Step B.</b> To a stirring solution of <i>N</i>-(<i>tert</i>-butoxycarbonyl)-(<i>R</i>)-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-<i>a</i>]isoindol-6(2<i>H</i>)-one (181 mg, 0.51 mmol) in dry ether (5 mL) was added concentrated HCl (1 mL). The reaction was stirred for 1 h and then concentrated <i>in vacuo</i> to a white solid. The solid was dissolved in water and lyophilized to 147 mg of <b>29</b> a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´ 7.90â7.97 (m, 2 H), 7.85 (t, <i>J</i> = 7.5 Hz, 1 H), 4.92 (dd, <i>J</i> = 12.1, 4.2 Hz, 1 H), 4.52â4.60 (m, 1 H), 4.11â4.15 (m, 1H), 3.46â3.57 (m, 2H), 3.01â3.12 (m, 1 H), 2.83 (t, <i>J</i> = 12.1 Hz, 1 H). MS (ESI) 257.3 (M â Cl). [Î±]<sub>D</sub> â8.4 (0.238 g/dL, MeOH). Anal. (C<sub>12</sub>H<sub>11</sub>F<sub>3</sub>N<sub>2</sub>OÂ·HClÂ·1.4 H<sub>2</sub>O), C, H, N. </div><div class="NLM_p"><b>(</b><b><i>S</i></b><b>)-1,3,4,10b-Tetrahydro-7-trifluoromethylpyrazino[2,1-</b><b><i>a</i></b><b>]isoindol-6(2</b><b><i>H</i></b><b>)-one Hydrochloric </b><b>Acid Salt (30).</b> Prepared according to procedures described for compound <b>29</b> with substitution of <i>N</i>-(<i>tert</i>-butoxycarbonyl)-(<i>S</i>)-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-<i>a</i>]isoindol-6(2<i>H</i>)-one for <i>N</i>-(<i>tert</i>-butoxycarbonyl)-(<i>R</i>)-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-<i>a</i>]isoindol-6(2<i>H</i>)-one at Step B. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´ 7.97 (d, <i>J</i> = 7.9 Hz, 1 H), 7.92 (d, <i>J</i> = 7.5 Hz, 1 H), 7.84 (t, <i>J</i> = 7.5 Hz, 1 H), 4.96 (dd, <i>J</i> = 11.7, 3.7 Hz, 1 H), 4.52â4.59 (m, 1 H), 4.15 (dd, <i>J</i> = 12.1, 3.7 Hz, 1 H), 3.48â3.60 (m, 2 H), 3.02â3.11 (m, 1 H), 2.82 (t, <i>J</i> = 12.1 Hz, 1 H). MS (ESI) 257.3 (M â Cl). [Î±]<sub>D</sub> +8.5 (0.212 g/dL, MeOH). Anal. (C<sub>12</sub>H<sub>11</sub>F<sub>3</sub>N<sub>2</sub>OÂ·HClÂ·H<sub>2</sub>O), C, H, N. </div><div class="NLM_p"><b>(</b>Â±<b>)-2-Methyl-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-</b><b><i>a</i></b><b>]isoindol-6(2</b><b><i>H</i></b><b>)-one (31).</b> To a stirring solution of (Â±)-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-<i>a</i>]isoindol-6(2<i>H</i>)-one (60 mg, 0.23 mmol) in water (1 mL) were added formic acid (0.22 mL, 5.9 mmol) and formaldehyde (190 mg, 2.3 mmol; 37% soln in water). The reaction flask was sealed with a rubber septum (no nitrogen inlet) and warmed to 60 Â°C. After 24 h, the reaction was cooled to room temperature and then diluted with saturated aqueous sodium bicarbonate and extracted with EtOAc (3 Ã 50 mL), and the combined organic layers were dried over sodium <a name="jm005000601373" id="jm005000601373"></a> sulfate, filtered, and concentrated <i>in vacuo</i>. The resulting residue was purified by radial chromatography (SiO<sub>2</sub>, 2% ammonium hydroxide in 8% methanol in dichloromethane) to afford <b>31</b> (33 mg, 52%) as a pale yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.75 (d, <i>J</i> = 6.2 Hz, 1 H) 7.57â7.65 (m, 2 H), 4.54 (dd, <i>J</i> = 11.0, 3.9 Hz, 1 H), 4.37 (dd, <i>J</i> = 13.2, 3.1 Hz, 1 H), 3.36 (dd, <i>J</i> = 10.8, 4.2 Hz, 1 H), 3.25 (dt, <i>J</i> = 12.7, 3.9 Hz, 1 H), 2.87 (dd, <i>J</i> = 11.4, 3.9 Hz, 1 H), 2.38 (s, 3 H), 1.98 (dt, <i>J</i> = 11.9, 4.2 Hz, 1 H), 1.64 (t, <i>J</i> = 10.8 Hz, 1 H). MS (ESI) 271.6 (M + H). Anal. (C<sub>13</sub>H<sub>13</sub>F<sub>3</sub>N<sub>2</sub>OÂ·0.7H<sub>2</sub>O), C, H, N. </div><div class="NLM_p"><b>(</b>Â±<b>)-3,3-Dimethyl-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-</b><b><i>a</i></b><b>]isoindol-6(2</b><b><i>H</i></b><b>)-one </b><b>Hydrochloric Acid Salt (32).</b> Prepared according to General Procedure A with the substitution of 1-amino-2-(benzyloxycarbonylamino)-2-methylpropane hydrochloride<sup><a onclick="showRef(event, 'jm0612968b00017'); return false;" href="javascript:void(0);" class="ref jm0612968b00017">17</a></sup> for 1-(benzyloxycarbonylamino)-2-aminoethane hydrochloride. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.77 (d, <i>J</i> = 6.6 Hz, 1 H), 7.59â7.65 (m, 2 H), 4.34 (dd, <i>J</i> = 10.8, 4.6 Hz, 1 H), 4.15 (d, <i>J</i> = 12.7 Hz, 1 H), 3.45 (dd, <i>J</i> = 12.7, 4.4 Hz, 1 H), 2.85 (d, <i>J</i> = 12.7 Hz, 1 H,) 2.64 (dd, <i>J</i> = 12.7, 11.0 Hz, 1 H), 1.24 (s, 3 H), 1.06 (s, 3 H). MS (ESI) 285 (M + H). Anal. (C<sub>14</sub>H<sub>15</sub>F<sub>3</sub>N<sub>2</sub>O<sub>2</sub>Â·HClÂ·0.7 H<sub>2</sub>O), C, H, N. </div><div class="NLM_p"><b>(3</b><b><i>S</i></b><b>,10b</b><b><i>R</i></b><b>)-3-Methyl-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-</b><b><i>a</i></b><b>]isoindol-6(2</b><b><i>H</i></b><b>)-o</b><b>ne Hydrochloric Acid Salt (33).</b> Prepared according to General Procedure A with the substitution of (<i>S</i>)-1-amino-2-(benzyloxycarbonylamino)propane hydrochloride for 1-(benzyloxycarbonylamino)-2-aminoethane hydrochloride. Separation of the diastereomers was carried out at the last step during purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.74â7.78 (m, 1 H), 7.59â7.64 (m, 2 H), 4.38â4.43 (m, 2 H), 3.63 (dd, <i>J</i> = 11.9, 4.2 Hz, 1 H), 2.67â2.76 (m, 2 H), 2.38 (app t, <i>J</i> = 11.7, 10.6 Hz, 1 H), 1.17 (d, <i>J</i> = 5.9 Hz, 3 H). MS (ESI) 271 (M â Cl). Anal. (C<sub>13</sub>H<sub>13</sub>F<sub>3</sub>N<sub>2</sub>OÂ·HClÂ·3.2H<sub>2</sub>O), C, H, N. </div><div class="NLM_p"><b>(3</b><b><i>R</i></b><b>,10b</b><b><i>R</i></b><b>)-3-Methyl-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-</b><b><i>a</i></b><b>]isoindol-6(2</b><b><i>H</i></b><b>)-o</b><b>ne Hydrochloric Acid Salt (34).</b> Prepared according to General Procedure A with the substitution of (<i>R</i>)-1-amino-2-(benzyloxycarbonylamino)propane hydrochloride for 1-(benzyloxycarbonylamino)-2-aminoethane hydrochloride. Separation of the diastereomers was carried out at the last step during purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.69 (d, <i>J</i> = 6.6, 1 H), 7.52â7.58 (m, 2 H), 4.34 (dd, <i>J</i> = 11.0, 4.4, 1 H), 3.28 â 3.37 (m, 2H), 3.23 (dd, <i>J</i> = 4.4, 13.2 Hz, 1 H), 2.59 (app t, <i>J</i> = 11.0, 12.2 Hz, 1 H), 1.60 (br s, 2H), 1.04 (d, <i>J</i> = 6.6 Hz, 3 H). MS (ESI) 271 (M â Cl). Anal. (C<sub>13</sub>H<sub>13</sub>F<sub>3</sub>N<sub>2</sub>OÂ·HCl), C, H, N. </div><div class="NLM_p"><b>(4</b><b><i>R</i></b><b>,10b</b><b><i>R</i></b><b>)-4-Methyl-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-</b><b><i>a</i></b><b>]isoindol-6(2</b><b><i>H</i></b><b>)-o</b><b>ne Hydrochloric Acid Salt (35).</b> Prepared according to General Procedure A with the substitution of (<i>R</i>)-2-amino-1-(benzyloxycarbonylamino)propane hydrochloride<sup><a onclick="showRef(event, 'jm0612968b00018'); return false;" href="javascript:void(0);" class="ref jm0612968b00018">18</a></sup> for 1-(benzyloxycarbonylamino)-2-aminoethane hydrochloride. Separation of the diastereomers was carried out at the last step during purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 9.88 (s, 1 H), 9.54 (s, 1 H), 8.08 (d, <i>J</i> = 7.5 Hz, 1 H), 7.91 (d, <i>J</i> = 7.9 Hz, 1 H), 7.85 (t, <i>J</i> = 7.7 Hz, 1 H), 4.96 (dd, <i>J</i> = 11.4, 3.9 Hz, 1 H), 4.62â4.69 (m, 1 H), 3.98â4.05 (m, 1 H), 3.31 (d, <i>J</i> = 12.7 Hz, 1 H), 3.04â3.13 (m, 1 H), 2.65â2.76 (m, 1 H), 1.41 (d, <i>J</i> = 7.0 Hz, 3 H). MS (ESI) 271 (M â Cl). (C<sub>13</sub>H<sub>13</sub>F<sub>3</sub>N<sub>2</sub>OÂ·HClÂ·0.7 H<sub>2</sub>O), C, H, N. </div><div class="NLM_p"><b>(4</b><b><i>S</i></b><b>,10b</b><b><i>R</i></b><b>)-4-Methyl-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-</b><b><i>a</i></b><b>]isoindol-6(2</b><b><i>H</i></b><b>)-o</b><b>ne Hydrochloric Acid Salt (36).</b> Prepared according to General Procedure A with the substitution of (<i>S</i>)-2-amino-1-(benzyloxycarbonylamino)propane hydrochloride<sup>17</sup> for 1-(benzyloxycarbonylamino)-2-aminoethane hydrochloride. Separation of the diastereomers was carried out at the last step during purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 8.02 (d, <i>J</i> = 7.5 Hz, 1 H), 7.89 (d, <i>J</i> = 7.9 Hz, 1 H), 7.82 (t, <i>J</i> = 7.7 Hz, 1 H,) 4.82 (dd, <i>J</i> = 11.4, 3.5 Hz, 1 H), 3.98â4.07 (m, 2 H), 3.34 (d, <i>J</i> = 12.7 Hz, 1 H), 2.83â2.93 (m, 1 H), 2.73â2.83 (m, 1 H), 1.72 (d, <i>J</i> = 6.6 Hz, 3 H). MS (ESI) 271 (M â Cl). (C<sub>13</sub>H<sub>13</sub>F<sub>3</sub>N<sub>2</sub>OÂ·1.1HClÂ·H<sub>2</sub>O), C, H, N. </div><div class="NLM_p"><b>(4</b><b><i>S</i></b><b>,10b</b><b><i>R</i></b><b>)-4-Isopropyl-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-</b><b><i>a</i></b><b>]isoindol-6(2</b><b><i>H</i></b><b>)</b><b>-one Hydrochloric Acid Salt (37).</b> Prepared according to General Procedure A with the substitution of (<i>S</i>)-2-amino-1-(benzyloxycarbonylamino)-3-methyl-butane<sup>15</sup> hydrochloride for 1-(benzyloxycarbonylamino)-2-aminoethane hydrochloride. Separation of the diastereomers was carried out at the last step during purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 8.01 (d, <i>J</i> = 7.5 Hz, 1 H), 7.89 (d, <i>J</i> = 7.9 Hz, 1 H), 7.82 (t, <i>J</i> = 7.7 Hz, 1 H), 4.83 (dd, <i>J</i> = 11.6, 3.7 Hz, 1 H), 4.00 (dd, <i>J</i> = 11.9, 3.5 Hz, 1 H), 3.59â3.71 (m, 1 H), 3.45 (d, <i>J</i> = 11.9 Hz, 1 H), 3.15â3.26 (m, 1 H), 2.91 (s, 1 H), 2.75 (s, 1 H), 1.08 (d, <i>J</i> = 6.6 Hz, 3 H), 0.99 (d, <i>J</i> = 6.6 Hz, 3 H). MS (ESI) 299 (M â Cl). Anal. (C<sub>15</sub>H<sub>17</sub>F<sub>3</sub>N<sub>2</sub>OÂ·HClÂ·1.8H<sub>2</sub>O), C, H, N. </div><div class="NLM_p"><b>(1</b><b><i>S</i></b><b>,10b</b><b><i>R</i></b><b>)-1-Methyl-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-</b><b><i>a</i></b><b>]isoindol-6(2</b><b><i>H</i></b><b>)-o</b><b>ne Hydrochloric Acid Salt (38). Step A.</b> To 3-hydroxy-7-(trifluoromethyl)isobenzofuran-1(3<i>H</i>)-one (5.6 g, 25.7 mmol; General Procedure A, Step C) in 10% acetic acid in 1,2-dichloroethane (250 mL) were added <i>N</i>-(<i>tert</i>-butoxycarbonyl)ethylenediamine (3.7 mL, 23.4 mmol) and sodium triacetoxyborohydride (7.4 g, 35.1 mmol). The resulting mixture was warmed to 50 Â°C and maintained at this temperature for 14 h. The reaction was cooled to 23 Â°C, diluted with brine, and extracted with EtOAc (Ã3). The combined organic layers were dried over sodium sulfate and filtered, and the filtrate was concentrated <i>in vacuo</i>. The resulting residue was purified by flash column chromatography (SiO<sub>2</sub>, 0â80% EtOAc in hexanes) to afford 2-[2-[(<i>tert</i>-butoxycarbonyl)amino]ethyl]-1,3-dihydro-4-trifluoromethylisoindol-3(1 <i>H</i>)-one (7.9 g, 89%) as an off-white oily solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.75 (d, <i>J</i> = 7.9 Hz, 1 H), 7.59â7.65 (m, 2 H), 4.81 (s, 1 H), 4.52 (s, 2 H), 3.74 (t, <i>J</i> = 6.2 Hz, 2 H), 3.45 (q, <i>J</i> = 5.9 Hz, 2 H), 1.25 (s, 9 H). MS (ESI) 345 (M + H). </div><div class="NLM_p"><b>Step B.</b> To 2-[2-[(<i>tert</i>-butoxycarbonyl)amino]ethyl]-1,3-dihydro-4-trifluoromethylisoindol-3(1<i>H</i>)-one (2.31 g, 6.71 mmol) in tetrahydrofuran at â78 Â°C was added <i>sec</i>-butyllithium (12.3 mL, 14.8 mmol; titrated with diphenylacetic acid, 1.2 M) in cyclohexane/hexane (92/8) in one portion. After stirring the reaction at â78 Â°C for 15 min, acetaldehyde (1.88 mL, 33.6 mmol) was added in one portion. The brown-green solution was warmed to 0 Â°C over 5 min and was then quenched with aq HCl (1 N) and brine. The mixture was extracted with EtOAc (Ã3), the combined organic layers were dried over sodium sulfate and filtered, and the filtrate was concentrated. The resulting residue was purified by flash column chromatography (SiO<sub>2</sub>, 0â50% EtOAc in hexanes) to afford (Â±)-2-[2-[(<i>tert</i>-butoxycarbonyl)amino]ethyl]-1,3-dihydro-1-(1-hydroxyethyl)-4-trifluoromethylisoindol-3(1<i>H</i>)-one (2.2 g, 84%) as a white foam-like solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.89 (d, <i>J</i> = 8.0 Hz, 0.33H), 7.68 (m, 1 H), 7.52â7.61 (m, 1.66 H), 4.93â5.02 (s, 0.65 H), 4.87â4.93 (s, 0.35 H), 4.73 (s, 1 H), 4.48â4.38 (1 H), 3.97â4.80 (m, 1 H), 3.86â3.96 (m, 0.55 H), 3.70â3.85 (m, 2.45 H), 1.98 (s, 3 H), 1.19 (s, 9 H). MS (ESI) 389 (M + H). </div><div class="NLM_p"><b>Step C.</b> To (Â±)-2-[2-[(<i>tert</i>-butoxycarbonyl)amino]ethyl]-1,3-dihydro-1-(1-hydroxyethyl)-4-trifluoromethylisoindol-3(1<i>H</i>)-one (2.2 g, 5.7 mmol) in dichloromethane at 23 Â°C was added DessâMartin periodinane (3.4 g, 7.9 mmol) in one portion. After 20 min, the reaction was quenched with methanol (10 mL) and concentrated <i>in vacuo</i>. The resulting white mixture was purified by flash column chromatography (SiO<sub>2</sub>, 0â50% EtOAc in hexanes) to afford (Â±)-2-[2-[(<i>tert</i>-butoxycarbonyl)amino]ethyl]-1,3-dihydro-1-(1-oxoethyl)-4-trifluoromethylisoindol-3(1<i>H</i>)-one (1.9 g, 86%) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.78â7.88 (m, 1 H), 7.64â7.73 (m, 2 H), 5.30 (s, 1 H), 4.77 (s, 1 H), 4.17â4.27 (m, 1 H), 3.58 (s, 1 H), 3.17â3.29 (m, 2 H), 1.99 (s, 3 H), 1.22 (s, 9 H). MS (ESI) 387 (M + H). </div><div class="NLM_p"><b>Step D.</b> Concentrated aqueous HCl (5 mL) was added to a mixture of diethyl ether (20 mL) and (Â±)-2-[2-[(<i>tert</i>-butoxycarbonyl)amino]ethyl]-1,3-dihydro-1-(1-oxoethyl)-4-trifluoromethylisoindol-3(1<i>H</i>)-one (1.9 g, 4.9 mmol). The resulting mixture was stirred for 5 min and became a yellow solution. The solution was concentrated <i>in vacuo</i> to dryness and azeotroped three times with toluene (5 mL). Finally, the residue was treated with dichloromethane (5 mL) and concentrated <i>in </i><i>vacuo</i> to a yellow orange solid. Di-<i>tert</i>-butyl dicarbonate (4.8 g, 22 mmol) was added to the residue, and the mixture was warmed to 55 Â°C. To this mixture was added 4-(dimethylamino)pyridine (1.2 g, 9.8 mmol). After 5 <a name="jm005000601374" id="jm005000601374"></a> min, the orange brown solution was directly purified by flash column chromatography (SiO<sub>2</sub>, 0â30% EtOAc in hexanes) to afford <i>N</i>-(<i>tert</i>-butoxycarbonyl)-3,4-dihydro-1-methyl-7-trifluoromethylpyrazino[2,1-<i>a</i>]isoindol-6(2<i>H</i>)-one (1.5 g, 83%) as a yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.93 (d, <i>J</i> = 7.9 Hz, 1 H), 7.71 (d, <i>J</i> = 7.5 Hz, 1 H), 7.63 (t, <i>J</i> = 7.7 Hz, 1 H), 3.88 (s, 2 H), 2.53 (s, 2 H), 1.54 (s, 12 H). MS (ESI) 369 (M + H). </div><div class="NLM_p"><b>Step E.</b> To a solution of <i>N</i>-(<i>tert</i>-butoxycarbonyl)-3,4-dihydro-1-methyl-7-trifluoromethylpyrazino[2,1-<i>a</i>]isoind ol-6(2<i>H</i>)-one (0.20 g, 0.54 mmol) in methanol (10 mL) was added palladium on carbon (20 mg, 10 wt %). The resulting mixture was degassed (vacuum then argon, Ã3) and subjected to a hydrogen atmosphere (60 psi) for 12 h. The mixture was then filtered, and the filtrate was concentrated <i>in vacuo</i>. The resulting residue was purified by flash column chromatography (SiO<sub>2</sub>, 0â50% EtOAc in hexanes) to afford <i>N</i>-(<i>tert</i>-butoxycarbonyl)-(Â±)-1-methyl-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-<i>a</i>]isoindol-6(2<i>H</i>)-one (0.19 g, 94%) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.78 (d, <i>J</i> = 7.5 Hz, 1 H), 7.59â7.68 (m, 2 H), 5.03â5.10 (m, 0.66 H), 4.78â4.85 (s, 0.33H), 4.63 (d, <i>J</i> = 4.4 Hz, 1 H), 4.35 (d, <i>J</i> = 9.7 Hz, 1 H), 4.10â4.20 (s, 0.33 H), 3.99â4.06 (m, 0.66 H), 2.97â3.21 (m, 2H), 1.51 (s, 12 H). MS (ESI) 371 (M + H). </div><div class="NLM_p"><b>Step F.</b> The mixture of enantiomers contained in <i>N</i>-(<i>tert</i>-butoxycarbonyl)-(Â±)-1-methyl-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-<i>a</i>]isoindol-6(2<i>H</i>)-one (81 mg, 0.22 mmol) was separated by chiral HPLC (Chiracell AD column with 90% heptane containing 0.1% diethylamine and 10% 1:1 MeOH:EtOH containing 0.1% diethylamine). The resulting solids were individually repurified by flash column chromatography (SiO<sub>2</sub>, 0â50% EtOAc in hexanes) to yield 35 mg of the (1<i>S</i>,10b<i>R</i>) enantiomer and 36 mg of the (1<i>R</i>,10b<i>S</i>) enantiomer as white solids. The solids were individually dissolved in dry ether (1 mL)and the treated with HCl (1 mL). The reactions were stirred for 5 min and then concentrated <i>in vacuo</i> to a white solid. The solids were dissolved in water and lyophilized to yield 28 mg (quant) of the (1<i>S</i>,10b<i>R</i>) enantiomer and 28 mg (93%) of the (1<i>R</i>,10b<i>S</i>) enantiomer as white solids. Enantiomeric excess >99:1 based on chiral HPLC. <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) Î´ 7.88â7.93 (m, 1 H), 7.80â7.84 (m, 2 H), 5.11 (d, <i>J</i> = 4.4 Hz, 1 H), 4.52â4.57 (m, 1 H), 4.49 (dd, <i>J</i>=14.9, 4.4 Hz, 1 H), 3.41â3.55 (m, 2 H), 3.33 (dt, <i>J</i> = 12.9, 4.4 Hz, 1 H), 0.80 (d, <i>J</i> = 6.6 Hz, 3 H). MS (ESI) 271 (M â Cl). Anal. (C<sub>13</sub>H<sub>13</sub>F<sub>3</sub>N<sub>2</sub>OÂ·HClÂ·0.4H<sub>2</sub>O), C, H, N. </div><div class="NLM_p"><b>(1</b><b><i>S</i></b><b>,10b</b><b><i>R</i></b><b>)-1-Ethyl-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-</b><b><i>a</i></b><b>]isoindol-6(2</b><b><i>H</i></b><b>)-one </b><b>Hydrochloric Acid Salt (39).</b> Prepared according to the procedures described in Example <b>38</b> with substitution of propionaldehyde for acetaldehyde at step B. Enantiomeric excess >99:1 based on chiral HPLC. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) 7.98 (d, <i>J</i> = 7.5 Hz, 1 H), 7.92 (d, <i>J</i> = 7.5 Hz, 1 H), 7.85 (t, <i>J</i> = 7.7 Hz, 1 H), 5.14 (d, <i>J</i> = 3.9 Hz, 1 H), 4.52 (dd, <i>J</i> = 14.3, 4.6 Hz, 1 H), 4.32 (ddd, <i>J</i> = 9.0, 4.8, 4.6 Hz, 1 H), 3.54 (dt, <i>J</i> = 13.4, 4.4 Hz, 1 H), 3.38â3.44 (m, 1 H), 3.26â3.34 (m, 1 H), 1.28â1.40 (m, 1 H), 0.99â1.10 (m, 1 H), 0.83 (t, <i>J</i> = 7.7 Hz, 3 H). MS (ESI) 285 (M â Cl) Anal. (C<sub>14</sub>H<sub>15</sub>F<sub>3</sub>N<sub>2</sub>OÂ·HClÂ·H<sub>2</sub>O), C, H, N. </div><div class="NLM_p"><b>((</b><b><i>R</i></b><b>)-10-Chloro-7-methoxy-1,3,4,10b-tetrahydropyrazino[2,1-</b><b><i>a</i></b><b>]isoindol-6(2 H)-one </b><b>Hydrochloric Acid Salt (40).</b> Prepared according to General Procedure B with substitution of 5-chloro-2-methoxybenzoic acid for 2-chlorobenzoic acid. Chiral resolution and deprotection were carried out according to the General Procedure for the preparation of chiral pyrazino[2,1-<i>a</i>]isoindol-6(2<i>H</i>)-one hydrochloric acid salts (Chiracell OJ chiral column and 10% (1:1) methanol/ethanol in heptane containing 0.1% diethylamine. Enantiomeric excess >99:1 based on chiral HPLC. <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) Î´ 7.58 (d, <i>J</i> = 8.8 Hz, 1 H), 7.12 (d, <i>J</i> = 9.2 Hz, 1 H), 4.92 (dd, <i>J</i> = 11.9, 3.9 Hz, 1 H), 4.44 (dd, <i>J</i>=14.5, 3.9 Hz, 1 H), 4.36 (dd, <i>J</i>=12.3, 3.9 Hz, 1 H), 3.89 (s, 3 H), 3.47â3.58 (m, 2 H) 3.03 (dt, <i>J</i>=12.5, 4.4 Hz, 1 H), 2.82 (t, <i>J</i>=12.1 Hz, 1 H). MS (ESI) 253, 255 (M â Cl). Anal. (C<sub>12</sub>H<sub>13</sub>ClN<sub>2</sub>O<sub>2</sub>Â·HClÂ·0.8H<sub>2</sub>O), C, H, N. </div><div class="NLM_p"><b>(</b><b><i>R</i></b><b>)-7-Chloro-10-methyl-1,3,4,10b-tetrahydropyrazino[2,1-</b><b><i>a</i></b><b>]isoindol-6(2</b><b><i>H</i></b><b>)-one </b><b>Hydrochloric Acid Salt (41). Step A.</b> To <i>N</i>-(<i>tert</i>-butoxycarbonyl)-(Â±)-7-chloro-10-hydroxy-1,3,4,10b-tetrahydropyrazino[2,1-<i>a]</i>isoindol-6(2<i>H</i>)-one (1.0 g, 2.96 mmol) [prepared from (a) 2-chloro-5-methylbenzoic acid according to General Procedure B and (b) the demethylation procedure used for compound <b>27</b> followed by reprotection with di-<i>tert</i>-butyl dicarbonate (1.0 equiv)] were added dichloromethane (30 mL), 2,6-lutidine (1.37 mL, 11.8 mmol), and trifluoromethanesulfonic anhydride (0.60 mL, 3.55 mmol) at 0 Â°C. After 40 min, the reaction was concentrated to a red mixture and purified by flash column chromatography (SiO<sub>2</sub>, 0â50% EtOAc in hexanes) to afford <i>N</i>-(<i>tert</i>-butoxycarbonyl)-(Â±)-7-chloro-1,3,4,10b-tetrahydro-10-trifluoromethanesulfonyl-pyrazino[2,1-<i>a</i>]isoindol-6(2<i>H</i>)-one (1.11 g, 80%) as a beige solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.53 (d, <i>J</i> = 8.8 Hz, 1H), 7.39 (d, <i>J</i> = 8.8 Hz, 1 H), 4.90 (br s, 1 H), 4.58 (dd, <i>J</i> = 10.8, 4.2 Hz, 1 H), 4.39 (dd, <i>J</i> = 13.4, 3.3 Hz, 1 H), 4.29 (br s, 1 H), 3.13â3.22 (m, 1 H), 2.65â2.76 (m, 1 H), 2.45 (br s, 1 H), 1.51 (s, 9 H). MS (ESI) 471.2, 473.2 (M â Cl). </div><div class="NLM_p"><b>Step B.</b><i>N</i>-(<i>tert</i>-Butoxycarbonyl)-(<i>R</i>)-7-chloro-10-methyl-1,3,4,10b-tetrahydropyrazino[2,1-<i>a</i>]isoindol-6(2<i>H</i>)-one was prepared according to the procedure described for <b>57</b> (substituting cesium carbonate for potassium carbonate and [1,1â-bis(diphenylphosphino)ferrocene]dichloropalladium(II) for tetrakis(triphenylphospine)palladium(0)) followed by chiral chromatography (Chiracell OJ column and 15% (1:1) methanol/ethanol in heptane containing 0.1% diethylamine). The carbamate was then treated with concentrated aqueous hydrogen chloride, concentrated <i>in vacuo</i>, and lyophilized from water to afford <b>41</b> as a white solid. Enantiomeric excess >99:1 based on chiral HPLC. <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) Î´ 7.33â7.38 (m, 2 H), 4.83 (dd, <i>J</i> = 11.9, 3.9 Hz, 1 H), 4.50 (dd, <i>J</i> = 14.3, 4.2 Hz, 1 H), 4.15 (dd, <i>J</i> = 12.3, 3.95 Hz, 1 H), 3.49â3.59 (m, 2 H), 3.02 (dt, <i>J</i> = 12.5, 4.4 Hz, 1 H), 2.75 (t, <i>J</i>=12.1 Hz, 1 H), 2.30 (s, 3 H). MS (ESI) 237.3, 239.3 (M â Cl). Anal. (C<sub>12</sub>H<sub>13</sub>ClN<sub>2</sub>OÂ·1.7HCl), C, H, N. </div><div class="NLM_p"><b>(</b><b><i>R</i></b><b>)-7-Chloro-10-ethyl-1,3,4,10b-tetrahydropyrazino[2,1-</b><b><i>a</i></b><b>]isoindol-6(2</b><b><i>H</i></b><b>)-one Hydrochloric </b><b>Acid Salt (42).</b> Prepared from <i>N</i>-(<i>tert</i>-butoxycarbonyl)-(Â±)-7-chloro-1,3,4,10b-tetrahydro-10-trifluoromethanesulfonylpyrazino[2,1-<i>a</i>]isoindol-6(2<i>H</i>)-one according to the procedures described for compounds <b>58</b> and <b>62</b>. Enantiomeric excess >99:1 based on chiral HPLC. <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) Î´ 7.35â7.41 (m, 2 H), 4.85 (dd, <i>J</i> = 11.6, 3.7 Hz, 1 H), 4.47 (dd, <i>J</i> = 14.3, 4.2 Hz, 1 H), 4.09 (dd, <i>J</i> = 12.3, 3.9 Hz, 1 H), 3.45â3.55 (m, 2 H), 2.99 (dt, <i>J</i> = 12.5, 4.4 Hz, 1 H),2.75 (t, <i>J</i> = 12.3 Hz, 1 H), 2.52â2.64 (m, 2 H), 1.15 (t, <i>J</i> = 7.5 Hz, 3 H). MS (ESI) 251.3, 253.3 (M â Cl). Anal. (C<sub>13</sub>H<sub>15</sub>ClN<sub>2</sub>OÂ·HClÂ·1.3H<sub>2</sub>O), C, H, N. </div><div class="NLM_p"><b>(</b><b><i>R</i></b><b>)-7-Chloro-10-methoxy-1,3,4,10b-tetrahydropyrazino[2,1-</b><b><i>a</i></b><b>]isoindol-6(2</b><b><i>H</i></b><b>)-one </b><b>Hydrochloric Acid Salt (43).</b> Prepared according to General Procedure B with substitution of 2-chloro-5-methoxybenzoic acid for 2-chlorobenzoic acid. Chiral resolution and deprotection were carried out according to the General Procedure for the preparation of chiral pyrazino[2,1-<i>a</i>]isoindol-6(2<i>H</i>)-one hydrochloric acid salts (Chiracell OJ chiral column and 15% (1:1) methanol/ethanol in heptane containing 0.1% diethylamine). Enantiomeric excess >99:1 based on chiral HPLC. <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) Î´ 7.43 (d, <i>J</i> = 8.8 Hz, 1 H), 7.14 (d, <i>J</i> = 8.8 Hz, 1 H), 4.80 (dd, <i>J</i> = 11.9, 3.9 Hz, 1 H), 4.44 (dd, <i>J</i> = 14.3, 4.2 Hz, 1 H), 4.15 (dd, <i>J</i> = 12.5, 4.2 Hz, 1 H), 3.84 (s, 3 H), 3.51â3.56 (m, 1 H), 3.42â3.51 (m, 1 H), 3.00 (dt, <i>J</i> = 12.7, 4.4 Hz, 1 H), 2.72 (t, <i>J</i> = 12.1 Hz, 1 H). MS (ESI) 253.3, 255.3 (M â Cl). Anal. (C<sub>12</sub>H<sub>13</sub>ClN<sub>2</sub>O<sub>2</sub>Â·HClÂ·1.7H<sub>2</sub>O), C, H, N. </div><div class="NLM_p"><b>(</b><b><i>R</i></b><b>)-10-Chloro-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-</b><b><i>a</i></b><b>]isoindol-6(2</b><b><i>H</i></b><b>)-one </b><b>Hydrochloric Acid Salt (44).</b> Prepared according to General Procedure B and the General Procedure for the preparation of chiral pyrazino[2,1-<i>a</i>]isoindol-6(2<i>H</i>)-one hydrochloric acid salts (Chiracell OJ chiral column and 20% (1:1) methanol/ethanol in heptane containing 0.1% diethylamine) from 5-chloro-2-trifluoromethylbenzoic acid. Enantiomeric excess >99:1 based on chiral HPLC. <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) Î´ 7.88 (d, <i>J</i> = 8.4 Hz, 1 H), 7.79 (d, <i>J</i> = 8.34 Hz, 1 H), 5.04 (dd, <i>J</i> = 11.9, 3.9 Hz, 1 H), 4.53 (dd, <i>J</i> = 13.2, 3.1 Hz, 1 H), 4.41 (dd, <i>J</i> = 12.5, 4.2 Hz, 1 H), 2.99â3.07 (m, 1 H) 3.49â3.61 (m, 2 H), 2.83 (t, <i>J</i> = 12.1 Hz, 1 H). MS (ESI) 291.3, 293.3 (M â Cl). Anal. (C<sub>12</sub>H<sub>10</sub>ClF<sub>3</sub>N<sub>2</sub>OÂ·HClÂ·0.7H<sub>2</sub>O), C, H, N. </div><div class="NLM_p"><a name="jm005000601375" id="jm005000601375"></a><b>(</b><b><i>R</i></b><b>)-7,8-Dichloro-1,3,4,10b-tetrahydropyrazino[2,1-</b><b><i>a</i></b><b>]isoindol-6(2</b><b><i>H</i></b><b>)-one Hydrochloric Acid </b><b>Salt (45).</b> Prepared according to General Procedure B with substitution of 2,3-dichlorobenzoic acid for 2-chlorobenzoic acid with chiral resolution and deprotection carried out according to the General Procedure described for compound <b>29</b>. Enantiomeric excess >99:1 based on chiral HPLC. <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) Î´ 7.80 (d, <i>J</i> = 8.4 Hz, 1 H), 7.51 (d, <i>J</i> = 8.4 Hz, 1H), 4.88 (dd, <i>J</i> = 11.9, 3.9 Hz, 1H), 4.51 (dd, <i>J</i> = 14.7, 4.2 Hz, 1H), 4.08 (dd, <i>J</i> = 12.3, 3.9 Hz, 1H), 3.51â3.61 (m, 1H), 3.51â3.56 (m, 1H), 3.04 (dt, <i>J</i> = 12.5, 4.4 Hz, 1H), 2.82 (t, <i>J</i> = 12.3 Hz, 1H). MS (ESI) 257 (M â Cl). Anal. (C<sub>11</sub>H<sub>10</sub>Cl<sub>2</sub>N<sub>2</sub>OÂ·1.3HClÂ·0.5H<sub>2</sub>O), C, H, N. </div><div class="NLM_p"><b>(</b><b><i>R</i></b><b>)-8-Chloro-7-methoxy-1,3,4,10b-tetrahydropyrazino[2,1-</b><b><i>a</i></b><b>]isoindol-6(2</b><b><i>H</i></b><b>)-one </b><b>Hydrochloric Acid Salt (46).</b> Prepared according to General Procedure B with substitution of 3-chloro-2-methoxybenzoic acid<sup><a onclick="showRef(event, 'jm0612968b00019'); return false;" href="javascript:void(0);" class="ref jm0612968b00019">19</a></sup> for 2-chlorobenzoic acid with chiral resolution and deprotection carried out according to the General Procedure described for compound <b>29</b>. Enantiomeric excess >99:1 based on chiral HPLC. <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) Î´ 7.72 (d, <i>J</i> = 7.9 Hz, 1 H), 7.33 (d, <i>J</i> = 8.8 Hz, 1 H), 4.86 (dd, <i>J</i> = 11.9, 3.9 Hz, 1 H), 4.46 (dd, <i>J</i> = 14.5, 3.9 Hz, 1 H), 4.05 (dd, <i>J</i> = 12.5, 4.2 Hz, 1 H), 3.95 (s, 3 H), 3.57 (dd, <i>J</i> = 12.7, 3.5 Hz, 1 H), 3.45â3.53 (m, 1 H), 3.03 (dt, <i>J</i> = 12.6, 4.6 Hz, 1 H), 2.79 (t, <i>J</i> = 12.1 Hz, 1 H). MS (ESI) 253 (M â Cl). Anal. (C<sub>12</sub>H<sub>13</sub>ClN<sub>2</sub>O<sub>2</sub>Â·HClÂ·0.90H<sub>2</sub>O). </div><div class="NLM_p"><b>(</b><b><i>R</i></b><b>)-8-Ethyl-7-methoxy-1,3,4,10b-tetrahydropyrazino[2,1-</b><b><i>a</i></b><b>]isoindol-6(2</b><b><i>H</i></b><b>)-one </b><b>Hydrochloric Acid Salt (47). Step A.</b> To <i>N</i>-(<i>tert</i>-butoxycarbonyl)-(Â±)-8-chloro-7-methoxy-1,3,4,10b-tetrahydropyrazino[2,1-<i>a</i>]isoindol-6(2<i>H</i>)-one (0.55 mg, 1.56 mmoL) prepared from 3-chloro-2-methoxybenzoic acid<sup>18</sup> using General Procedure B was added bis(tri-<i>tert</i>-butylphosphine)palladium(0) (32 mg, 0.06 mmol), 2,4,6-trivinylcyclotriboroxane pyridine complex (653 mg, 1.72 mmol), potassium fluoride (633 mg, 11 mmol), and dioxane (16 mL). The mixture was degassed and warmed to reflux. After 6 h, an additional portion of catalyst (32 mg) was added. The reaction was maintained at reflux for another 8 h and was then cooled to room temperature. The mixture was diluted with saturated aqueous sodium hydrogen carbonate and brine before being extracted with EtOAc (Ã3). The combined organic layers were dried over sodium sulfate, filtered, and concentrated <i>in vacuo</i>. The resulting residue was purified by flash column chromatography (SiO<sub>2</sub>, 0â50% EtOAc in hexanes) to afford <i>N</i>-(<i>tert</i>-butoxycarbonyl)-(Â±)-8-ethenyl-7-methoxy-1,3,4,10b-tetrahydropyrazino[2,1-<i>a]</i>isoindol-6(2<i>H</i>)-one as a yellow solid (475 mg, 88%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.68 (d, <i>J</i> = 7.9 Hz, 1 H), 7.04â7.13 (m, 2 H), 5.76 (d, <i>J</i> = 18.9 Hz, 1 H), 5.33 (d, <i>J</i> = 11.0 Hz, 1 H), 4.67 (s, 1 H), 4.29â4.40 (m, 2 H), 4.10 (s, 1 H), 4.04 (s, 3 H), 3.05â3.14 (m, 1 H), 2.72 (s, 1 H), 2.33 (s, 1 H), 1.50 (s, 9 H). MS (ESI) 345.3 (M + H). </div><div class="NLM_p"><b>Step B.</b> Final product was prepared according to the procedures of compound <b>58</b> substituting <i>N</i>-(<i>tert</i>-butoxycarbonyl)-(Â±)-8-ethenyl-7-methoxy-1,3,4,10b-tetrahydropyrazino[2,1-<i>a</i>]isoindol-6(2<i>H</i>)-one for <i>N</i>-(<i>tert</i>-butoxycarbonyl)-(<i>R</i>)-9-ethyl-1,3,4,10b-tetrahydro-7-trifluoromethyl-pyrazino[2,1-<i>a</i>]isoindol-6(2<i>H</i>)-one to yield <b>47</b>. Enantiomeric excess >99:1 based on chiral HPLC. <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) Î´ 7.57 (d, <i>J</i> = 7.9 Hz, 1 H), 7.30 (d, <i>J</i> = 7.9 Hz, 1 H), 4.83 (dd, <i>J</i> = 11.8, 4.4 Hz, 1 H), 4.46 (dd, <i>J</i> = 14.7, 4.2 Hz, 1 H), 4.05 (dd, <i>J</i> = 12.3, 3.9 Hz, 1 H), 3.89 (s, 3 H), 3.57 (dd, <i>J</i> = 12.7, 3.9 Hz, 1 H), 3.45â3.53 (m, 1 H), 3.03 (dt, <i>J</i> = 12.6, 4.6 Hz, 1 H), 2.65â2.75 (m, 3 H), 1.15 (t, <i>J</i> = 7.5 Hz, 3 H). MS (ESI) 247 (M â Cl). Anal. (C<sub>14</sub>H<sub>18</sub>N<sub>2</sub>O<sub>2</sub>Â·HClÂ·1.1H<sub>2</sub>O), C, H, N. </div><div class="NLM_p"><b>(</b><b><i>R</i></b><b>)-9-Chloro-8-methoxy-1,3,4,10b-tetrahydropyrazino[2,1-</b><b><i>a</i></b><b>]isoindol-6(2</b><b><i>H</i></b><b>)-one </b><b>Hydrochloric Acid Salt (48).</b> Prepared according to General Procedure B with substitution of 4-chloro-3-methoxybenzoic acid for 2-chlorobenzoic acid. Chiral resolution and deprotection were carried out according to the General Procedure for the preparation of chiral pyrazino[2,1-<i>a</i>]isoindol-6(2<i>H</i>)-one Hydrochloric acid salts. Enantiomeric excess >99:1 based on chiral HPLC. <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) Î´ 7.70 (s, 1 H), 7.47 (s, 1 H), 4.86 (dd, <i>J</i> = 11.9, 4.4 Hz, 1 H), 4.44â4.50 (m, 1 H), 4.05 (dd, <i>J</i> = 12.7, 3.9 Hz, 1 H), 3.96 (s, 3 H), 3.53â3.61 (m, 2 H), 3.00â3.08 (m, 1 H), 2.78 (t, <i>J</i> = 12.3 Hz, 1 H). MS (ESI) 253.3, 255.3 (M â Cl). Anal. (C<sub>12</sub>H<sub>13</sub>ClN<sub>2</sub>O<sub>2</sub>Â·HCl), C, H, N. </div><div class="NLM_p"><b>(</b><b><i>R</i></b><b>)-9-Ethyl-8-methoxy-1,3,4,10b-tetrahydropyrazino[2,1-</b><b><i>a</i></b><b>]isoindol-6(2</b><b><i>H</i></b><b>)-one </b><b>Hydrochloric Acid Salt (49).</b> Prepared according to the procedure of compound <b>47</b> from <i>N</i>-(<i>tert</i>-butoxycarbonyl)-(Â±)-9-chloro-8-methoxy-1,3,4,10b-tetrahydropyrazino[2,1-<i>a</i>]isoindol-6(2<i>H</i>)-one. Enantiomeric excess >99:1 based on chiral HPLC. <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) Î´ 7.44 (s, 1 H), 7.30 (s, 1 H), 4.81 (dd, <i>J</i> = 11.9, 3.9 Hz, 1 H), 4.47 (dd, <i>J</i> = 13.6, 3.5 Hz, 1 H), 4.07 (dd, <i>J</i> = 12.3, 3.9 Hz, 1 H), 3.88 (s, 3 H), 3.50â3.61 (m, 2 H), 3.00â3.09 (m, 1 H), 2.64â2.73 (m, 2 H), 1.15 (t, <i>J</i> = 7.7 Hz, 3 H). MS (ESI) 247.3 (M â Cl). Anal. (C<sub>14</sub>H<sub>18</sub>N<sub>2</sub>O<sub>2</sub>Â·HCl), C, H, N. </div><div class="NLM_p"><b>(</b><b><i>R</i></b><b>)-7-Chloro-9-methoxy-1,3,4,10b-tetrahydropyrazino[2,1-</b><b><i>a</i></b><b>]isoindol-6(2</b><b><i>H</i></b><b>)-one </b><b>Hydrochloric Acid Salt (50). Step A.</b> To a solution of 2-chloro-4-hydroxybenzoic acid hydrate (2.0 g, 12 mmol), iodomethane (2.9 mL, 46 mmol) and <i>N</i>,<i>N</i>-dimethylformamide (50 mL) was added sodium hydride (1.9 g, 46 mmol; 60% dispersion in mineral oil) in one portion. After the mixture was vigorously stirred for 16 h, the reaction was quenched with water and washed with EtOAc. The aqueous layer was then acidified with aqueous HCl (6 N) to give a white precipitate. The mixture was filtered and washed with water, and the filter cake was dried in a vacuum oven to give the desired acid as an off-white solid (1.4 g, 65%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 8.02 (d, <i>J</i> = 8.8 Hz, 1H), 6.98 (d, <i>J</i> = 2.6 Hz, 1H), 6.83 (dd, <i>J</i> = 8.8, 2.6 Hz, 1H), 3.85 (s, 3H). MS (ESI) 187.1, 189.1 (M + H). </div><div class="NLM_p"><b>Step B.</b> Final compound was prepared according to General Procedure B, substituting 2-chloro-4-methoxybenzoic acid for 2-chlorobenzoic acid at Step A with chiral separation according to General Procedures to yield <b>50</b>. Enantiomeric excess >99:1 based on chiral HPLC. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´ 7.18 (s, 1 H), 7.12 (d, <i>J</i> = 2.20 Hz, 1 H), 4.76 (dd, <i>J</i> = 11.9, 3.9 Hz, 1 H), 4.52 (dd, <i>J</i> = 14.7, 4.2 Hz, 1 H), 4.03 (dd, <i>J</i> = 12.1, 3.7 Hz, 1 H), 3.90 (s, 3 H), 3.51 (dd, <i>J</i> = 12.5, 3.7 Hz, 1 H), 3.37â3.46 (m, 1 H), 3.02 (dt, <i>J</i> = 12.5, 4.4 Hz, 1 H), 2.79 (t, <i>J</i> = 12.1 Hz, 1 H). MS (ESI) 253.2, 255.2 (M â Cl). Anal. (C<sub>12</sub>H<sub>13</sub>ClN<sub>2</sub>O<sub>2</sub>Â·HClÂ·H<sub>2</sub>O), C, H, N. </div><div class="NLM_p"><b>(</b><b><i>R</i></b><b>)-7-Chloro-9-ethyl-1,3,4,10b-tetrahydropyrazino[2,1-</b><b><i>a</i></b><b>]isoindol-6(2</b><b><i>H</i></b><b>)-one HCl (51). Step </b><b>A.</b> To a stirring solution of 4-bromo-2-chlorobenzoic acid (5.0 g, 21.2 mmol) in dry CH<sub>2</sub>Cl<sub>2</sub> (150 mL) was added a 2 M solution of oxalyl chloride in CH<sub>2</sub>Cl<sub>2</sub> (21.2 mL). Dry DMF (0.1 mL) was added and the reaction was stirred for 4 h and then concentrated <i>in vacuo</i> to a white solid. The solid was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (150 mL), and diethylamine (4.8 mL, 46.6 mmol) was added dropwise over 15 min. The reaction was washed with brine, dried over sodium sulfate, filtered, and concentrated <i>in vacuo</i>. The resulting residue was purified by flash chromatography (SiO<sub>2</sub>, 1:5, EtOAc:hexanes) to yield <i>N,N</i>-diethyl-4-bromo-2-chlorobenzamide (6.2 g, 100%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.56 (d, <i>J</i> = 1.8 Hz, 1 H), 7.43 (dd, <i>J</i> = 8.4, 1.8 Hz, 1 H), 7.14 (d, <i>J</i> = 7.9 Hz, 1 H), 3.71â3.82 (m, 1 H), 3.30â3.41 (m, 1 H), 3.07â3.18 (m, 2 H), 1.25 (t, <i>J</i> = 7.0 Hz, 3 H). 1.05 (t, <i>J</i> = 7.5 Hz, 3 H). MS (ESI) 290 (M + H). </div><div class="NLM_p"><b>Step B.</b> Tetrakis(triphenylphospine)palladium(0) (30 mg, 0.026 mmol) was added in one portion to a degassed mixture of <i>N,N</i>-diethyl-4-bromo-2-chlorobenzamide (0.6 g, 2.1 mmol), potassium carbonate (0.29 g, 2.1 mmol), and 2,4,6-trivinylcyclotriboroxane pyridine complex (0.78 g, 2.1 mmol) in 1,2-dimethoxyethane (16 mL) and water (5 mL). The mixture was warmed to 100 Â°C. After 14 h, the reaction was cooled to room temperature, diluted with brine, and extracted with EtOAc (Ã3), and the combined organic layers were dried over sodium sulfate, filtered, and concentrated <i>in vacuo</i>. The resulting residue was purified by flash column chromatography (SiO<sub>2</sub>, 0â50% ethylacetate/hexanes) to give <i>N,N</i>-diethyl-2-chloro-4-ethenylbenzamide as a off-white solid (0.47 g, 96%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.41 (d, <i>J</i> = 1.3 Hz, 1 H), 7.31 (dd, <i>J</i> = 7.9, 1.3 Hz, 1 H), 7.21 (d, <i>J</i> = 7.9 Hz, 1 H), 6.64 (dd, <i>J</i> = 17.6, 11.0 Hz, 1 H), 5.78 (d, <i>J</i> = 17.6 Hz, 1 H), 5.34 (d, <i>J</i> = 11.0 Hz, 1 H), 3.73â3.83 (m, 1 H), 3.35 (dd, <i>J</i> = 13.2, 6.2 <a name="jm005000601376" id="jm005000601376"></a> Hz, 1 H), 3.15 (dt, <i>J</i> = 11.4, 7.0 Hz, 2 H), 1.25 (t, <i>J</i> = 7.3 Hz, 3 H) 1.05 (t, <i>J</i> = 7.0 Hz, 3 H). MS (ESI) 238 (M + H). </div><div class="NLM_p"><b>Step C.</b> To <i>N,N</i>-diethyl-2-chloro-4-ethenylbenzamide (0.15 g, 0.62mmol) was added ethanol (5 mL), and the resulting solution was degassed via alternating exposure to vacuum and argon. To this mixture was added Raney nickel and the black suspension was subjected a hydrogen atmosphere (1 atm). After 3 h, the reaction was filtered and concentrated <i>in vacuo</i>, and the resulting yellow residue was purified by radial chromatography (SiO<sub>2</sub>, 0â50% EtOAc/hexanes) to afford <i>N,N</i>-diethyl-2-chloro-4-ethylbenzamide (0.11 g, 70%) as a clear residue. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.20 (d, <i>J</i> = 1.3 Hz, 1 H), 7.16 (d, <i>J</i> = 7.9 Hz, 1 H), 7.10 (dd, <i>J</i>= 7.9, 1.3 Hz, 1 H), 3.77 (s, 1 H), 3.36 (s, 1 H), 3.15 (qd, <i>J</i> = 7.0, 2.2 Hz, 2 H), 2.63 (q, <i>J</i> = 7.6 Hz, 2 H), 1.20â1.27 (m, 6 H), 1.05 (t, <i>J</i> = 7.0 Hz, 3 H). MS (ESI) 240 (M â Cl). </div><div class="NLM_p"><b>Step D.</b> (<i>R</i>)-7-Chloro-9-ethyl-1,3,4,10b-tetrahydropyrazino[2,1-<i>a</i>]isoindol-6(2<i>H</i>)-one HCl was prepared from <i>N,N</i>-diethyl-2-chloro-4-ethylbenzamide according to General Procedure B and the General Procedure for the synthesis of chiral pyrazino[2,1-<i>a</i>]isoindol-6(2<i>H</i>)-one hydrochloric acid salts. Enantiomeric excess >99:1 based on chiral HPLC. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´ 7.47 (s, 1 H), 7.41 (s, 1 H), 4.83 (dd, <i>J</i> = 11.9, 3.9 Hz, 1 H), 4.53 (dd, <i>J</i> = 14.1, 4.4 Hz, 1 H), 4.07 (dd, <i>J</i> = 12.3, 3.94 Hz, 1 H), 3.47â3.56 (m, 2 H), 3.05 (dt, <i>J</i> = 12.2, 4.6 Hz, 1 H), 2.74â2.82 (m, 3 H), 1.29 (t, <i>J</i> = 7.5 Hz, 3 H), MS (ESI) 251 (M â Cl). Anal. (C<sub>13</sub>H<sub>15</sub>ClN<sub>2</sub>OÂ·HClÂ·H<sub>2</sub>O), C, H, N. </div><div class="NLM_p"><b>(</b><b><i>R</i></b><b>)-9-Acetyl-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-</b><b><i>a</i></b><b>]isoindol-6(2</b><b><i>H</i></b><b>)-one </b><b>Hydrochloric Acid Salt (53). Step A.</b> To a stirring solution of (<i>R</i>)-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-<i>a</i>]isoindol-6(2<i>H</i>)-one hydrochloric acid salt (688 mg, 2.4 mmol) were added concentrated sulfuric acid (2.4 mL) [conc. sulfuric acid is neat, not aqueous] and <i>N</i>-bromosuccinimide (420 mg, 2.4 mmol). The resulting brown solution was covered with aluminum foil and stirred in the dark for 24 h. The reaction was then diluted with iceâwater and basified with saturated aqueous sodium bicarbonate. The resulting mixture was diluted with tetrahydrofuran (30 mL) and treated with di-<i>tert</i>-butyl dicarbonate (567 mg, 2.6 mmol). After 4 h, the reaction was extracted with EtOAc (3 Ã 50 mL), and the combined organic layers were dried over sodium sulfate, filtered, and concentrated <i>in vacuo</i>. The resulting residue was purified by radial chromatography (SiO<sub>2</sub>, 25% EtOAc in hexanes) to afford <i>N</i>-(<i>tert</i>-butoxycarbonyl)-(<i>R</i>)-9-bromo-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-<i>a</i>]isoindol-6(2<i>H</i>)-one (878 mg, 85%) as a white foam-like solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.93 (s, 1 H), 7.80 (s, 1 H), 4.75 (s, 1H), 4.44 (dd, <i>J</i> = 11.0, 4.4 Hz, 1 H), 4.38 (dd, <i>J</i> = 13.6, 3.1 Hz, 1 H), 4.20 (s, 1 H), 3.10â3.18 (m, 1 H), 2.77 (s, 1 H), 2.37 (s, 1 H), 1.51 (s, 9 H). MS (ESI) 435.2, 437.2 (M + H). </div><div class="NLM_p"><b>Step B.</b> To a degassed solution of tetrakis(triphenylphospine)palladium(0) (3 mg, 0.002 mmol) in toluene (2 mL) was added <i>N</i>-(<i>tert</i>-butoxycarbonyl)-(<i>R</i>)-9-bromo-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-<i>a</i>]isoindol-6(2<i>H</i>)-one (50 mg, 0.12 mmol). The resulting solution was degassed by exposure to vacuum and then an argon atmosphere (Ã3). To this solution was added tributyl(1-ethoxyvinyl)tin (0.041 mL, 0.12 mmol). The resulting solution was degassed a final time and was then warmed to reflux. The light yellow solution was maintained at reflux conditions for 14 h and became gray in color. The reaction was cooled and diluted with EtOAc, aqueous HCl (1 N), and saturated aqueous sodium chloride. The layers were separated and the aqueous layer was extracted with EtOAc. The combined organic layers were dried over sodium sulfate, filtered, and concentrated <i>in vacuo</i>. The resulting residue was purified by radial chromatography (SiO<sub>2</sub>, 10â30% EtOAc in hexanes) to give a clear residue. To the residue was added concentrated aqueous HCl (1 mL). After 5 min, the solution was concentrated <i>in vacuo</i>, diluted with water, and lyophilized to give <b>53</b> as a white solid (33 mg, 62%). Enantiomeric excess >99:1 based on chiral HPLC. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´ 8.57 (s, 1 H), 8.41 (s, 1 H), 5.02 (dd, <i>J</i> = 11.6, 3.7 Hz, 1 H), 4.53â4.63 (m, 1 H), 4.23 (dd, <i>J</i> = 12.3, 3.9 Hz, 1 H), 3.51â3.62 (m, 2 H), 3.03â3.13 (m, 1 H), 2.88 (t, <i>J</i> = 12.1 Hz, 1 H), 2.73 (s, 3 H). MS (ESI) 299.3 (M â Cl). Anal. (C<sub>14</sub>H<sub>13</sub>F<sub>3</sub>N<sub>2</sub>O<sub>2</sub>Â·HClÂ·1.3H<sub>2</sub>O), C, H, N. </div><div class="NLM_p"><b>(</b><b><i>R</i></b><b>)-9-Chloro-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-</b><b><i>a</i></b><b>]isoindol-6(2</b><b><i>H</i></b><b>)-one </b><b>Hydrochloric Acid Salt (52). Step A.</b> To a stirring degassed solution of <i>N</i>-(<i>tert</i>-butoxycarbonyl)-(<i>R</i>)-9-bromo-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-<i>a</i>]isoindol-6(2<i>H</i>)-one (464 mg, 1.1 mmol) in dry DMF (5 mL) was added copper(I) chloride (211 mg, 2.1 mmol). The reaction was heated to reflux for 4 h and then cooled to room temperature. The reaction was treated with di-<i>tert</i>-butyl dicarbonate (350 mg, 1.6 mmol). The reaction was stirred for 1 h and then quenched with 9:1 saturated NH<sub>4</sub>Cl:NH<sub>4</sub>OH. After 15 min, the reaction was extracted with EtOAc (3 Ã 10 mL). The organic layers were combined, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated <i>in vacuo</i> to a brown oil. The oil was purified by flash chromatography (SiO<sub>2</sub>, 0â50% EtOAc in hexanes) to yield 140 mg of a colorless oil. To the oil was added concentrated aqueous HCl (1 mL). After 5 min, the solution was concentrated <i>in vacuo</i>, diluted with water, and lyophilized to give <b>52</b> as a white solid (114 mg, 36%). Enantiomeric excess >99:1 based on chiral HPLC. <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) Î´ 7.95 (s, 1 H), 7.90 (s, 1 H), 4.97 (dd, <i>J</i> = 11.9, 3.9 Hz, 1 H), 4.50 (dd, <i>J</i> = 14.3, 4.2 Hz, 1 H), 4.10 (dd, <i>J</i> = 12.5, 4.2 Hz, 1 H), 3.60 (dd, <i>J</i> = 12.7, 3.5 Hz, 1 H), 3.48â3.57 (m, 1 H), 3.03 (dt, <i>J</i> = 12.7, 4.4 Hz, 1 H), 2.82 (t, <i>J</i> = 12.3 Hz, 1 H), MS (ESI) 291 (M â Cl). Anal. (C<sub>12</sub>H<sub>10</sub>ClF<sub>3</sub>N<sub>2</sub>O<sub>2</sub>Â·HClÂ·1.5H<sub>2</sub>O), C, H, N. </div><div class="NLM_p"><b>(</b><b><i>R</i></b><b>)-9-Hydroxymethyl-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-</b><b><i>a</i></b><b>]isoindol-6(2</b><b><i>H</i></b><b>)-</b><b>one Hydrochloric Acid Salt (54).</b> To a stirring solution of <i>N</i>-(<i>tert</i>-butoxycarbonyl)-(<i>R</i>)-9-(<i>cis</i>-1-propenyl)-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-<i>a</i>]isoindol-6(2<i>H</i>)-one (182 mg, 0.46 mmol) in MeOH (5.0 mL) at â78 Â°C was bubbled ozone for 5 min until the reaction turned a light blue color. After 5 min, sodium borohydride (23 mg, 0.6 mmol) was added. The reaction was stir for 1 h and then warmed to room temperature. The reaction was concentrated <i>in vacuo</i> to a white solid and then dissolved in 1 M aq HCl. After 15 min, the reaction was diluted with EtOAc, basified with NaHCO<sub>3</sub>, and treated with di-<i>tert</i>-butyl dicarbonate (125 mg, 0.58 mmol). After 1 h, the reaction was extracted with EtOAc (3 Ã 5 mL). The organic layers were combined, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated <i>in vacuo</i> to a colorless oil. The oil was purified by flash chromatography (silica gel, 0â50% EtOAc in hexanes) to give 141 mg of a white solid. To 14 mg of the white solid was added concentrated aqueous HCl (1 mL). After 5 min, the solution was concentrated <i>in vacuo</i>, diluted with water, and lyophilized to give <b>54</b> as a white solid (11 mg). Enantiomeric excess >99:1 based on chiral HPLC. <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) Î´ 7.90 (s, 1 H), 7.84 (s, 1 H), 4.99 (dd, <i>J</i> = 11.9, 3.9 Hz, 1 H), 4.79 (s, 2 H), 4.53 (dd, <i>J</i> = 14.5, 4.4 Hz, 1 H), 4.15 (dd, <i>J</i> = 12.3, 3.9 Hz, 1 H), 3.50â3.65 (m, 2 H), 3.06 (dt, <i>J</i> = 12.3, 4.4 Hz, 1 H,) 2.83 (t, <i>J</i> = 12.1 Hz, 1 H). MS (ESI) 287 (M â Cl). (C<sub>13</sub>H<sub>13</sub>F<sub>3</sub>N<sub>2</sub>O<sub>2</sub>Â·1.25HClÂ·0.5H<sub>2</sub>O), C, H, N. </div><div class="NLM_p"><b>(</b><b><i>R</i></b><b>)-9-Methoxy-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-</b><b><i>a</i></b><b>]isoindol-6(2</b><b><i>H</i></b><b>)-one </b><b>Hydrochloric Acid Salt (55). Step A.</b> To a stirring degassed solution of <i>N</i>-(<i>tert</i>-butoxycarbonyl)-(<i>R</i>)-9-bromo-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-<i>a</i>]isoindol-6(2<i>H</i>)-one (435 mg, 1.0 mmol), bis(pinacolato)diboron (279 mg, 1.1 mmol), and potassium acetate (294 mg, 3.0 mmol) in dry DMF (5.0 mL) was added palladium(II) acetate (6.7 mg, 0.03 mmol). The reaction was heated to 80 Â°C for 2 h and then cooled to room temperature. The reaction was quenched with water and extracted with EtOAc (3 Ã 5 mL). The organic layers were combined, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated <i>in vacuo</i> to a brown oil. The oil was dissolved in THF (5 mL) and acetic acid (0.05 mL) and treated with hydrogen peroxide (0.25 mL). The reaction was stirred for 15 min and then quenched with saturated aqueous NaHSO<sub>3</sub>. The reaction was extracted with EtOAc (3 Ã 5 mL). The organic layers were combined, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated <i>in vacuo</i> to a brown oil. The oil was purified by flash chromatography (SiO<sub>2</sub>, 0â70% EtOAc in hexanes) to give 347 mg of <i>N</i>-(<i>tert</i>-butoxycarbonyl)-(<i>R</i>)-9-methoxy-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-<i>a</i>]isoindol-6(2<i>H</i>)-one as a pale yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.86 (s, 1 H), 7.28 (s, 2 H), 7.17 <a name="jm005000601377" id="jm005000601377"></a> (s, 2 H), 4.56 (s, 1 H), 4.48 (dd, <i>J</i> = 10.6, 3.9 Hz, 1 H), 4.08 (dd, <i>J</i> = 12.7, 3.5 Hz, 1 H), 4.01 (d, <i>J</i> = 7.0 Hz, 1 H), 3.03 (dt, <i>J</i> = 12.7, 3.9 Hz, 1 H), 2.64â2.76 (m, 1 H), 2.38 (s, 1 H), 1.44 (s, 9 H). MS (ESI) 373 (M + H). </div><div class="NLM_p"><b>Step B.</b> To a stirring degassed solution of <i>N</i>-(<i>tert</i>-butoxycarbonyl)-(<i>R</i>)-9-methoxy-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-<i>a</i>]isoindol-6(2<i>H</i>)-one (58 mg, 0.16 mmol), and potassium carbonate (33 mg, 0.24 mmol) in dry DMF (1.0 mL) was added methyl iodide (24 mg, 0.17 mmol). The reaction was stirred for 2 h and then quenched with brine. The reaction was extracted with EtOAc (3 Ã 5 mL). The organic layers were combined, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated <i>in vacuo</i> to a pale yellow oil. The oil was purified by flash chromatography (SiO<sub>2</sub>, 0â50% EtOAc in hexanes) to give 41 mg of a colorless oil. To the oil was added concd aq HCl (1 mL). After 5 min, the solution was concentrated <i>in vacuo</i>, diluted with water, and lyophilized to give <b>54</b> as a white solid (30 mg, 50%). Enantiomeric excess >99:1 based on chiral HPLC. <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) Î´ ppm 7.44 (s, 1 H), 7.38 (s, 1 H), 4.93 (d, <i>J</i> = 11.9 Hz, 1 H), 4.49 (dd, <i>J</i> = 14.7, 4.2 Hz, 1 H), 4.09 (dd, <i>J</i> = 12.7, 3.9 Hz, 1 H), 3.92 (s, 3 H), 3.60 (dd, <i>J</i> = 12.7, 3.5 Hz, 1 H), 3.48â3.56 (m, 2 H), 3.04 (dt, <i>J </i>= 12.6, 4.2 Hz, 1 H), 2.82 (t, <i>J</i> = 12.1 Hz, 1 H). MS (ESI) 287 (M â Cl). Anal. (C<sub>13</sub>H<sub>13</sub>F<sub>3</sub>N<sub>2</sub>O<sub>2</sub>Â·HClÂ·H<sub>2</sub>O), C, H, N. </div><div class="NLM_p"><b>(</b><b><i>R</i></b><b>)-9-Ethoxy-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-</b><b><i>a</i></b><b>]isoindol -6(2</b><b><i>H</i></b><b>)-one </b><b>Hydrochloric Acid Salt (56).</b> Prepared according to procedures described for compound <b>55</b> with substitution of ethyl iodide for methyl iodide in Step B. Enantiomeric excess >99:1 based on chiral HPLC. <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) Î´ 7.43 (s, 1 H), 7.35 (s, 1 H), 4.91 (dd, <i>J</i> = 11.9, 3.9 Hz, 1 H), 4.49 (dd, <i>J</i> = 14.7, 4.2 Hz, 1 H), 4.20 (q, <i>J</i> = 7.0 Hz, 2 H), 4.08 (dd, <i>J</i> = 12.5, 4.2 Hz, 1 H), 3.59 (dd, <i>J</i> = 12.7, 3.5 Hz, 1 H), 3.47â3.55 (m, 1 H), 3.03 (dt, <i>J</i> = 12.6, 4.6 Hz, 1 H), 2.81 (t, <i>J</i> = 12.3 Hz, 1 H), 1.38 (t, <i>J</i> = 7.0 Hz, 3 H). MS (ESI) 301 (M â Cl). Anal. (C<sub>14</sub>H<sub>15</sub>F<sub>3</sub>N<sub>2</sub>O<sub>2</sub>Â·HClÂ·1.2H<sub>2</sub>O), C, H, N. </div><div class="NLM_p"><b>(</b><b><i>R</i></b><b>)-9-Ethenyl-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-</b><b><i>a</i></b><b>]isoindo l-6(2</b><b><i>H</i></b><b>)-one </b><b>Hydrochloric Acid Salt (62).</b> Tetrakis(triphenylphospine)palladium(0) (305 mg, 0.26 mmol) was added in one portion to a degassed mixture of <i>N</i>-(<i>tert</i>-butoxycarbonyl)-(<i>R</i>)-9-bromo-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-<i>a</i>]isoindol-6(2<i>H</i>)-one (4.6 g, 11 mmol), potassium carbonate (1.8 g, 13 mmol), and 2,4,6-trivinylcyclotriboroxane pyridine complex (4.2 g, 11 mmol) in 1,2-dimethoxyethane (80 mL) and water (25 mL). The mixture was warmed to 100 Â°C. After 1 h, the reaction was cooled to room temperature, diluted with brine, and extracted with EtOAc (Ã3), and the combined organic layers were dried over sodium sulfate, filtered, and concentrated <i>in vacuo</i>. The resulting residue was purified by flash column chromatography (SiO<sub>2</sub>, 0â50% ethyl acetate/hexanes) to as a off-white solid (3.53 g, 87%). To 15 mg of white solid was added concentrated aqueous HCl (1 mL). After 5 min, the solution was concentrated <i>in vacuo</i>, diluted with water, and lyophilized to give <b>62</b> as a white solid (11 mg). Enantiomeric excess >99:1 based on chiral HPLC. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´ 8.04 (s, 1 H), 7.94 (s, 1 H), 6.94 (dd, <i>J</i> = 17.6, 11.0 Hz, 1 H), 6.11 (d, <i>J</i> = 17.6 Hz, 1 H), 5.56 (d, <i>J</i> = 11.0 Hz, 1 H), 4.88â4.93 (m, 1 H), 4.55 (dd, <i>J</i> = 14.3, 4.2 Hz, 1 H,) 4.14 (dd, <i>J</i> = 12.3, 3.9 Hz, 1 H), 3.52â3.58 (m, 1 H), 3.45â3.50 (m, 1 H), 3.06 (dt, <i>J</i> = 12.2, 4.2 Hz, 1 H), 2.85 (t, <i>J</i> = 12.1 Hz, 1 H). MS (ESI) 283 (M â Cl). Anal. (C<sub>14</sub>H<sub>13</sub>F<sub>3</sub>N<sub>2</sub>OÂ·1.3HClÂ·2H<sub>2</sub>O), C, H, N. </div><div class="NLM_p"><b>(</b><b><i>R</i></b><b>)-9-Ethyl-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-</b><b><i>a</i></b><b>]isoindol-6(2</b><b><i>H</i></b><b>)-one </b><b>Hydrochloric Acid Salt (58).</b> To <i>N</i>-(<i>tert</i>-butoxycarbonyl)-(<i>R</i>)-9-ethenyl-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-<i>a</i>]isoindol-6(2<i>H</i>)-one (3.53 mg, 9.22) was added methanol (50 mL), and the resulting solution was degassed via alternating exposure to vacuum and argon. To this solution was added 10% palladium on carbon (300 mg, 10 wt %), and the black suspension was subjected a hydrogen atmosphere (1 atm). After 1 h, the reaction was filtered and concentrated <i>in vacuo</i>, and the resulting yellow residue was purified by flash column chromatography (SiO<sub>2</sub>, 0â50% EtOAc/hexanes) to afford a white foam solid (3.1 g, 87%). To the 21 mg of white solid was added concentrated aqueous HCl (1 mL). After 5 min, the solution was concentrated <i>in vacuo</i>, diluted with water, and lyophilized to give <b>58</b> as a white solid (17 mg). Enantiomeric excess >99:1 based on chiral HPLC. <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) Î´ 7.80 (s, 1 H), 7.75 (s, 1 H), 4.87â4.90 (m, 1 H), 4.53 (dd, <i>J</i> = 14.1, 4.4 Hz, 1 H), 4.11 (dd, <i>J</i> = 12.3, 3.9 Hz, 1 H), 3.51â3.56 (m, 1 H), 3.44â3.49 (m, 1 H), 2.99â3.08 (m, 1 H), 2.87 (q, <i>J</i> = 7.5 Hz, 2 H), 2.80 (t, <i>J</i> = 12.1 Hz, 1 H), 1.31 (t, <i>J</i> = 7.7 Hz, 3 H). <sup>13</sup>C (100 MHz, d<sub>6</sub>-DMSO) Î´ 162.0 (s, 1H), 148.8 (s, 1H), 144.8 (s, 1H), 126.6 (s, 1H), 126.1 (s, 1H), 126.0 (s, 1H), 125.0 (q, <i>J</i> = 33.6 Hz, 1H), 122.9 (q, <i>J</i> = 271.0 Hz, 1H), 53.0 (s, 1H), 45.8 (s, 1H), 41.8 (s, 1H), 35.6 (s, 1H), 28.1 (s, 1H), 15.1 (s, 1H). MS (ESI) 271.3 (M + H). [Î±]<sub>D</sub> â23.3 (0.660 g/dL, MeOH). Anal. (C<sub>14</sub>H<sub>15</sub>F<sub>3</sub>N<sub>2</sub>OÂ·HCl), C, H, N. </div><div class="NLM_p"><b>(</b><b><i>R</i></b><b>)-9-Methyl-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-</b><b><i>a</i></b><b>]isoindol-6(2</b><b><i>H</i></b><b>)-one </b><b>Hydrochloric Acid Salt (57).</b> Prepared according to procedures described for compound <b>62</b> with substitution of trimethylboroxine for 2,4,6-trivinylcyclotriboroxane pyridine complex. Enantiomeric excess >99:1 based on chiral HPLC. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) 7.76 (s, 1 H), 7.66 (s, 1 H), 4.92 (dd, <i>J</i> = 11.9, 3.9 Hz, 1 H), 4.51 (dd, <i>J</i> = 14.7, 4.2 Hz, 1 H), 4.10 (dd, <i>J</i> = 12.3, 4.4 Hz, 1 H), 3.60 (dd, <i>J</i> = 12.7, 3.9 Hz, 1 H), 3.48â3.57 (m, 1 H), 3.04 (dt, <i>J</i> = 12.6, 4.2 Hz, 1 H), 2.79 (t, <i>J</i> = 12.3 Hz, 1 H), 2.48 (s, 3 H). MS (ESI) 271 (M â Cl). Anal. (C<sub>13</sub>H<sub>13</sub>F<sub>3</sub>N<sub>2</sub>OÂ·HClÂ·0.7H<sub>2</sub>O), C, H, N. </div><div class="NLM_p"><b>(</b><b><i>R</i></b><b>)-9-Propyl-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-</b><b><i>a</i></b><b>]isoindol-6(2</b><b><i>H</i></b><b>)-one </b><b>Hydrochloric Acid Salt (59).</b> Prepared according to the procedures of compound <b>62</b> and <b>58</b> with the substitution of <i>cis</i>-1-propenylboronic acid for 2,4,6-trivinylcyclotriboroxane pyridine complex. Enantiomeric excess >99:1 based on chiral HPLC. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´ 7.79 (s, 1 H), 7.73 (s, 1 H), 4.88â4.92 (m, 1 H), 4.54 (dd, <i>J</i> = 13.8, 4.2 Hz, 1 H), 4.13 (dd, <i>J</i> = 12.3, 3.9 Hz, 1 H), 3.46â3.58 (m, 2 H), 3.00â3.09 (m, 1 H), 2.77â2.85 (m, 3 H), 1.68â1.77 (m, 2 H), 0.98 (t, <i>J</i> = 7.5 Hz, 3 H). MS (ESI) 299.3 (M â Cl). Anal. (C<sub>15</sub>H<sub>17</sub>F<sub>3</sub>N<sub>2</sub>OÂ·HClÂ·0.4H<sub>2</sub>O), C, H, N. </div><div class="NLM_p"><b>(</b><b><i>R</i></b><b>)-9-Butyl-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-</b><b><i>a</i></b><b>]isoindol-6(2</b><b><i>H</i></b><b>)-one </b><b>Hydrochloric Acid Salt (60).</b> Prepared according to procedures described in Example <b>62</b> with substitution of n-butylboronic acid for <i>cis</i>-1-propenylboronic acid and 1,1â-bis(diphenylphosphino)ferrocene palladium(II) dichloride dichloromethane complex for tetrakis(triphenylphosphine)-palladium(0). Enantiomeric excess >99:1 based on chiral HPLC. <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) Î´ 7.76 (s, 1 H), 7.67 (s, 1 H), 4.91 (dd, <i>J</i> = 11.9, 3.9 Hz, 1 H), 4.50 (dd, <i>J</i> = 14.5, 3.9 Hz, 1 H), 4.09 (dd, <i>J</i> = 12.5, 4.2 Hz, 1 H), 3.59 (dd, <i>J</i> = 12.7, 3.9 Hz, 1 H), 3.47â3.56 (m, 1 H), 3.03 (dt, <i>J</i> = 12.5, 4.4 Hz, 1 H), 2.72â2.82 (m, 3 H), 1.55â1.64 (m, 2 H), 1.25 (dq, <i>J</i> = 14.9, 7.5 Hz, 2 H), 0.84 (t, <i>J</i> = 7.0 Hz, 3 H). MS (ESI) 313 (M â Cl). Anal. (C<sub>16</sub>H<sub>19</sub>F<sub>3</sub>N<sub>2</sub>OÂ·HClÂ·1.1H<sub>2</sub>O), C, H, N. </div><div class="NLM_p"><b>(</b><b><i>R</i></b><b>)-9-Isopropyl-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-</b><b><i>a</i></b><b>]isoindol-6(2</b><b><i>H</i></b><b>)-one </b><b>Hydrochloric Acid Salt (61).</b> Prepared according to procedures described for compound <b>62</b> and <b>58</b> with substitution of isopropenylboronic acid for 2,4,6-trivinylcyclotriboroxane pyridine complex. Enantiomeric excess >99:1 based on chiral HPLC. <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) Î´ 7.82 (s, 1 H), 7.74 (s, 1 H), 4.93 (dd, <i>J</i> = 11.9, 3.9 Hz, 1 H), 4.51 (dd, <i>J</i> = 14.9, 3.9 Hz, 1 H), 4.11 (dd, <i>J</i> = 12.3, 3.5 Hz, 1 H), 3.62 (d, <i>J</i> = 2.6 Hz, 1 H), 3.54â3.64 (m, 1 H), 3.47â3.53 (m, 1 H), 3.00â3.13 (m, 1 H), 2.78 (t, <i>J</i> = 12.1 Hz, 1 H), 1.24 (d, <i>J</i> = 7.0 Hz, 6 H). MS (ESI) 299 (M â Cl). Anal. (C<sub>15</sub>H<sub>18</sub>F<sub>3</sub>N<sub>2</sub>OÂ·1.6HClÂ·H<sub>2</sub>O), C, H, N. </div><div class="NLM_p"><b>(</b><b><i>R</i></b><b>)-9-Ethynyl-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-</b><b><i>a</i></b><b>]isoindol-6(2</b><b><i>H</i></b><b>)-one </b><b>Hydrochloric Acid Salt (63).</b> To a stirring solution of <i>N</i>-(<i>tert</i>-butoxycarbonyl)-(<i>R</i>)-1,3,4,10b-tetrahydro-9-trimethylsilylethynyl-7-trifluoromethylpyrazino[2,1-<i>a</i>]isoindol-6(2<i>H</i>)-one (44 mg, 0.1 mmol) [prepared according to procedures described for compound <b>52</b> with substitution of tributyl(trimethylsilylethynyl)tin for tributyl(1-ethoxyvinyl)tin] in MeOH (1.0 mL) was added potassium carbonate (13 mg, 0.1 mmol). The reaction was stirred for 5 min and then quenched with brine. The reaction was extracted with EtOAc (2 Ã 5 mL). The organic layers were combined, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated <i>in vacuo</i> to a pale <a name="jm005000601378" id="jm005000601378"></a> yellow oil. The oil was purified by radial chromatography (SiO<sub>2</sub>, 30% EtOAc in hexanes) to give 27 mg of a pale yellow oil. To the oil was added concentrated aqueous HCl (1 mL). After 5 min, the solution was concentrated <i>in vacuo</i>, diluted with water, and lyophilized to give <b>59</b> as a white solid (21 mg). Enantiomeric excess >99:1 based on chiral HPLC. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´ 8.05 (s, 1 H), 7.96 (s, 1 H), 4.90 (dd, <i>J</i> = 11.6, 4.2 Hz, 1 H), 4.55 (dd, <i>J</i> = 14.1, 3.9 Hz, 1 H), 4.11 (dd, <i>J</i> = 12.3, 3.9 Hz, 1 H), 4.00 (s, 1 H), 3.51â3.57 (m, 1 H), 3.44â3.49 (m, 1 H), 3.05 (dt, <i>J</i> = 12.4, 4.6 Hz, 1 H), 2.85 (t, <i>J</i>=12.1 Hz, 1 H). MS (ESI) 281 (M â Cl). Anal. (C<sub>14</sub>H<sub>11</sub>F<sub>3</sub>N<sub>2</sub>OÂ·HClÂ·1.1H<sub>2</sub>O), C, H, N. </div><div class="NLM_p"><b>(</b><b><i>R</i></b><b>)-9-Cyclopropyl-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-</b><b><i>a</i></b><b>]isoindol-6(2</b><b><i>H</i></b><b>)-one </b><b>Hydrochloric Acid Salt (64).</b> Prepared according to procedures described for compound <b>62</b> with substitution of 2-cyclopropyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane for 2,4,6-trivinylcyclotriboroxane pyridine complex and 1,1â-bis(diphenylphosphino)ferrocene palladium(II) dichloride dichloromethane complex for tetrakis(triphenylphosphine)palladium(0). Enantiomeric excess >99:1 based on chiral HPLC. <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) Î´ 7.62 (s, 1 H), 7.52 (s, 1 H), 4.90 (dd, <i>J</i> = 12.1, 4.2 Hz, 1 H), 4.50 (dd, <i>J</i> = 14.7, 4.2 Hz, 1 H), 4.08 (dd, <i>J</i> = 12.3, 4.4 Hz, 1 H), 3.56â3.62 (m, 1 H), 3.47â3.56 (m, 1 H), 3.03 (dt, <i>J</i> = 12.6, 4.6 Hz, 1 H), 2.77 (t, <i>J</i> = 14.0 Hz, 1H), 2.07â2.13 (m, 1 H), 1.09â1.14 (m, 2 H), 0.81â0.85 (m, 2 H). MS (ESI) 297 (M â Cl). Anal. (C<sub>15</sub>H<sub>15</sub>F<sub>3</sub>N<sub>2</sub>OÂ·HClÂ·0.9H<sub>2</sub>O), C, H, N. </div><div class="NLM_p"><b>(</b><b><i>R</i></b><b>)-9-(1-Methylcyclopropyl)-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-</b><b><i>a</i></b><b>]isoindol-</b><b>6(2</b><b><i>H</i></b><b>)-one Hydrochloric Acid Salt (65).</b> To a stirring degassed solution of <i>N</i>-(<i>tert</i>-butoxycarbonyl)-(<i>R</i>)-9-isopropenyl-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-<i>a</i>]isoindol-6(2<i>H</i>)-one (185 mg, 0.47 mmol) and palladium(II) acetate (1 mg, 0.004 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (1 mL) under Ar was added a 0.5 M solution of diazomethane in ether (2.6 mL). After 1 h, the reaction was warmed to room temperature for 16 h. The addition of diazomethane was repeated twice more. The reaction was filtered and then concentrated <i>in vacuo</i> to a pale yellow oil. The oil was dissolved in acetone (2 mL) and treated with 4-methylmorpholine <i>N</i>-oxide (55 mg, 0.47 mmole) and osmium tetraoxide in water (1.0 mg in 0.16 mL). The reaction was stirred for 1 h and then quenched with sat. aq Na<sub>2</sub>SO<sub>3</sub>. The reaction was extracted with EtOAc (3 Ã 10 mL). The organic layers were combined, dried over MgSO<sub>4</sub>, and concentrated <i>in vacuo</i> to a pale yellow oil. The oil was purified by flash chromatography (SiO<sub>2</sub>, 0â50% EtOAc in hexanes) to yield a colorless oil (83 mg, 43%). To the oil was added concentrated aqueous HCl (1 mL). After 5 min, the solution was concentrated <i>in vacuo</i>, diluted with water, and lyophilized to give <b>65</b> as a white solid (63 mg). Enantiomeric excess >99:1 based on chiral HPLC. <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) Î´ 7.75 (s, 1 H), 7.71 (s, 1 H), 4.89 (dd, <i>J</i> = 11.9, 3.9 Hz, 1 H), 4.49 (dd, <i>J</i> = 14.5, 4.4 Hz, 1 H), 4.08 (dd, <i>J</i> = 12.3, 3.9 Hz, 1 H), 3.49â3.60 (m, 2 H), 3.01 (dt, <i>J</i> = 12.5, 3.9 Hz, 1 H), 2.75 (t, <i>J</i> = 12.3 Hz, 1 H), 1.40 (s, 3 H), 0.92â0.98 (m, 2 H), 0.87â0.91 (m, 2 H). MS (ESI) 311 (M â Cl). Anal. (C<sub>16</sub>H<sub>17</sub>F<sub>3</sub>N<sub>2</sub>OÂ·HClÂ·1.6H<sub>2</sub>O), C, H, N. </div><div class="NLM_p"><b>Binding Assays for the 5-HT</b><b><sub>2A</sub></b><b>, 5-HT</b><b><sub>2B</sub></b><b>, and 5-HT</b><b><sub>2C</sub></b><b> Receptors.</b> Radioligand binding studies were conducted to determine the binding affinities (<i>K</i><sub>i</sub> values) of compounds for the human recombinant 5-HT<sub>2A</sub>, 5-HT<sub>2B</sub>, and 5-HT<sub>2C</sub> receptors stably expressed in HEK293E cell line.<sup><a onclick="showRef(event, 'jm0612968b00020'); return false;" href="javascript:void(0);" class="ref jm0612968b00020">20</a></sup> Assays were conducted in disposable polypropylene 96-well plates (Costar Corp., Cambridge, MA) and were initiated by the addition of 5-HT<sub>2A</sub>,5-HT<sub>2B</sub>, or 5-HT<sub>2C</sub> membrane homogenate in tissue buffer (10â30 Î¼g/well) to assay buffer (50 mM Tris HCl, 0.5 mM EDTA, 10 mM pargyline, 10 mM MgSO<sub>4</sub>, 0.05% ascorbic acid, pH 7.5) containing [<sup>125</sup>I]DOI for the 5-HT<sub>2A</sub> and 5-HT<sub>2C</sub> receptors (0.3â0.5 nM, final) or [<sup>3</sup>H]LSD (1â2.0 nM, final) for the 5-HT<sub>2B</sub> receptor, with or without competing drug. For a typical competition experiment, a fixed concentration of radioligand was competed with duplicate concentrations of compound (12 concentrations ranging from 10 pM to 10 Î¼M). The reaction mixtures were incubated to equilibrium for 45 min at 37 Â°C and terminated by rapid filtration (Packard cell harvester; Perkin-Elmer) over GFF glass-fiber filters that had been presoaked in 0.3% polyethyleneimine. Filters were washed in ice-cold 50 mM Tris HCl buffer (pH 7.5) prior to determining radioactivity content on a Top Count (Packard). </div><div class="NLM_p"><b>Functional Assays for the 5-HT</b><b><sub>2A</sub></b><b>, 5-HT</b><b><sub>2B</sub></b><b>, and 5-HT</b><b><sub>2C</sub></b><b> Receptors.</b> HEK293E cells stably expressing the human 5-HT<sub>2A</sub>, 5-HT<sub>2C</sub>, or 5-HT<sub>2B</sub> receptors were maintained Dulbecco's modified Eagle's media with high glucose (DMEM; Gibco BRL) containing 10% dialyzed fetal bovine serum (FBS) and 500 Î¼g/mL G418 (Gibco BRL). The cells was lifted with 2 mL Cellstripper (Mediatech/Cellgro) and plated at a density of 20â000 cells/25 Î¼L/well onto poly-<span class="smallcaps smallerCapital">d</span>-lysine-coated 384-well plates (Biocoat; Becton Dickinson, Bedford, MA) in phenol red free Dulbecco's modified Eagle's media (DMEM; Gibco BRL) containing a high concentration of glucose without FBS. Following an overnight (â¼15â18 h) incubation at 37 Â°C, the cell plates were removed from the incubator and dye loading buffer (25 Î¼L of 1x Hanks BSS without calcium and magnesium with 25 mM HEPES) containing 5 Î¼M of the calcium dye reagent Fluo-4 was added to each well. Following the dye loading of the cells for 1 h at room temperature, the cell plates were transferred to the FLIPR<sup>384</sup> (Molecular Devices, Sunnyvale, CA). Eleven concentrations of test compounds in 25 Î¼L loading buffer were added to the cell plate on the FLIPR<sup>384</sup> to determine a concentrationâresponse curve, and the changes in fluorescence units due to the elevation of intracellular calcium were monitored for a period of 90 s. The raw data from time sequence recording was normalized to the percentage response obtained from the positive control (Serotonin 3 Î¼M) on the same plate and analyzed to fit the four-parameter logistic equation in order to assess the compound's potency (EC<sub>50</sub>) and efficacy (intrinsic activity) from the 384-FLIPR agonist assay. </div><div class="NLM_p"><b>Rat Pharmacokinetic Study.</b> Male Sprague Dawley rats (Charles River, MA) weighing between 200 and 250 g were used. Animals were allowed free access to a standard laboratory chow and water. They were housed in a constant temperatureâhumidity environment. Three rats were used in each of the iv and oral (po) arms of the studies. Doses of 4.4 mg/kg and 8.86 mg/kg were administered via iv and po routes, respectively. The vehicle consisted of polyethylene glycol 400:Tween 80:water (15:1:84, v/v). Blood was sampled from the jugular vein at 0.25, 0.5, 1, 2, 4, 6, 8, 10, and 24 h postdose. Plasma was obtained after centrifugation of the blood samples. Following protein precipitation using acetonitrile and subsequent centrifugation, samples were analyzed using LC/MSâMS. </div><div class="NLM_p"><b>Rat 20</b><b> h</b><b> Operant Feeding Assay.</b> Compounds were assessed for their ability to reduce food consumption during a 20 h period, which began at the onset of the dark cycle. Male SpragueâDawley rats, obtained from Charles River Laboratories, were trained in operant chambers (Coulbourn Instruments, Allentown, Pa) equipped with a lever, a food hopper, a water bottle with photocells, and an infrared activity monitor. Rats were trained on a fixed ratio three (FR3) response paradigm which required three consecutive bar presses in order to obtain a food pellet (Research Diets purified food pellet). The number of bar presses and pellets consumed serve as the measure of food intake by the animal. Rats (<i>n</i> = 6) were administered (po) test compound or vehicle (14% PPG, 1% Tween, 85% water, v/v) 60 min prior to the onset of the dark cycle. Treated animals were then placed in individual operant boxes for 20 h period (12 h of dark cycle and the first 8 h of the light cycle). Percent reduction in food intake was calculated as the ratio of total food intake of drug-treated animals divided to the total food intake of vehicle-treated counterparts. Simultaneous measurements of water intake and locomotor activity are also measured during the period to evaluate potential adverse effects. </div><div class="NLM_p"><b>Rat 4-Day Body Weight Loss Model</b>. Male Sprague Dawley (Charles River Breeding Laboratory) rats weighing approximately 240 g were placed in individual plastic cages with AlphaDri bedding. There were eight rats per treatment group. The room was maintained at 72 Â°F and 50% humidity, and a 12/12 light-dark cycle with lights out at 1600 h. The rats were conditioned for 5 days prior to the start of the study to have a choice of two diets:â (1) standard chow (Harlan Teklad, 2018) containing 18% protein, 5% fat, and 73% carbohydrate and (2) a high fat, high sugar diet <a name="jm005000601379" id="jm005000601379"></a> (Research Diets (D2327) containing 20% protein, 40% fat, and 40% carbohydrate where the carbohydrate is entirely sucrose and the fat is soybean and coconut oil. Drug treatment was po at 2.0 mL/kg as a solution in 15% propylene glycol, 1% Tween 80 in water at 1500 h beginning on day 0, and continuing daily through day 4. Body weight and consumption of both diets and water were measured daily. Water was available ad libitum throughout the study. Body weight data was converted to percent change from baseline where baseline body weight was measured prior to drug treatment on day 0 of the study. Differences between dose groups at specified time points were analyzed using ANOVA followed by Fisher's PLSD as the posthoc measure for dose differences. </div><div class="NLM_p last"><b>Gastric Parietal Cell Necrosis Assay.</b> Male CD-1 mice, obtained from Charles River Laboratories, received a single oral dose (by gavage) of 0, 30, 100, 200, or 300 mg/kg (<i>n</i> = 5/group) of an experimental compound or an internal tetracyclic indoline, as a positive control. Control animals were dosed with vehicle (aqueous 1% Tween 80/14% propylene glycol; 5 mL/kg). Mice were euthanized 24-h after dosing, and a blood sample was collected to determine plasma concentrations. Stomachs were removed, cleaned, and fixed in formalin prior to routine processing for histopathology evaluation following staining with hematoxylin and eosin (H&E). </div></div><div class="NLM_back"><div class="article_supporting-info" id=""><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm0612968/suppl_file/jm0612968si20070109_081041.pdf">jm0612968si20070109_081041.pdf (40.62 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm0612968" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84831" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84831" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><ul></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dean A. Wacker</span> - <span class="hlFld-Affiliation affiliation">Departments of Discovery Chemistry, Metabolic Diseases, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Pharmaceutical Research Institute, P.O. Box 5400, Princeton, New Jersey 08543-5400 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeffrey G. Varnes</span> - <span class="hlFld-Affiliation affiliation">Departments of Discovery Chemistry, Metabolic Diseases, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Pharmaceutical Research Institute, P.O. Box 5400, Princeton, New Jersey 08543-5400 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sarah E. Malmstrom</span> - <span class="hlFld-Affiliation affiliation">Departments of Discovery Chemistry, Metabolic Diseases, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Pharmaceutical Research Institute, P.O. Box 5400, Princeton, New Jersey 08543-5400 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xueying Cao</span> - <span class="hlFld-Affiliation affiliation">Departments of Discovery Chemistry, Metabolic Diseases, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Pharmaceutical Research Institute, P.O. Box 5400, Princeton, New Jersey 08543-5400 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chen-Pin Hung</span> - <span class="hlFld-Affiliation affiliation">Departments of Discovery Chemistry, Metabolic Diseases, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Pharmaceutical Research Institute, P.O. Box 5400, Princeton, New Jersey 08543-5400 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thao Ung</span> - <span class="hlFld-Affiliation affiliation">Departments of Discovery Chemistry, Metabolic Diseases, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Pharmaceutical Research Institute, P.O. Box 5400, Princeton, New Jersey 08543-5400 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ginger Wu</span> - <span class="hlFld-Affiliation affiliation">Departments of Discovery Chemistry, Metabolic Diseases, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Pharmaceutical Research Institute, P.O. Box 5400, Princeton, New Jersey 08543-5400 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ge Zhang</span> - <span class="hlFld-Affiliation affiliation">Departments of Discovery Chemistry, Metabolic Diseases, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Pharmaceutical Research Institute, P.O. Box 5400, Princeton, New Jersey 08543-5400 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eva Zuvich</span> - <span class="hlFld-Affiliation affiliation">Departments of Discovery Chemistry, Metabolic Diseases, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Pharmaceutical Research Institute, P.O. Box 5400, Princeton, New Jersey 08543-5400 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael A. Thomas</span> - <span class="hlFld-Affiliation affiliation">Departments of Discovery Chemistry, Metabolic Diseases, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Pharmaceutical Research Institute, P.O. Box 5400, Princeton, New Jersey 08543-5400 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">William J. Keim</span> - <span class="hlFld-Affiliation affiliation">Departments of Discovery Chemistry, Metabolic Diseases, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Pharmaceutical Research Institute, P.O. Box 5400, Princeton, New Jersey 08543-5400 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mary Jane Cullen</span> - <span class="hlFld-Affiliation affiliation">Departments of Discovery Chemistry, Metabolic Diseases, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Pharmaceutical Research Institute, P.O. Box 5400, Princeton, New Jersey 08543-5400 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kenneth W. Rohrbach</span> - <span class="hlFld-Affiliation affiliation">Departments of Discovery Chemistry, Metabolic Diseases, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Pharmaceutical Research Institute, P.O. Box 5400, Princeton, New Jersey 08543-5400 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qinling Qu</span> - <span class="hlFld-Affiliation affiliation">Departments of Discovery Chemistry, Metabolic Diseases, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Pharmaceutical Research Institute, P.O. Box 5400, Princeton, New Jersey 08543-5400 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rangaraj Narayanan</span> - <span class="hlFld-Affiliation affiliation">Departments of Discovery Chemistry, Metabolic Diseases, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Pharmaceutical Research Institute, P.O. Box 5400, Princeton, New Jersey 08543-5400 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Karen Rossi</span> - <span class="hlFld-Affiliation affiliation">Departments of Discovery Chemistry, Metabolic Diseases, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Pharmaceutical Research Institute, P.O. Box 5400, Princeton, New Jersey 08543-5400 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Evan Janovitz</span> - <span class="hlFld-Affiliation affiliation">Departments of Discovery Chemistry, Metabolic Diseases, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Pharmaceutical Research Institute, P.O. Box 5400, Princeton, New Jersey 08543-5400 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lois Lehman-McKeeman</span> - <span class="hlFld-Affiliation affiliation">Departments of Discovery Chemistry, Metabolic Diseases, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Pharmaceutical Research Institute, P.O. Box 5400, Princeton, New Jersey 08543-5400 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mary F. Malley</span> - <span class="hlFld-Affiliation affiliation">Departments of Discovery Chemistry, Metabolic Diseases, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Pharmaceutical Research Institute, P.O. Box 5400, Princeton, New Jersey 08543-5400 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James Devenny</span> - <span class="hlFld-Affiliation affiliation">Departments of Discovery Chemistry, Metabolic Diseases, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Pharmaceutical Research Institute, P.O. Box 5400, Princeton, New Jersey 08543-5400 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mary Ann Pelleymounter</span> - <span class="hlFld-Affiliation affiliation">Departments of Discovery Chemistry, Metabolic Diseases, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Pharmaceutical Research Institute, P.O. Box 5400, Princeton, New Jersey 08543-5400 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Keith J. Miller</span> - <span class="hlFld-Affiliation affiliation">Departments of Discovery Chemistry, Metabolic Diseases, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Pharmaceutical Research Institute, P.O. Box 5400, Princeton, New Jersey 08543-5400 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeffrey A. Robl</span> - <span class="hlFld-Affiliation affiliation">Departments of Discovery Chemistry, Metabolic Diseases, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Pharmaceutical Research Institute, P.O. Box 5400, Princeton, New Jersey 08543-5400 </span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01466" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01466" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank Cindy Li for assistance in structural elucidations. </p></div><div class="refs-header-label"></div><p class="references-count">
            This article references 20 other publications.
        </p><ol id="references" class="useLabel"><li id="jm0612968b00001"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0612968b00001'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="jm0612968b00001_1"><span><span class="NLM_string-ref">National Center for Health Statistics. <a class="ext-link" href="http://www.cdc.gov/nchs/fastats/overwt.htm" target="_blank">http://www.cdc.gov/nchs/fastats/overwt.htm</a> (accessed Sept 2006).</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=National+Center+for+Health+Statistics.&title=http%3A%2F%2Fwww.cdc.gov%2Fnchs%2Ffastats%2Foverwt.htm+%28accessed"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0612968b00001_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3D%26aulast%3D%26aulast%3D%26btitle%3Dhttp%253A%252F%252Fwww.cdc.gov%252Fnchs%252Ffastats%252Foverwt.htm%2520%2528accessed%26date%3D2006http%3A%2F%2Fwww.cdc.gov%2Fnchs%2Ffastats%2Foverwt.htm" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0612968b00002"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0612968b00002'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="jm0612968b00002_1"><span><span class="NLM_string-ref">Eckel, R. H.; York, D. A.; Rossner, S.; Hubbard, V.; Caterson, I.; St. Joer, S. T.; Hayman. L. L.; Mullis, R. M.; Blair, S. N. Prevention conference VII:â Obesity, a worldwide epidemic related to heart disease and stroke:â executive summary. <i>  Circulation</i><b>2004</b>, <i>110</i>, e463âe470.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2004&pages=e470&author=R.+H.+Eckel&author=D.+A.+York&author=S.+Rossner&author=V.+Hubbard&author=I.+Caterson&author=S.+T.+St.+Joer&author=L.+L.+Hayman&author=R.+M.+Mullis&author=S.+N+Blair&title=Prevention+conference+VII%3A%E2%80%89+Obesity%2C+a+worldwide+epidemic+related+to+heart+disease+and+stroke%3A%E2%80%89+executive+summary"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0612968b00002_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEckel%26aufirst%3DR.%2BH.%26atitle%3DPrevention%2520conference%2520VII%253A%25E2%2580%2589%2520Obesity%252C%2520a%2520worldwide%2520epidemic%2520related%2520to%2520heart%2520disease%2520and%2520stroke%253A%25E2%2580%2589%2520executive%2520summary%26jtitle%3DCirculation%26date%3D2004%26volume%3D110%26spage%3De470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0612968b00003"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0612968b00003'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="jm0612968b00003_1"><span><span class="NLM_string-ref">Ogden, C. L.; Carroll, M. D.; Flegal, K. M. Epidemiologic trends in overweight and obesity. <i>  Endocrinol. Metab. Clin. North Am.</i><b>2003</b>, <i>32</i>, 741â760.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2003&pages=760&author=C.+L.+Ogden&author=M.+D.+Carroll&author=K.+M+Flegal&title=Epidemiologic+trends+in+overweight+and+obesity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0612968b00003_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOgden%26aufirst%3DC.%2BL.%26atitle%3DEpidemiologic%2520trends%2520in%2520overweight%2520and%2520obesity%26jtitle%3DEndocrinol.%2520Metab.%2520Clin.%2520North%2520Am.%26date%3D2003%26volume%3D32%26spage%3D760" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0612968b00004"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0612968b00004'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="jm0612968b00004_1"><span><span class="NLM_string-ref">El-Atat, F.; Aneja, A.; McFarlane, S.; Sowers, J. Obesity and hypertension. <i>  Endocrinol. Metab. Clin. North Am.</i><b>2003</b>, <i>32</i>, 823â854.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2003&pages=854&author=F.+El-Atat&author=A.+Aneja&author=S.+McFarlane&author=J+Sowers&title=Obesity+and+hypertension"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0612968b00004_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEl-Atat%26aufirst%3DF.%26atitle%3DObesity%2520and%2520hypertension%26jtitle%3DEndocrinol.%2520Metab.%2520Clin.%2520North%2520Am.%26date%3D2003%26volume%3D32%26spage%3D854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0612968b00005"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0612968b00005'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="jm0612968b00005_1"><span><span class="NLM_string-ref">Tuthill, A.; Slawik, H.; O'Rahilly, S.; Finer, N. Psychiatric co-morbidities in patients attending specialist obesity services in the UK. <i>  Q. J. Med.:â </i><i>Monthly J. Assoc. Physicians</i><b>2006</b>, <i>99</i>, 317â325.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=A.+Tuthill&author=H.+Slawik&author=S.+O%27Rahilly&author=N.+Finer&title=Psychiatric+co-morbidities+in+patients+attending+specialist+obesity+services+in+the+UK.+Q.+J.+Med.%3A%E2%80%89+Monthly+J.+Assoc.+Physicians"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0612968b00005_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DTuthill%26aufirst%3DA.%26btitle%3DPsychiatric%2520co-morbidities%2520in%2520patients%2520attending%2520specialist%2520obesity%2520services%2520in%2520the%2520UK.%2520Q.%2520J.%2520Med.%253A%25E2%2580%2589%2520Monthly%2520J.%2520Assoc.%2520Physicians%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0612968b00006"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0612968b00006'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="jm0612968b00006_1"><span><span class="NLM_string-ref">Vickers, S. P; Benwell, K. R.; Porter, R. H.; Bickerdike, M. J.; Kennett, G. A.; Dourish, C. T. Comparative effects of continuous infusion of mCPP, Ro 60-0175. and d-fenfluramine on food intake, water intake, body weight and locomotor activity in rats. <i>  Br. J. Pharmacol.</i><b>2000</b>, <i>130</i>, 1305â1314.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2000&pages=1314&author=S.+Vickers&author=K.+R.+Benwell&author=R.+H.+Porter&author=M.+J.+Bickerdike&author=G.+A.+Kennett&author=C.+T+Dourish&title=Comparative+effects+of+continuous+infusion+of+mCPP%2C+Ro+60-0175.+and+d-fenfluramine+on+food+intake%2C+water+intake%2C+body+weight+and+locomotor+activity+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0612968b00006_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVickers%26aufirst%3DS.%26atitle%3DComparative%2520effects%2520of%2520continuous%2520infusion%2520of%2520mCPP%252C%2520Ro%252060-0175.%2520and%2520d-fenfluramine%2520on%2520food%2520intake%252C%2520water%2520intake%252C%2520body%2520weight%2520and%2520locomotor%2520activity%2520in%2520rats%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2000%26volume%3D130%26spage%3D1314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0612968b00007"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0612968b00007'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="jm0612968b00007_1"><span><span class="NLM_string-ref">Kennett, G. A.; Wood, M. D.; Bright, F.; Trail, B.; Riley, G.; Holland, V.; Avenell, K. Y.; Stean, T.; Upton, N.; Bromidge, S.; Forbes, I. T.; Brown, A. M.; Middlemiss, D. N.; Blackburn, T. P. SB 242084, a selective and brain penetrant 5-HT<sub>2C</sub> receptor antagonist. <i>  Neuropharmacology</i><b>1997</b>, <i>36</i>, 609â620.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1997&pages=620&author=G.+A.+Kennett&author=M.+D.+Wood&author=F.+Bright&author=B.+Trail&author=G.+Riley&author=V.+Holland&author=K.+Y.+Avenell&author=T.+Stean&author=N.+Upton&author=S.+Bromidge&author=I.+T.+Forbes&author=A.+M.+Brown&author=D.+N.+Middlemiss&author=T.+P.+Blackburn&title=a+selective+and+brain+penetrant+5-HT2C+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0612968b00007_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKennett%26aufirst%3DG.%2BA.%26atitle%3Da%2520selective%2520and%2520brain%2520penetrant%25205-HT2C%2520receptor%2520antagonist%26jtitle%3DNeuropharmacology%26date%3D1997%26volume%3D36%26spage%3D620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0612968b00008"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0612968b00008'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="jm0612968b00008_1"><span><span class="NLM_string-ref">Tecott, L. H.; Sun, L. M.; Akana, S. F.; Strack, A. M.; Lowenstein, D. H.; Dallman, M. F.; Julius, D. Eating disorder and epilepsy in mice lacking 5-HT<sub>2C</sub> serotonin receptors. <i>  Nature</i><b>1995</b>, <i>374</i>, 542â546.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=374&publication_year=1995&pages=546&author=L.+H.+Tecott&author=L.+M.+Sun&author=S.+F.+Akana&author=A.+M.+Strack&author=D.+H.+Lowenstein&author=M.+F.+Dallman&author=D+Julius&title=Eating+disorder+and+epilepsy+in+mice+lacking+5-HT2C+serotonin+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0612968b00008_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTecott%26aufirst%3DL.%2BH.%26atitle%3DEating%2520disorder%2520and%2520epilepsy%2520in%2520mice%2520lacking%25205-HT2C%2520serotonin%2520receptors%26jtitle%3DNature%26date%3D1995%26volume%3D374%26spage%3D546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0612968b00009"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0612968b00009'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="jm0612968b00009_1"><span><span class="NLM_string-ref">(a) Walsh, A. E.; Smith, K. A.; Oldman, A. D.; Williams, C.; Goodall, E. M.; Cowen, P. J. m-Chlorophenylpiperazine decreases food intake in a test meal. <i>  Psychopharmacology</i><b>1994</b>, <i>116</i> (1), 120â122.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=1994&pages=122&issue=1&author=A.+E.+Walsh&author=K.+A.+Smith&author=A.+D.+Oldman&author=C.+Williams&author=E.+M.+Goodall&author=P.+J+Cowen&title=m-Chlorophenylpiperazine+decreases+food+intake+in+a+test+meal"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0612968b00009_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWalsh%26aufirst%3DA.%2BE.%26atitle%3Dm-Chlorophenylpiperazine%2520decreases%2520food%2520intake%2520in%2520a%2520test%2520meal%26jtitle%3DPsychopharmacology%26date%3D1994%26volume%3D116%26issue%3D1%26spage%3D122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm0612968b00009_2"><span><span class="NLM_string-ref">(b) Sargent, P. A.; Sharpley, A. L.; Williams, C.; Goodall, E. M.; Cowen, P. J. 5-HT<sub>2C</sub> receptor activation decreases appetite and body weight in obese subjects. <i>  Psychopharmacology</i><b>1997</b>, <i>133</i>, 309â312.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=1997&pages=312&author=P.+A.+Sargent&author=A.+L.+Sharpley&author=C.+Williams&author=E.+M.+Goodall&author=P.+J.+Cowen&title=receptor+activation+decreases+appetite+and+body+weight+in+obese+subjects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0612968b00009_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSargent%26aufirst%3DP.%2BA.%26atitle%3Dreceptor%2520activation%2520decreases%2520appetite%2520and%2520body%2520weight%2520in%2520obese%2520subjects%26jtitle%3DPsychopharmacology%26date%3D1997%26volume%3D133%26spage%3D312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0612968b00010"><div class="reference"><div class="NLM_citation" id="jm0612968b00010_1"><span><span class="NLM_string-ref">(a) Lacivita, E.; Leopoldo, M. Selective agents for serotonin2C (5-HT<sub>2C</sub>) receptor. <i>  Curr. Topics in Med. Chem.</i><b>2006</b>, <i>6</i> (18), 1927â1970.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=1970&issue=18&author=E.+Lacivita&author=M+Leopoldo&title=Selective+agents+for+serotonin2C+%285-HT2C%29+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0612968b00010_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLacivita%26aufirst%3DE.%26atitle%3DSelective%2520agents%2520for%2520serotonin2C%2520%25285-HT2C%2529%2520receptor%26jtitle%3DCurr.%2520Topics%2520in%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26issue%3D18%26spage%3D1970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm0612968b00010_2"><span><span class="NLM_string-ref">(b) Nilsson, B. M. 5 -Hydroxytryptamine 2C (5-HT<sub>2C</sub>) receptor agonists as potential antiobesity agents. <i>  J. Med. Chem.</i><b>2006</b>, <i>49</i>, 4023â4034.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4034&author=B.+M+Nilsson&title=5+-Hydroxytryptamine+2C+%285-HT2C%29+receptor+agonists+as+potential+antiobesity+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0612968b00010_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNilsson%26aufirst%3DB.%2BM%26atitle%3D5%2520-Hydroxytryptamine%25202C%2520%25285-HT2C%2529%2520receptor%2520agonists%2520as%2520potential%2520antiobesity%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm0612968b00010_3"><span><span class="NLM_string-ref">(c) Fitzgerald, L. W.; Ennis, M. D. 5-HT<sub>2C</sub> receptor modulators:â progress in development of new CNS medicines. <i>  Annu. Rep. Med. Chem.</i><b>2002</b>, <i>37</i>, 21â30.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2002&pages=30&author=L.+W.+Fitzgerald&author=M.+D.+Ennis&title=progress+in+development+of+new+CNS+medicines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0612968b00010_3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFitzgerald%26aufirst%3DL.%2BW.%26atitle%3Dprogress%2520in%2520development%2520of%2520new%2520CNS%2520medicines%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2002%26volume%3D37%26spage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0612968b00011"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0612968b00011'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="jm0612968b00011_1"><span><span class="NLM_string-ref">(a) Fitzgerald, L. W.; Burn, T. C.; Brown, B. S.; Patterson, J. P.; Corjay, M. H.; Valentine, P. A.; Sun, J.-H.; Link, J. R.; Abbaszade, I.; Hollis, J. M.; Largent, B. L.; Hartig, P. R.; Hollis, G. F.; Meunier, P. C.; Robichaud, A. J.; Robertson, D. W. Possible role of valvular serotonin 5-HT2B receptors in the cardiopathy associated with fenfluramine. <i>  Mol. Pharmacol.</i><b>2000</b>, <i>57</i>, 75â81.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2000&pages=81&author=L.+W.+Fitzgerald&author=T.+C.+Burn&author=B.+S.+Brown&author=J.+P.+Patterson&author=M.+H.+Corjay&author=P.+A.+Valentine&author=J.-H.+Sun&author=J.+R.+Link&author=I.+Abbaszade&author=J.+M.+Hollis&author=B.+L.+Largent&author=P.+R.+Hartig&author=G.+F.+Hollis&author=P.+C.+Meunier&author=A.+J.+Robichaud&author=D.+W+Robertson&title=Possible+role+of+valvular+serotonin+5-HT2B+receptors+in+the+cardiopathy+associated+with+fenfluramine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0612968b00011_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFitzgerald%26aufirst%3DL.%2BW.%26atitle%3DPossible%2520role%2520of%2520valvular%2520serotonin%25205-HT2B%2520receptors%2520in%2520the%2520cardiopathy%2520associated%2520with%2520fenfluramine%26jtitle%3DMol.%2520Pharmacol.%26date%3D2000%26volume%3D57%26spage%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm0612968b00011_2"><span><span class="NLM_string-ref">(b) Rothman, R. B.; Baumann, M. H.; Savage, J. E.; Rauser, L.; McBride, A.; Hufeisen, S. J.; Roth, B. L. Evidence for possible involvement of 5-HT<sub>2B</sub> receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications. <i>  Circulation</i><b>2000</b>, <i>102</i>, 2836â2841.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2000&pages=2841&author=R.+B.+Rothman&author=M.+H.+Baumann&author=J.+E.+Savage&author=L.+Rauser&author=A.+McBride&author=S.+J.+Hufeisen&author=B.+L+Roth&title=Evidence+for+possible+involvement+of+5-HT2B+receptors+in+the+cardiac+valvulopathy+associated+with+fenfluramine+and+other+serotonergic+medications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0612968b00011_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRothman%26aufirst%3DR.%2BB.%26atitle%3DEvidence%2520for%2520possible%2520involvement%2520of%25205-HT2B%2520receptors%2520in%2520the%2520cardiac%2520valvulopathy%2520associated%2520with%2520fenfluramine%2520and%2520other%2520serotonergic%2520medications%26jtitle%3DCirculation%26date%3D2000%26volume%3D102%26spage%3D2841" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm0612968b00011_3"><span><span class="NLM_string-ref">(c) Xu, J.; Jian, B.; Chu, R.; Lu, Z.; Li, Q.; Dunlop, J.; Rosenzweig-Lipson, S.; McGonigle, P.; Levy, R. J.; Liang, B. Serotonin mechanisms in heart valve disease II:â The 5-HT2 receptor and its signaling pathway in aortic valve interstitial cells. <i>  Am. J. Pathol.</i><b>2002</b>, <i>161</i>, 2209â2218.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=161&publication_year=2002&pages=2218&author=J.+Xu&author=B.+Jian&author=R.+Chu&author=Z.+Lu&author=Q.+Li&author=J.+Dunlop&author=S.+Rosenzweig-Lipson&author=P.+McGonigle&author=R.+J.+Levy&author=B+Liang&title=Serotonin+mechanisms+in+heart+valve+disease+II%3A%E2%80%89+The+5-HT2+receptor+and+its+signaling+pathway+in+aortic+valve+interstitial+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0612968b00011_3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DJ.%26atitle%3DSerotonin%2520mechanisms%2520in%2520heart%2520valve%2520disease%2520II%253A%25E2%2580%2589%2520The%25205-HT2%2520receptor%2520and%2520its%2520signaling%2520pathway%2520in%2520aortic%2520valve%2520interstitial%2520cells%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2002%26volume%3D161%26spage%3D2218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0612968b00012"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0612968b00012'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="jm0612968b00012_1"><span><span class="NLM_string-ref">(a) Robichaud, A. J.; Chen, W.; McClung, C.; McClung, C.; Clark, D.; Deng, W.; Brondyke-Calvello, E.; Mitchell, I. S.; Lee, T.; Rajagopalan, P.; Fitzgerald, L. W.; Conklin, D. S.; McElroy, J. F.; Rohrbach, K. W.; Miller, K. J.; Largent, B. L.; Robertson, D. W. Synthesis and biological evaluation of novel, selective 5-HT2C receptor agonists for the treatment of obesity. <i>  Abstracts of Papers</i>; 221st American Chemical Society National Meeting, San Diego, CA, American Chemical Society:â Washington, DC, 2001, MEDI-105.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&author=A.+J.+Robichaud&author=W.+Chen&author=C.+McClung&author=C.+McClung&author=D.+Clark&author=W.+Deng&author=E.+Brondyke-Calvello&author=I.+S.+Mitchell&author=T.+Lee&author=P.+Rajagopalan&author=L.+W.+Fitzgerald&author=D.+S.+Conklin&author=J.+F.+McElroy&author=K.+W.+Rohrbach&author=K.+J.+Miller&author=B.+L.+Largent&author=D.+W.+Robertson&title=Synthesis+and+biological+evaluation+of+novel%2C+selective+5-HT2C+receptor+agonists+for+the+treatment+of+obesity.+Abstracts+of+Papers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0612968b00012_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DRobichaud%26aufirst%3DA.%2BJ.%26btitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520novel%252C%2520selective%25205-HT2C%2520receptor%2520agonists%2520for%2520the%2520treatment%2520of%2520obesity.%2520Abstracts%2520of%2520Papers%26pub%3DAmerican%2520Chemical%2520Society%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm0612968b00012_2"><span><span class="NLM_string-ref">(b) Lee, T.; Robichaud, A. J.; Chen, W.; Lu, Y.; Dowdell, S.; Boyle, K. E.; Mitchell, I. S.; Fevig, J. M.; Wexler, R. R.; Miller, K. J.; Largent, B. L.; Rohrbach, K. W.; Devenny, J. J.; McElroy, J. F. Synthesis and biological evaluation of novel, selective 5-HT<sub>2C</sub> receptor agonists for obesity. <i>  Abstracts of Papers</i>; 229th American Chemical Society National Meeting, San Diego, CA; American Chemical Society:â Washington, DC, 2005; MEDI-283.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=T.+Lee&author=A.+J.+Robichaud&author=W.+Chen&author=Y.+Lu&author=S.+Dowdell&author=K.+E.+Boyle&author=I.+S.+Mitchell&author=J.+M.+Fevig&author=R.+R.+Wexler&author=K.+J.+Miller&author=B.+L.+Largent&author=K.+W.+Rohrbach&author=J.+J.+Devenny&author=J.+F.+McElroy&title=Synthesis+and+biological+evaluation+of+novel%2C+selective+5-HT2C+receptor+agonists+for+obesity.+Abstracts+of+Papers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0612968b00012_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DT.%26btitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520novel%252C%2520selective%25205-HT2C%2520receptor%2520agonists%2520for%2520obesity.%2520Abstracts%2520of%2520Papers%26pub%3DAmerican%2520Chemical%2520Society%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0612968b00013"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0612968b00013'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="jm0612968b00013_1"><span><span class="NLM_string-ref">Richter, H. G. F.; Adams, D. R.; Benardeau, A.; Bickerdike, M. J.; Bentley, J. M.; Blench, T. J.; Cliffe, I. A.; Dourish, C.; Hebeisen, P.; Kennett, G. A.; Knight, A. R.; Malcolm, C. S.; Mattei, P.; Misra, A.; Mizrahi, J.; Monck, N. J. T.; Plancher, J.-M.; Roever, S.; Roffey, J. R. A.; Taylor, S.; Vickers, S. P. Synthesis and biological evaluation of novel hexahydro-pyrido[3â,2â:4,5]pyrrolo[1,2-a]pyrazines as potent and selective 5-HT<sub>2C</sub> receptor agonists. <i>  Bioorg. Med. Chem. Lett.</i><b>2006</b>, <i>16</i>, 1207â1211.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=1211&author=H.+G.+F.+Richter&author=D.+R.+Adams&author=A.+Benardeau&author=M.+J.+Bickerdike&author=J.+M.+Bentley&author=T.+J.+Blench&author=I.+A.+Cliffe&author=C.+Dourish&author=P.+Hebeisen&author=G.+A.+Kennett&author=A.+R.+Knight&author=C.+S.+Malcolm&author=P.+Mattei&author=A.+Misra&author=J.+Mizrahi&author=N.+J.+T.+Monck&author=J.-M.+Plancher&author=S.+Roever&author=J.+R.+A.+Roffey&author=S.+Taylor&author=S.+P+Vickers&title=Synthesis+and+biological+evaluation+of+novel+hexahydro-pyrido%5B3%E2%80%98%2C2%E2%80%98%3A4%2C5%5Dpyrrolo%5B1%2C2-a%5Dpyrazines+as+potent+and+selective+5-HT2C+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0612968b00013_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRichter%26aufirst%3DH.%2BG.%2BF.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520novel%2520hexahydro-pyrido%255B3%25E2%2580%2598%252C2%25E2%2580%2598%253A4%252C5%255Dpyrrolo%255B1%252C2-a%255Dpyrazines%2520as%2520potent%2520and%2520selective%25205-HT2C%2520receptor%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D1211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0612968b00014"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0612968b00014'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="jm0612968b00014_1"><span><span class="NLM_string-ref">Welch, W. M. Synthesis of the 1,2,3,4-tetrahydropyrazino[2,1-<i>a</i>]isoindol-6(2<i>H</i>)-one ring system. <i>  J. Org. </i><i>Chem.</i><b>1982</b>, <i>47</i>, 886â888.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1982&pages=888&author=W.+M+Welch&title=Synthesis+of+the+1%2C2%2C3%2C4-tetrahydropyrazino%5B2%2C1-a%5Disoindol-6%282H%29-one+ring+system"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0612968b00014_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWelch%26aufirst%3DW.%2BM%26atitle%3DSynthesis%2520of%2520the%25201%252C2%252C3%252C4-tetrahydropyrazino%255B2%252C1-a%255Disoindol-6%25282H%2529-one%2520ring%2520system%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1982%26volume%3D47%26spage%3D888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0612968b00015"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0612968b00015'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="jm0612968b00015_1"><span><span class="NLM_string-ref">Absolute stereochemistry was determined from the (<i>S</i>)-10-camphorsulfamide of compound <b>30</b> and correlated to all other compounds by chiral HPLC retention times. Crystallographic data (excluding structure factors) for compound <b>30</b> have been deposited with the Cambridge Crystallographic Data Centre as supplementary publication number CCDC 632659. Copies of the data can be obtained free of charge upon application to CCDC, 12 Union Road, Cambridge CB21EZ, UK (Fax:â (+44)1223-336-033. E-mail:â <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="9ffbfaeff0ecf6ebdf">[emailÂ protected]</a> ccdc.cam.ac.uk).</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Absolute+stereochemistry+was+determined+from+the+%28S%29-10-camphorsulfamide+of+compound+30+and+correlated+to+all+other+compounds+by+chiral+HPLC+retention+times.+Crystallographic+data+%28excluding+structure+factors%29+for+compound+30+have+been+deposited+with+the+Cambridge+Crystallographic+Data+Centre+as+supplementary+publication+number+CCDC+632659.+Copies+of+the+data+can+be+obtained+free+of+charge+upon+application+to+CCDC%2C+12+Union+Road%2C+Cambridge+CB21EZ%2C+UK+%28Fax%3A%E2%80%89+%28%2B44%291223-336-033.+E-mail%3A%E2%80%89+deposit%40+ccdc.cam.ac.uk%29.+Absolute+stereochemistry+was+determined+from+the+%28S%29-10-camphorsulfamide+of+compound+30+and+correlated+to+all+other+compounds+by+chiral+HPLC+retention+times.+Crystallographic+data+%28excluding+structure+factors%29+for+compound+30+have+been+deposited+with+the+Cambridge+Crystallographic+Data+Centre+as+supplementary+publication+number+CCDC+632659.+Copies+of+the+data+can+be+obtained+free+of+charge+upon+application+to+CCDC%2C+12+Union+Road%2C+Cambridge+CB21EZ%2C+UK+%28Fax%3A%E2%80%89+%28%2B44%291223-336-033.+E-mail%3A%E2%80%89+deposit%40+ccdc.cam.ac.uk%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0612968b00015_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dother%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0612968b00016"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0612968b00016'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="jm0612968b00016_1"><span><span class="NLM_string-ref">Bromidge, S. M.; Dabbs, S.; Davies, D. T.; Davies, S.; Duckworth, D. M.; Forbes, I. T.; Gaster, L. M.; Ham, P.; Jones, G. E.; King, F. D.; Mulholland, K. R.; Saunders, D. V.; Wyman, P. A.; Blaney, F. E.; Clarke, S. E.; Blackburn, T. P.; Holland, V.; Kennett, G. A.; Lightowler, S.; Middlemiss, D. N.; Trail, B.; Riley, G. J.; Wood, M. D. Biarylcarbamoylindolines Are Novel and Selective 5-HT2C Receptor Inverse Agonists:â Identification of 5-Methyl-1-[[2-[(2-methyl-3-pyridyl)oxy]-5-pyridyl]carbamoyl]-6-trifluoromethylindoline (SB-243213) as a Potential Antidepressant/Anxiolytic Agent. <i>  J. Med. Chem.</i><b>2000</b>, <i>43</i>, 1123â1134.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=1134&author=S.+M.+Bromidge&author=S.+Dabbs&author=D.+T.+Davies&author=S.+Davies&author=D.+M.+Duckworth&author=I.+T.+Forbes&author=L.+M.+Gaster&author=P.+Ham&author=G.+E.+Jones&author=F.+D.+King&author=K.+R.+Mulholland&author=D.+V.+Saunders&author=P.+A.+Wyman&author=F.+E.+Blaney&author=S.+E.+Clarke&author=T.+P.+Blackburn&author=V.+Holland&author=G.+A.+Kennett&author=S.+Lightowler&author=D.+N.+Middlemiss&author=B.+Trail&author=G.+J.+Riley&author=M.+D+Wood&title=Biarylcarbamoylindolines+Are+Novel+and+Selective+5-HT2C+Receptor+Inverse+Agonists%3A%E2%80%89+Identification+of+5-Methyl-1-%5B%5B2-%5B%282-methyl-3-pyridyl%29oxy%5D-5-pyridyl%5Dcarbamoyl%5D-6-trifluoromethylindoline+%28SB-243213%29+as+a+Potential+Antidepressant%2FAnxiolytic+Agent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0612968b00016_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBromidge%26aufirst%3DS.%2BM.%26atitle%3DBiarylcarbamoylindolines%2520Are%2520Novel%2520and%2520Selective%25205-HT2C%2520Receptor%2520Inverse%2520Agonists%253A%25E2%2580%2589%2520Identification%2520of%25205-Methyl-1-%255B%255B2-%255B%25282-methyl-3-pyridyl%2529oxy%255D-5-pyridyl%255Dcarbamoyl%255D-6-trifluoromethylindoline%2520%2528SB-243213%2529%2520as%2520a%2520Potential%2520Antidepressant%252FAnxiolytic%2520Agent%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D1134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0612968b00017"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0612968b00017'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="jm0612968b00017_1"><span><span class="NLM_string-ref">Alongi, M.; Minetto, G.; Taddei, M. New pyrrole-based amino acids for the synthesis of peptidomimetic constrained scaffolds. <i>  Tetrahedron Lett.</i><b>2005</b>, <i>46</i>, 7069â7072.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2005&pages=7072&author=M.+Alongi&author=G.+Minetto&author=M+Taddei&title=New+pyrrole-based+amino+acids+for+the+synthesis+of+peptidomimetic+constrained+scaffolds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0612968b00017_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAlongi%26aufirst%3DM.%26atitle%3DNew%2520pyrrole-based%2520amino%2520acids%2520for%2520the%2520synthesis%2520of%2520peptidomimetic%2520constrained%2520scaffolds%26jtitle%3DTetrahedron%2520Lett.%26date%3D2005%26volume%3D46%26spage%3D7072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0612968b00018"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0612968b00018'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="jm0612968b00018_1"><span><span class="NLM_string-ref">Pittelkow, M.; Lewinsky, R.; Christensen, J. B. Selective synthesis of carbamate protected polyamines using alkyl phenyl carbonates. <i>  Synthesis</i><b>2002</b>, 2195â2202.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2195&publication_year=2002&pages=2202&author=M.+Pittelkow&author=R.+Lewinsky&author=J.+B+Christensen&title=Selective+synthesis+of+carbamate+protected+polyamines+using+alkyl+phenyl+carbonates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0612968b00018_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPittelkow%26aufirst%3DM.%26atitle%3DSelective%2520synthesis%2520of%2520carbamate%2520protected%2520polyamines%2520using%2520alkyl%2520phenyl%2520carbonates%26jtitle%3DSynthesis%26date%3D2002%26volume%3D2195%26spage%3D2202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0612968b00019"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm0612968b00019'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="jm0612968b00019_1"><span><span class="NLM_string-ref">Short, J. H. Antiemetic and antipsychotic agents. U.S. Patent 4 470 977, 1984.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1984&author=J.+H.+Short&title=Antiemetic+and+antipsychotic+agents.+U.S.+Patent+4+470+977"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0612968b00019_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DShort%26aufirst%3DJ.%2BH.%26btitle%3DAntiemetic%2520and%2520antipsychotic%2520agents.%2520U.S.%2520Patent%25204%2520470%2520977%26date%3D1984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm0612968b00020"><div class="reference"><div class="NLM_citation" id="jm0612968b00020_1"><span><span class="NLM_string-ref">Fitzgerald, L. W.; Conklin, D. S.; Krause, C. M.; Marshall, A. P.; Patterson, J. P.; Tran, D. P.; Iyer, G.; Kostich, W. A.; Largent, B. L.; Hartig, P. R. High-affinity agonist binding correlates with efficacy (intrinsic activity) at the human serotonin 5-HT<sub>2A</sub> and 5-HT<sub>2C</sub> receptors:â evidence favoring the ternary complex and two-state models of agonist action. <i>  J. </i><i>Neurochem.</i><b>1999</b>, <i>72</i>, 2127â2134.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1999&pages=2134&author=L.+W.+Fitzgerald&author=D.+S.+Conklin&author=C.+M.+Krause&author=A.+P.+Marshall&author=J.+P.+Patterson&author=D.+P.+Tran&author=G.+Iyer&author=W.+A.+Kostich&author=B.+L.+Largent&author=P.+R+Hartig&title=High-affinity+agonist+binding+correlates+with+efficacy+%28intrinsic+activity%29+at+the+human+serotonin+5-HT2A+and+5-HT2C+receptors%3A%E2%80%89+evidence+favoring+the+ternary+complex+and+two-state+models+of+agonist+action"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0612968b00020_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFitzgerald%26aufirst%3DL.%2BW.%26atitle%3DHigh-affinity%2520agonist%2520binding%2520correlates%2520with%2520efficacy%2520%2528intrinsic%2520activity%2529%2520at%2520the%2520human%2520serotonin%25205-HT2A%2520and%25205-HT2C%2520receptors%253A%25E2%2580%2589%2520evidence%2520favoring%2520the%2520ternary%2520complex%2520and%2520two-state%2520models%2520of%2520agonist%2520action%26jtitle%3DJ.%2520Neurochem.%26date%3D1999%26volume%3D72%26spage%3D2134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'jm0612968b00001':['jm0612968b00001_1'],'jm0612968b00002':['jm0612968b00002_1'],'jm0612968b00003':['jm0612968b00003_1'],'jm0612968b00004':['jm0612968b00004_1'],'jm0612968b00005':['jm0612968b00005_1'],'jm0612968b00006':['jm0612968b00006_1'],'jm0612968b00007':['jm0612968b00007_1'],'jm0612968b00008':['jm0612968b00008_1'],'jm0612968b00009':['jm0612968b00009_1','jm0612968b00009_2'],'jm0612968b00010':['jm0612968b00010_1','jm0612968b00010_2','jm0612968b00010_3'],'jm0612968b00011':['jm0612968b00011_1','jm0612968b00011_2','jm0612968b00011_3'],'jm0612968b00012':['jm0612968b00012_1','jm0612968b00012_2'],'jm0612968b00013':['jm0612968b00013_1'],'jm0612968b00014':['jm0612968b00014_1'],'jm0612968b00015':['jm0612968b00015_1'],'jm0612968b00016':['jm0612968b00016_1'],'jm0612968b00017':['jm0612968b00017_1'],'jm0612968b00018':['jm0612968b00018_1'],'jm0612968b00019':['jm0612968b00019_1'],'jm0612968b00020':['jm0612968b00020_1']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 26 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Chao Yao, Yishu Bao, Tao Lu, <span class="NLM_string-name hlFld-ContribAuthor">Qingfa Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Stereoselective Synthesis of Functionalized Benzooxazepino[5,4-a]isoindolone Derivatives via Cesium Carbonate Catalyzed Formal [5 + 2] Annulation of 2-(2-Hydroxyphenyl)isoindoline-1,3-dione with Allenoates. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2018,</strong> <em>20 </em>
                                    (8)
                                     , 2152-2155. <a href="https://doi.org/10.1021/acs.orglett.8b00382" title="DOI URL">https://doi.org/10.1021/acs.orglett.8b00382</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.8b00382&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.8b00382%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DStereoselective%252BSynthesis%252Bof%252BFunctionalized%252BBenzooxazepino%25255B5%25252C4-a%25255Disoindolone%252BDerivatives%252Bvia%252BCesium%252BCarbonate%252BCatalyzed%252BFormal%252B%25255B5%252B%25252B%252B2%25255D%252BAnnulation%252Bof%252B2-%2525282-Hydroxyphenyl%252529isoindoline-1%25252C3-dione%252Bwith%252BAllenoates%26aulast%3DYao%26aufirst%3DChao%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D02022018%26date%3D04042018%26volume%3D20%26issue%3D8%26spage%3D2152%26epage%3D2155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joseph  Carpenter</span>, <span class="hlFld-ContribAuthor ">Ying  Wang</span>, <span class="hlFld-ContribAuthor ">Gang  Wu</span>, <span class="hlFld-ContribAuthor ">Jianxin  Feng</span>, <span class="hlFld-ContribAuthor ">Xiang-Yang  Ye</span>, <span class="hlFld-ContribAuthor ">Christian L.  Morales</span>, <span class="hlFld-ContribAuthor ">Matthias  Broekema</span>, <span class="hlFld-ContribAuthor ">Karen A.  Rossi</span>, <span class="hlFld-ContribAuthor ">Keith J.  Miller</span>, <span class="hlFld-ContribAuthor ">Brian J.  Murphy</span>, <span class="hlFld-ContribAuthor ">Ginger  Wu</span>, <span class="hlFld-ContribAuthor ">Sarah E.  Malmstrom</span>, <span class="hlFld-ContribAuthor ">Anthony V.  Azzara</span>, <span class="hlFld-ContribAuthor ">Philip M.  Sher</span>, <span class="hlFld-ContribAuthor ">John M.  Fevig</span>, <span class="hlFld-ContribAuthor ">Andrew  Alt</span>, <span class="hlFld-ContribAuthor ">Robert L.  Bertekap, Jr.</span>, <span class="hlFld-ContribAuthor ">Mary Jane  Cullen</span>, <span class="hlFld-ContribAuthor ">Timothy M.  Harper</span>, <span class="hlFld-ContribAuthor ">Kimberly  Foster</span>, <span class="hlFld-ContribAuthor ">Emily  Luk</span>, <span class="hlFld-ContribAuthor ">Qian  Xiang</span>, <span class="hlFld-ContribAuthor ">Mary F.  Grubb</span>, <span class="hlFld-ContribAuthor ">Jeffrey A.  Robl</span>, and <span class="hlFld-ContribAuthor ">Dean A.  Wacker</span>  . </span><span class="cited-content_cbyCitation_article-title">Utilization of an Active Site Mutant Receptor for the Identification of Potent and Selective Atypical 5-HT2C Receptor Agonists. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (14)
                                     , 6166-6190. <a href="https://doi.org/10.1021/acs.jmedchem.7b00385" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00385</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00385&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00385%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DUtilization%252Bof%252Ban%252BActive%252BSite%252BMutant%252BReceptor%252Bfor%252Bthe%252BIdentification%252Bof%252BPotent%252Band%252BSelective%252BAtypical%252B5-HT2C%252BReceptor%252BAgonists%26aulast%3DCarpenter%26aufirst%3DJoseph%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D10032017%26date%3D07072017%26date%3D27072017%26date%3D21062017%26volume%3D60%26issue%3D14%26spage%3D6166%26epage%3D6190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chang-Hua  Ding</span> and <span class="hlFld-ContribAuthor ">Xue-Long  Hou</span>  . </span><span class="cited-content_cbyCitation_article-title">Catalytic Asymmetric Propargylation. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2011,</strong> <em>111 </em>
                                    (3)
                                     , 1914-1937. <a href="https://doi.org/10.1021/cr100284m" title="DOI URL">https://doi.org/10.1021/cr100284m</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cr100284m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcr100284m%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DCatalytic%252BAsymmetric%252BPropargylation%26aulast%3DDing%26aufirst%3DChang-Hua%26date%3D2011%26date%3D2011%26date%3D2010%26date%3D28082010%26date%3D23022011%26date%3D09032011%26volume%3D111%26issue%3D3%26spage%3D1914%26epage%3D1937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sung Jin  Cho</span>, <span class="hlFld-ContribAuthor ">Niels H.  Jensen</span>, <span class="hlFld-ContribAuthor ">Toru  Kurome</span>, <span class="hlFld-ContribAuthor ">Sudhakar  Kadari</span>, <span class="hlFld-ContribAuthor ">Michael L.  Manzano</span>, <span class="hlFld-ContribAuthor ">Jessica E.  Malberg</span>, <span class="hlFld-ContribAuthor ">Barbara  Caldarone</span>, <span class="hlFld-ContribAuthor ">Bryan L.  Roth</span> and <span class="hlFld-ContribAuthor ">Alan P.  Kozikowski</span>. </span><span class="cited-content_cbyCitation_article-title">Selective 5-Hydroxytryptamine 2C Receptor Agonists Derived from the Lead Compound Tranylcypromine: Identification of Drugs with Antidepressant-Like Action. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2009,</strong> <em>52 </em>
                                    (7)
                                     , 1885-1902. <a href="https://doi.org/10.1021/jm801354e" title="DOI URL">https://doi.org/10.1021/jm801354e</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm801354e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm801354e%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSelective%252B5-Hydroxytryptamine%252B2C%252BReceptor%252BAgonists%252BDerived%252Bfrom%252Bthe%252BLead%252BCompound%252BTranylcypromine%25253A%252BIdentification%252Bof%252BDrugs%252Bwith%252BAntidepressant-Like%252BAction%26aulast%3DCho%26aufirst%3DSung%2BJin%26date%3D2009%26date%3D2009%26date%3D2008%26date%3D09%252004%25202009%26date%3D13%252003%25202009%26date%3D27%252010%25202008%26volume%3D52%26issue%3D7%26spage%3D1885%26epage%3D1902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xinjie  Liang</span>, <span class="hlFld-ContribAuthor ">Hui  Li</span>, <span class="hlFld-ContribAuthor ">Fangyu  Du</span>, <span class="hlFld-ContribAuthor ">Yongsheng  Zhang</span>, <span class="hlFld-ContribAuthor ">Jinhua  Dong</span>, <span class="hlFld-ContribAuthor ">Xuefei  Bao</span>, <span class="hlFld-ContribAuthor ">Ying  Wu</span>, <span class="hlFld-ContribAuthor ">Guoliang  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Copper and l-(â)-quebrachitol catalyzed hydroxylation and amination of aryl halides under air. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2020,</strong> <em>61 </em>
                                    (33)
                                     , 152222. <a href="https://doi.org/10.1016/j.tetlet.2020.152222" title="DOI URL">https://doi.org/10.1016/j.tetlet.2020.152222</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2020.152222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2020.152222%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DCopper%252Band%252Bl-%252528%2525E2%252588%252592%252529-quebrachitol%252Bcatalyzed%252Bhydroxylation%252Band%252Bamination%252Bof%252Baryl%252Bhalides%252Bunder%252Bair%26aulast%3DLiang%26aufirst%3DXinjie%26date%3D2020%26volume%3D61%26issue%3D33%26spage%3D152222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Oleksandr O.  Grygorenko</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of saturated nitrogen heterocycles by Strecker reaction â nucleophilic cyclization. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2020,</strong> <em>61 </em>
                                    (12)
                                     , 151645. <a href="https://doi.org/10.1016/j.tetlet.2020.151645" title="DOI URL">https://doi.org/10.1016/j.tetlet.2020.151645</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2020.151645&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2020.151645%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DSynthesis%252Bof%252Bsaturated%252Bnitrogen%252Bheterocycles%252Bby%252BStrecker%252Breaction%252B%2525E2%252580%252593%252Bnucleophilic%252Bcyclization%26aulast%3DGrygorenko%26aufirst%3DOleksandr%2BO.%26date%3D2020%26volume%3D61%26issue%3D12%26spage%3D151645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Myoung Jong  Song</span>, <span class="hlFld-ContribAuthor ">Ji Soo  Park</span>, <span class="hlFld-ContribAuthor ">B. Moon  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Eantiospecific Synthesis of Chiral Pyrrolidine-fused Piperazine Derivatives
              via
              Diaza-Cope Rearrangement. </span><span class="cited-content_cbyCitation_journal-name">Bulletin of the Korean Chemical Society</span><span> <strong>2017,</strong> <em>38 </em>
                                    (11)
                                     , 1365-1367. <a href="https://doi.org/10.1002/bkcs.11297" title="DOI URL">https://doi.org/10.1002/bkcs.11297</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/bkcs.11297&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fbkcs.11297%26sid%3Dliteratum%253Aachs%26jtitle%3DBulletin%2520of%2520the%2520Korean%2520Chemical%2520Society%26atitle%3DEantiospecific%252BSynthesis%252Bof%252BChiral%252BPyrrolidine-fused%252BPiperazine%252BDerivatives%252Bvia%252BDiaza-Cope%252BRearrangement%26aulast%3DSong%26aufirst%3DMyoung%2BJong%26date%3D2017%26date%3D2017%26volume%3D38%26issue%3D11%26spage%3D1365%26epage%3D1367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chang-Li  SUN</span>, <span class="hlFld-ContribAuthor ">Chang-An  GENG</span>, <span class="hlFld-ContribAuthor ">Xiao-Yan  HUANG</span>, <span class="hlFld-ContribAuthor ">Yun-Bao  MA</span>, <span class="hlFld-ContribAuthor ">Xiao-Hong  ZHENG</span>, <span class="hlFld-ContribAuthor ">Tong-Hua  YANG</span>, <span class="hlFld-ContribAuthor ">Xing-Long  CHEN</span>, <span class="hlFld-ContribAuthor ">Xiu-Juan  YIN</span>, <span class="hlFld-ContribAuthor ">Xue-Mei  ZHANG</span>, <span class="hlFld-ContribAuthor ">Ji-Jun  CHEN</span>. </span><span class="cited-content_cbyCitation_article-title">Bioassay-guided isolation of saikosaponins with agonistic activity on 5-hydroxytryptamine 2C receptor from Bupleurum chinense and their potential use for the treatment of obesity. </span><span class="cited-content_cbyCitation_journal-name">Chinese Journal of Natural Medicines</span><span> <strong>2017,</strong> <em>15 </em>
                                    (6)
                                     , 467-473. <a href="https://doi.org/10.1016/S1875-5364(17)30070-5" title="DOI URL">https://doi.org/10.1016/S1875-5364(17)30070-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/S1875-5364(17)30070-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FS1875-5364%2817%2930070-5%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Journal%2520of%2520Natural%2520Medicines%26atitle%3DBioassay-guided%252Bisolation%252Bof%252Bsaikosaponins%252Bwith%252Bagonistic%252Bactivity%252Bon%252B5-hydroxytryptamine%252B2C%252Breceptor%252Bfrom%252BBupleurum%252Bchinense%252Band%252Btheir%252Bpotential%252Buse%252Bfor%252Bthe%252Btreatment%252Bof%252Bobesity%26aulast%3DSUN%26aufirst%3DChang-Li%26date%3D2017%26volume%3D15%26issue%3D6%26spage%3D467%26epage%3D473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhusheng  Huang</span>, <span class="hlFld-ContribAuthor ">Qingqing  Chen</span>, <span class="hlFld-ContribAuthor ">Xiuqin  Yang</span>, <span class="hlFld-ContribAuthor ">Yang  Liu</span>, <span class="hlFld-ContribAuthor ">Li  Zhang</span>, <span class="hlFld-ContribAuthor ">Tao  Lu</span>, <span class="hlFld-ContribAuthor ">Qingfa  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Phosphine-mediated domino reactions of phthalimidomalonates with allenoates or but-2-ynoate: facile entry into highly functionalized pyrroloisoindolinone derivatives. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2017,</strong> <em>4 </em>
                                    (6)
                                     , 967-971. <a href="https://doi.org/10.1039/C6QO00775A" title="DOI URL">https://doi.org/10.1039/C6QO00775A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6QO00775A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6QO00775A%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DPhosphine-mediated%252Bdomino%252Breactions%252Bof%252Bphthalimidomalonates%252Bwith%252Ballenoates%252Bor%252Bbut-2-ynoate%25253A%252Bfacile%252Bentry%252Binto%252Bhighly%252Bfunctionalized%252Bpyrroloisoindolinone%252Bderivatives%26aulast%3DHuang%26aufirst%3DZhusheng%26date%3D2017%26date%3D2017%26volume%3D4%26issue%3D6%26spage%3D967%26epage%3D971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qing-Fa  Zhou</span>, <span class="hlFld-ContribAuthor ">Fei-Fei  Ge</span>, <span class="hlFld-ContribAuthor ">Qing-Qing  Chen</span>, <span class="hlFld-ContribAuthor ">Tao  Lu</span>. </span><span class="cited-content_cbyCitation_article-title">Construction of pyrazolo[5,1-a]isoindol-8(3aH)-one derivatives via phosphine-catalyzed cyclization of electron-deficient alkynes and N-amino substituted phthalimide. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2016,</strong> <em>6 </em>
                                    (2)
                                     , 1395-1402. <a href="https://doi.org/10.1039/C5RA17267E" title="DOI URL">https://doi.org/10.1039/C5RA17267E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5RA17267E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5RA17267E%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DConstruction%252Bof%252Bpyrazolo%25255B5%25252C1-a%25255Disoindol-8%2525283aH%252529-one%252Bderivatives%252Bvia%252Bphosphine-catalyzed%252Bcyclization%252Bof%252Belectron-deficient%252Balkynes%252Band%252BN-amino%252Bsubstituted%252Bphthalimide%26aulast%3DZhou%26aufirst%3DQing-Fa%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D2%26spage%3D1395%26epage%3D1402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Killian  Oukoloff</span>, <span class="hlFld-ContribAuthor ">FrÃ©dÃ©ric  Buron</span>, <span class="hlFld-ContribAuthor ">Sylvain  Routier</span>, <span class="hlFld-ContribAuthor ">Ludovic  Jean</span>, <span class="hlFld-ContribAuthor ">Pierre-Yves  Renard</span>. </span><span class="cited-content_cbyCitation_article-title">Synthetic Route to Rare Isoindolones Derivatives. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2015,</strong> <em>2015 </em>
                                    (11)
                                     , 2450-2456. <a href="https://doi.org/10.1002/ejoc.201403649" title="DOI URL">https://doi.org/10.1002/ejoc.201403649</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201403649&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201403649%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthetic%252BRoute%252Bto%252BRare%252BIsoindolones%252BDerivatives%26aulast%3DOukoloff%26aufirst%3DKillian%26date%3D2015%26date%3D2015%26volume%3D2015%26issue%3D11%26spage%3D2450%26epage%3D2456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrzej  JÃ³Åºwiak</span>, <span class="hlFld-ContribAuthor ">Piotr M.  ZagÃ³rski</span>, <span class="hlFld-ContribAuthor ">MieczysÅaw W.  PÅotka</span>, <span class="hlFld-ContribAuthor ">Dariusz  Cal</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of phosphorylated isoindolinone derivatives. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2014,</strong> <em>55 </em>
                                    (15)
                                     , 2420-2422. <a href="https://doi.org/10.1016/j.tetlet.2014.02.127" title="DOI URL">https://doi.org/10.1016/j.tetlet.2014.02.127</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2014.02.127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2014.02.127%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DSynthesis%252Bof%252Bphosphorylated%252Bisoindolinone%252Bderivatives%26aulast%3DJ%25C3%25B3%25C5%25BAwiak%26aufirst%3DAndrzej%26date%3D2014%26volume%3D55%26issue%3D15%26spage%3D2420%26epage%3D2422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dipankar  Koley</span>, <span class="hlFld-ContribAuthor ">Kyatham  Srinivas</span>, <span class="hlFld-ContribAuthor ">Yarkali  Krishna</span>, <span class="hlFld-ContribAuthor ">Archita  Gupta</span>. </span><span class="cited-content_cbyCitation_article-title">A biomimetic approach for bicyclic alkaloids using acetal pro-nucleophile: total synthesis of (Â±)-epilupinine and formal syntheses of (Â±)-laburnine, (Â±)-isoretronecanol, (Â±)-tashiromine. </span><span class="cited-content_cbyCitation_journal-name">RSC Adv.</span><span> <strong>2014,</strong> <em>4 </em>
                                    (8)
                                     , 3934-3937. <a href="https://doi.org/10.1039/C3RA44762F" title="DOI URL">https://doi.org/10.1039/C3RA44762F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C3RA44762F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC3RA44762F%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Adv.%26atitle%3DA%252Bbiomimetic%252Bapproach%252Bfor%252Bbicyclic%252Balkaloids%252Busing%252Bacetal%252Bpro-nucleophile%25253A%252Btotal%252Bsynthesis%252Bof%252B%252528%2525C2%2525B1%252529-epilupinine%252Band%252Bformal%252Bsyntheses%252Bof%252B%252528%2525C2%2525B1%252529-laburnine%25252C%252B%252528%2525C2%2525B1%252529-isoretronecanol%25252C%252B%252528%2525C2%2525B1%252529-tashiromine%26aulast%3DKoley%26aufirst%3DDipankar%26date%3D2014%26date%3D2014%26volume%3D4%26issue%3D8%26spage%3D3934%26epage%3D3937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guohua  Zhao</span>, <span class="hlFld-ContribAuthor ">Chet  Kwon</span>, <span class="hlFld-ContribAuthor ">Sharon N.  Bisaha</span>, <span class="hlFld-ContribAuthor ">Philip D.  Stein</span>, <span class="hlFld-ContribAuthor ">Karen A.  Rossi</span>, <span class="hlFld-ContribAuthor ">Xueying  Cao</span>, <span class="hlFld-ContribAuthor ">Thao  Ung</span>, <span class="hlFld-ContribAuthor ">Ginger  Wu</span>, <span class="hlFld-ContribAuthor ">Chen-Pin  Hung</span>, <span class="hlFld-ContribAuthor ">Sarah E.  Malmstrom</span>, <span class="hlFld-ContribAuthor ">Ge  Zhang</span>, <span class="hlFld-ContribAuthor ">Qinling  Qu</span>, <span class="hlFld-ContribAuthor ">Jinping  Gan</span>, <span class="hlFld-ContribAuthor ">William J.  Keim</span>, <span class="hlFld-ContribAuthor ">Mary Jane  Cullen</span>, <span class="hlFld-ContribAuthor ">Kenneth W.  Rohrbach</span>, <span class="hlFld-ContribAuthor ">James  Devenny</span>, <span class="hlFld-ContribAuthor ">Mary Ann  Pelleymounter</span>, <span class="hlFld-ContribAuthor ">Keith J.  Miller</span>, <span class="hlFld-ContribAuthor ">Jeffrey A.  Robl</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and SAR of potent and selective tetrahydropyrazinoisoquinolinone 5-HT2C receptor agonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (13)
                                     , 3914-3919. <a href="https://doi.org/10.1016/j.bmcl.2013.04.061" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.04.061</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.04.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.04.061%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252BSAR%252Bof%252Bpotent%252Band%252Bselective%252Btetrahydropyrazinoisoquinolinone%252B5-HT2C%252Breceptor%252Bagonists%26aulast%3DZhao%26aufirst%3DGuohua%26date%3D2013%26volume%3D23%26issue%3D13%26spage%3D3914%26epage%3D3919" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chen-ming  Hu</span>, <span class="hlFld-ContribAuthor ">Lian-you  Zheng</span>, <span class="hlFld-ContribAuthor ">Ya-zhong  Pei</span>, <span class="hlFld-ContribAuthor ">Xu  Bai</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of novel 3-aryl isoindolinone derivatives. </span><span class="cited-content_cbyCitation_journal-name">Chemical Research in Chinese Universities</span><span> <strong>2013,</strong> <em>29 </em>
                                    (3)
                                     , 487-494. <a href="https://doi.org/10.1007/s40242-013-2294-5" title="DOI URL">https://doi.org/10.1007/s40242-013-2294-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40242-013-2294-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40242-013-2294-5%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Research%2520in%2520Chinese%2520Universities%26atitle%3DSynthesis%252Bof%252Bnovel%252B3-aryl%252Bisoindolinone%252Bderivatives%26aulast%3DHu%26aufirst%3DChen-ming%26date%3D2013%26date%3D2013%26volume%3D29%26issue%3D3%26spage%3D487%26epage%3D494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John M.  Fevig</span>, <span class="hlFld-ContribAuthor ">Jianxin  Feng</span>, <span class="hlFld-ContribAuthor ">Karen A.  Rossi</span>, <span class="hlFld-ContribAuthor ">Keith J.  Miller</span>, <span class="hlFld-ContribAuthor ">Ginger  Wu</span>, <span class="hlFld-ContribAuthor ">Chen-Pin  Hung</span>, <span class="hlFld-ContribAuthor ">Thao  Ung</span>, <span class="hlFld-ContribAuthor ">Sarah E.  Malmstrom</span>, <span class="hlFld-ContribAuthor ">Ge  Zhang</span>, <span class="hlFld-ContribAuthor ">William J.  Keim</span>, <span class="hlFld-ContribAuthor ">Mary Jane  Cullen</span>, <span class="hlFld-ContribAuthor ">Kenneth W.  Rohrbach</span>, <span class="hlFld-ContribAuthor ">Qinling  Qu</span>, <span class="hlFld-ContribAuthor ">Jinping  Gan</span>, <span class="hlFld-ContribAuthor ">Mary Ann  Pelleymounter</span>, <span class="hlFld-ContribAuthor ">Jeffrey A.  Robl</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and SAR of 2,3,3a,4-tetrahydro-1H-pyrrolo[3,4-c]isoquinolin-5(9bH)-ones as 5-HT2C receptor agonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (1)
                                     , 330-335. <a href="https://doi.org/10.1016/j.bmcl.2012.10.091" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.10.091</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.10.091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.10.091%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252BSAR%252Bof%252B2%25252C3%25252C3a%25252C4-tetrahydro-1H-pyrrolo%25255B3%25252C4-c%25255Disoquinolin-5%2525289bH%252529-ones%252Bas%252B5-HT2C%252Breceptor%252Bagonists%26aulast%3DFevig%26aufirst%3DJohn%2BM.%26date%3D2013%26volume%3D23%26issue%3D1%26spage%3D330%26epage%3D335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">K.  Vamshikrishna</span>, <span class="hlFld-ContribAuthor ">P.  Srihari</span>. </span><span class="cited-content_cbyCitation_article-title">Total synthesis of (+)-varitriol and (+)-6â²-epi-varitriol. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2012,</strong> <em>68 </em>
                                    (5)
                                     , 1540-1546. <a href="https://doi.org/10.1016/j.tet.2011.12.008" title="DOI URL">https://doi.org/10.1016/j.tet.2011.12.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2011.12.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2011.12.008%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DTotal%252Bsynthesis%252Bof%252B%252528%25252B%252529-varitriol%252Band%252B%252528%25252B%252529-6%2525E2%252580%2525B2-epi-varitriol%26aulast%3DVamshikrishna%26aufirst%3DK.%26date%3D2012%26volume%3D68%26issue%3D5%26spage%3D1540%26epage%3D1546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">JosÃ© Luis  Viveros-Ceballos</span>, <span class="hlFld-ContribAuthor ">Carlos  Cativiela</span>, <span class="hlFld-ContribAuthor ">Mario  OrdÃ³Ã±ez</span>. </span><span class="cited-content_cbyCitation_article-title">One-pot three-component highly diastereoselective synthesis of isoindolin-1-one-3-phosphonates under solvent and catalyst free-conditions. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron: Asymmetry</span><span> <strong>2011,</strong> <em>22 </em>
                                    (13)
                                     , 1479-1484. <a href="https://doi.org/10.1016/j.tetasy.2011.08.003" title="DOI URL">https://doi.org/10.1016/j.tetasy.2011.08.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetasy.2011.08.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetasy.2011.08.003%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%253A%2520Asymmetry%26atitle%3DOne-pot%252Bthree-component%252Bhighly%252Bdiastereoselective%252Bsynthesis%252Bof%252Bisoindolin-1-one-3-phosphonates%252Bunder%252Bsolvent%252Band%252Bcatalyst%252Bfree-conditions%26aulast%3DViveros-Ceballos%26aufirst%3DJos%25C3%25A9%2BLuis%26date%3D2011%26volume%3D22%26issue%3D13%26spage%3D1479%26epage%3D1484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kiran Kumar Solingapuram  Sai</span>, <span class="hlFld-ContribAuthor ">Matthew J.  OâConnor</span>, <span class="hlFld-ContribAuthor ">Douglas A.  Klumpp</span>. </span><span class="cited-content_cbyCitation_article-title">Aza-Nazarov cyclization cascades. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2011,</strong> <em>52 </em>
                                    (17)
                                     , 2195-2198. <a href="https://doi.org/10.1016/j.tetlet.2010.11.164" title="DOI URL">https://doi.org/10.1016/j.tetlet.2010.11.164</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2010.11.164&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2010.11.164%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DAza-Nazarov%252Bcyclization%252Bcascades%26aulast%3DSai%26aufirst%3DKiran%2BKumar%2BSolingapuram%26date%3D2011%26volume%3D52%26issue%3D17%26spage%3D2195%26epage%3D2198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marcello  Leopoldo</span>, <span class="hlFld-ContribAuthor ">Enza  Lacivita</span>, <span class="hlFld-ContribAuthor ">Paola  De Giorgio</span>, <span class="hlFld-ContribAuthor ">Francesco  Berardi</span>, <span class="hlFld-ContribAuthor ">Roberto  Perrone</span>. </span><span class="cited-content_cbyCitation_article-title">The Medicinal Chemistry of 5-HT2C Receptor Ligands. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2011,</strong>,, 29-50. <a href="https://doi.org/10.1007/978-1-60761-941-3_3" title="DOI URL">https://doi.org/10.1007/978-1-60761-941-3_3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-60761-941-3_3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-60761-941-3_3%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BMedicinal%252BChemistry%252Bof%252B5-HT2C%252BReceptor%252BLigands%26aulast%3DLeopoldo%26aufirst%3DMarcello%26date%3D2011%26date%3D2010%26spage%3D29%26epage%3D50%26pub%3DHumana%2520Press%26atitle%3D5-HT2C%252BReceptors%252Bin%252Bthe%252BPathophysiology%252Bof%252BCNS%252BDisease%26aulast%3DDi%2BGiovanni%26aufirst%3DGiuseppe%26date%3D2011%26volume%3D2000012481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Keith J  Miller</span>, <span class="hlFld-ContribAuthor ">Dean A  Wacker</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and development of 5-HT
              2C
              receptor agonists for obesity: is there light at the end of the tunnel?. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2010,</strong> <em>2 </em>
                                    (12)
                                     , 1761-1775. <a href="https://doi.org/10.4155/fmc.10.261" title="DOI URL">https://doi.org/10.4155/fmc.10.261</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.10.261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.10.261%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252Bdevelopment%252Bof%252B5-HT%252B2C%252Breceptor%252Bagonists%252Bfor%252Bobesity%25253A%252Bis%252Bthere%252Blight%252Bat%252Bthe%252Bend%252Bof%252Bthe%252Btunnel%25253F%26aulast%3DMiller%26aufirst%3DKeith%2BJ%26date%3D2010%26volume%3D2%26issue%3D12%26spage%3D1761%26epage%3D1775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Junwon  Lee</span>, <span class="hlFld-ContribAuthor ">Myung Eun  Jung</span>, <span class="hlFld-ContribAuthor ">Jinhwa  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">5-HT2C receptor modulators: a patent survey. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2010,</strong> <em>20 </em>
                                    (11)
                                     , 1429-1455. <a href="https://doi.org/10.1517/13543776.2010.518956" title="DOI URL">https://doi.org/10.1517/13543776.2010.518956</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2010.518956&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2010.518956%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3D5-HT2C%252Breceptor%252Bmodulators%25253A%252Ba%252Bpatent%252Bsurvey%26aulast%3DLee%26aufirst%3DJunwon%26date%3D2010%26date%3D2010%26volume%3D20%26issue%3D11%26spage%3D1429%26epage%3D1455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Saleem  Ahmad</span>, <span class="hlFld-ContribAuthor ">Khehyong  Ngu</span>, <span class="hlFld-ContribAuthor ">Keith J.  Miller</span>, <span class="hlFld-ContribAuthor ">Ginger  Wu</span>, <span class="hlFld-ContribAuthor ">Chen-pin  Hung</span>, <span class="hlFld-ContribAuthor ">Sarah  Malmstrom</span>, <span class="hlFld-ContribAuthor ">Ge  Zhang</span>, <span class="hlFld-ContribAuthor ">Eva  OâTanyi</span>, <span class="hlFld-ContribAuthor ">William J.  Keim</span>, <span class="hlFld-ContribAuthor ">Mary Jane  Cullen</span>, <span class="hlFld-ContribAuthor ">Kenneth W.  Rohrbach</span>, <span class="hlFld-ContribAuthor ">Michael  Thomas</span>, <span class="hlFld-ContribAuthor ">Thao  Ung</span>, <span class="hlFld-ContribAuthor ">Qinling  Qu</span>, <span class="hlFld-ContribAuthor ">Jinping  Gan</span>, <span class="hlFld-ContribAuthor ">Rangaraj  Narayanan</span>, <span class="hlFld-ContribAuthor ">Mary Ann  Pelleymounter</span>, <span class="hlFld-ContribAuthor ">Jeffrey A.  Robl</span>. </span><span class="cited-content_cbyCitation_article-title">Tricyclic dihydroquinazolinones as novel 5-HT2C selective and orally efficacious anti-obesity agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (3)
                                     , 1128-1133. <a href="https://doi.org/10.1016/j.bmcl.2009.12.014" title="DOI URL">https://doi.org/10.1016/j.bmcl.2009.12.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2009.12.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2009.12.014%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DTricyclic%252Bdihydroquinazolinones%252Bas%252Bnovel%252B5-HT2C%252Bselective%252Band%252Borally%252Befficacious%252Banti-obesity%252Bagents%26aulast%3DAhmad%26aufirst%3DSaleem%26date%3D2010%26volume%3D20%26issue%3D3%26spage%3D1128%26epage%3D1133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Keith J.  Miller</span>, <span class="hlFld-ContribAuthor ">Ginger Y.  Wu</span>, <span class="hlFld-ContribAuthor ">Jeffrey G.  Varnes</span>, <span class="hlFld-ContribAuthor ">Paul  Levesque</span>, <span class="hlFld-ContribAuthor ">Julia  Li</span>, <span class="hlFld-ContribAuthor ">Danshi  Li</span>, <span class="hlFld-ContribAuthor ">Jeffrey A.  Robl</span>, <span class="hlFld-ContribAuthor ">Karen A.  Rossi</span>, <span class="hlFld-ContribAuthor ">Dean A.  Wacker</span>. </span><span class="cited-content_cbyCitation_article-title">Position 5.46 of the Serotonin 5-HT
              2A
              Receptor Contributes to a Species-Dependent Variation for the 5-HT
              2C
              Agonist (
              R
              )-9-Ethyl-1,3,4,10
              b
              -tetrahydro-7-trifluoromethylpyrazino[2,1-
              a
              ]isoindol-6(2
              H
              )-one: Impact on Selectivity and Toxicological Evaluation. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmacology</span><span> <strong>2009,</strong> <em>76 </em>
                                    (6)
                                     , 1211-1219. <a href="https://doi.org/10.1124/mol.109.059204" title="DOI URL">https://doi.org/10.1124/mol.109.059204</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/mol.109.059204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fmol.109.059204%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmacology%26atitle%3DPosition%252B5.46%252Bof%252Bthe%252BSerotonin%252B5-HT%252B2A%252BReceptor%252BContributes%252Bto%252Ba%252BSpecies-Dependent%252BVariation%252Bfor%252Bthe%252B5-HT%252B2C%252BAgonist%252B%252528%252BR%252B%252529-9-Ethyl-1%25252C3%25252C4%25252C10%252Bb%252B-tetrahydro-7-trifluoromethylpyrazino%25255B2%25252C1-%252Ba%252B%25255Disoindol-6%2525282%252BH%252B%252529-one%25253A%252BImpact%252Bon%252BSelectivity%252Band%252BToxicological%252BEvaluation%26aulast%3DMiller%26aufirst%3DKeith%2BJ.%26date%3D2009%26date%3D2009%26volume%3D76%26issue%3D6%26spage%3D1211%26epage%3D1219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A. Stephen K.  Hashmi</span>, <span class="hlFld-ContribAuthor ">Sascha  SchÃ¤fer</span>, <span class="hlFld-ContribAuthor ">Jan W.  Bats</span>, <span class="hlFld-ContribAuthor ">Wolfgang  Frey</span>, <span class="hlFld-ContribAuthor ">Frank  Rominger</span>. </span><span class="cited-content_cbyCitation_article-title">Gold Catalysis and Chiral Sulfoxides: Enantioselective Synthesis of Dihydroisoindol-4-ols. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2008,</strong> <em>2008 </em>
                                    (29)
                                     , 4891-4899. <a href="https://doi.org/10.1002/ejoc.200800656" title="DOI URL">https://doi.org/10.1002/ejoc.200800656</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.200800656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.200800656%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DGold%252BCatalysis%252Band%252BChiral%252BSulfoxides%25253A%252BEnantioselective%252BSynthesis%252Bof%252BDihydroisoindol-4-ols%26aulast%3DHashmi%26aufirst%3DA.%2BStephen%2BK.%26date%3D2008%26volume%3D2008%26issue%3D29%26spage%3D4891%26epage%3D4899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nathaniel J.T.  Monck</span>, <span class="hlFld-ContribAuthor ">Guy A.  Kennett</span>. </span><span class="cited-content_cbyCitation_article-title">6 5-HT2C Ligands: Recent Progress. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2008,</strong>,, 281-390. <a href="https://doi.org/10.1016/S0079-6468(07)00006-9" title="DOI URL">https://doi.org/10.1016/S0079-6468(07)00006-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/S0079-6468(07)00006-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FS0079-6468%2807%2900006-9%26sid%3Dliteratum%253Aachs%26atitle%3D6%252B5-HT2C%252BLigands%25253A%252BRecent%252BProgress%26aulast%3DMonck%26aufirst%3DNathaniel%2BJ.T.%26date%3D2008%26spage%3D281%26epage%3D390%26pub%3DElsevier%26atitle%3DProgress%252Bin%252BMedicinal%252BChemistry%252BVolume%252B46%26date%3D2008%26volume%3D46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-6/jm0612968/production/images/medium/jm0612968n00001.gif" alt="" id="_i2" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-6/jm0612968/production/images/large/jm0612968n00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0612968&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm0612968f00001" data-index="1" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-6/jm0612968/production/images/medium/jm0612968f00001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-6/jm0612968/production/images/large/jm0612968f00001.jpeg" id="rightTab-_i5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 1 Published and proposed 5-HT<sub>2C</sub> agonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-6/jm0612968/production/images/large/jm0612968f00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0612968&amp;id=jm0612968f00001"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm0612968h00001" data-index="2" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-6/jm0612968/production/images/medium/jm0612968h00001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-6/jm0612968/production/images/large/jm0612968h00001.jpeg" id="rightTab-_i7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 1.â Synthesis of Pyrazinoisoindolones (Method A)<i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup>âReagents:â (a) (1) Oxalyl chloride, 0.1 equiv of DMF, CH<sub>2</sub>Cl<sub>2</sub>, (2) 2.2 equiv of diethylamine, CH<sub>2</sub>Cl<sub>2</sub>; (b) (1) <i>s</i>-BuLi, TMEDA, THF, â78 Â°C, 15 min, then DMF, â78 Â°C to rt, 1 h; (c) 6 M aq HCl, reflux, 16 h; (d) NaOAc, NaCN, <i>N</i>-Cbz-ethylenediamine hydrochloride, 2:1 EtOH:AcOH; (e) 60 psi H<sub>2</sub>, 10% Pd/C, concd HCl, MeOH; (f) (1) Boc<sub>2</sub>O, CH<sub>2</sub>Cl<sub>2</sub>, (2) chiral separation, (3) 12 M HCl; (g) (1) NBS, concd H<sub>2</sub>SO<sub>4</sub>, (2) Boc<sub>2</sub>O, Na<sub>2</sub>CO<sub>3</sub>, THF; (h) (1) R<sub>9</sub>-B(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, DME, H<sub>2</sub>O, reflux or R<sub>9</sub>-Sn(<i>n</i>-Bu)<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, Tol, reflux<sub>,</sub> (2) 12 M HCl.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-6/jm0612968/production/images/large/jm0612968h00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0612968&amp;id=jm0612968h00001"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm0612968h00002" data-index="3" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-6/jm0612968/production/images/medium/jm0612968h00002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-6/jm0612968/production/images/large/jm0612968h00002.jpeg" id="rightTab-_i8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 2.â Alternative Synthesis of Pyrazinoisoindolones (Method B)<i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup>âReagents:â (a) NaOAc, NaCN, 2,2-diethoxyethylamine, 2:1 EtOH:AcOH; (b) 1 atm H<sub>2</sub>, Raney Ni, EtOH; (c) (1) 12 M HCl, (2) NaBH(OAc)<sub>3</sub>, MeOH, ClCH<sub>2</sub>CH<sub>2</sub>Cl, (3) Boc<sub>2</sub>O, Na<sub>2</sub>CO<sub>3</sub>, EtOAc; (d) 12 M HCl. </p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-6/jm0612968/production/images/large/jm0612968h00002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0612968&amp;id=jm0612968h00002"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm0612968h00003" data-index="4" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-6/jm0612968/production/images/medium/jm0612968h00003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-6/jm0612968/production/images/large/jm0612968h00003.jpeg" id="rightTab-_i10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 3.â Synthesis of 1-Substituted Pyrazinoisoindolone Core<i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup>âReagents:â (a) NaBH(OAc)<sub>3</sub>, <i>N</i>-Boc-ethylenediamine hydrochloride, AcOH, ClCH<sub>2</sub>CH<sub>2</sub>Cl; (b) (1) <i>s</i>-BuLi, THF, â78 Â°C, 15 min, (2) RCOH, â78 Â°C â 0 Â°C, 5 min; (c) DessâMartin periodinane, CH<sub>2</sub>Cl<sub>2</sub>; (d) (1) 12 M aq HCl, Et<sub>2</sub>O, (2) Boc<sub>2</sub>O, 2 equiv of DMAP; (e) (1) 60 psi H<sub>2</sub>, 10% Pd/C, MeOH, (2) chiral separation; (f) 12 M HCl.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-6/jm0612968/production/images/large/jm0612968h00003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0612968&amp;id=jm0612968h00003"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm0612968f00002" data-index="5" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-6/jm0612968/production/images/medium/jm0612968f00002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-6/jm0612968/production/images/large/jm0612968f00002.jpeg" id="rightTab-_i17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 2 20-h rat operant feeding model with compound <b>58</b>. Values indicate percent reduction in consumed pellets from vehicle dosed animals.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-6/jm0612968/production/images/large/jm0612968f00002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0612968&amp;id=jm0612968f00002"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm0612968f00003" data-index="6" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-6/jm0612968/production/images/medium/jm0612968f00003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-6/jm0612968/production/images/large/jm0612968f00003.jpeg" id="rightTab-_i18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 3 Antagonist reversal in the 20-h rat operant feeding model. </p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-6/jm0612968/production/images/large/jm0612968f00003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0612968&amp;id=jm0612968f00003"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm0612968f00004" data-index="7" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-6/jm0612968/production/images/medium/jm0612968f00004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-6/jm0612968/production/images/large/jm0612968f00004.jpeg" id="rightTab-_i20" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 4 4-Day rat weight loss model with compound <b>58</b>. Values indicate percent reduction in weight gain from vehicle dosed animals. </p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-6/jm0612968/production/images/large/jm0612968f00004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm0612968&amp;id=jm0612968f00004"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"></div><p class="rightTab-references-count">
            This article references 20 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-jm0612968b00001"><div class="reference"><strong class="refLabel"><a href="#jm0612968b00001" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-jm0612968b00001_1"><span><span class="NLM_string-ref">National Center for Health Statistics. <a class="ext-link" href="http://www.cdc.gov/nchs/fastats/overwt.htm" target="_blank">http://www.cdc.gov/nchs/fastats/overwt.htm</a> (accessed Sept 2006).</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=National+Center+for+Health+Statistics.&title=http%3A%2F%2Fwww.cdc.gov%2Fnchs%2Ffastats%2Foverwt.htm+%28accessed"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0612968b00001_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3D%26aulast%3D%26aulast%3D%26btitle%3Dhttp%253A%252F%252Fwww.cdc.gov%252Fnchs%252Ffastats%252Foverwt.htm%2520%2528accessed%26date%3D2006http%3A%2F%2Fwww.cdc.gov%2Fnchs%2Ffastats%2Foverwt.htm" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0612968b00002"><div class="reference"><strong class="refLabel"><a href="#jm0612968b00002" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-jm0612968b00002_1"><span><span class="NLM_string-ref">Eckel, R. H.; York, D. A.; Rossner, S.; Hubbard, V.; Caterson, I.; St. Joer, S. T.; Hayman. L. L.; Mullis, R. M.; Blair, S. N. Prevention conference VII:â Obesity, a worldwide epidemic related to heart disease and stroke:â executive summary. <i>  Circulation</i><b>2004</b>, <i>110</i>, e463âe470.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2004&pages=e470&author=R.+H.+Eckel&author=D.+A.+York&author=S.+Rossner&author=V.+Hubbard&author=I.+Caterson&author=S.+T.+St.+Joer&author=L.+L.+Hayman&author=R.+M.+Mullis&author=S.+N+Blair&title=Prevention+conference+VII%3A%E2%80%89+Obesity%2C+a+worldwide+epidemic+related+to+heart+disease+and+stroke%3A%E2%80%89+executive+summary"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0612968b00002_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEckel%26aufirst%3DR.%2BH.%26atitle%3DPrevention%2520conference%2520VII%253A%25E2%2580%2589%2520Obesity%252C%2520a%2520worldwide%2520epidemic%2520related%2520to%2520heart%2520disease%2520and%2520stroke%253A%25E2%2580%2589%2520executive%2520summary%26jtitle%3DCirculation%26date%3D2004%26volume%3D110%26spage%3De470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0612968b00003"><div class="reference"><strong class="refLabel"><a href="#jm0612968b00003" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-jm0612968b00003_1"><span><span class="NLM_string-ref">Ogden, C. L.; Carroll, M. D.; Flegal, K. M. Epidemiologic trends in overweight and obesity. <i>  Endocrinol. Metab. Clin. North Am.</i><b>2003</b>, <i>32</i>, 741â760.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2003&pages=760&author=C.+L.+Ogden&author=M.+D.+Carroll&author=K.+M+Flegal&title=Epidemiologic+trends+in+overweight+and+obesity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0612968b00003_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOgden%26aufirst%3DC.%2BL.%26atitle%3DEpidemiologic%2520trends%2520in%2520overweight%2520and%2520obesity%26jtitle%3DEndocrinol.%2520Metab.%2520Clin.%2520North%2520Am.%26date%3D2003%26volume%3D32%26spage%3D760" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0612968b00004"><div class="reference"><strong class="refLabel"><a href="#jm0612968b00004" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-jm0612968b00004_1"><span><span class="NLM_string-ref">El-Atat, F.; Aneja, A.; McFarlane, S.; Sowers, J. Obesity and hypertension. <i>  Endocrinol. Metab. Clin. North Am.</i><b>2003</b>, <i>32</i>, 823â854.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2003&pages=854&author=F.+El-Atat&author=A.+Aneja&author=S.+McFarlane&author=J+Sowers&title=Obesity+and+hypertension"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0612968b00004_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEl-Atat%26aufirst%3DF.%26atitle%3DObesity%2520and%2520hypertension%26jtitle%3DEndocrinol.%2520Metab.%2520Clin.%2520North%2520Am.%26date%3D2003%26volume%3D32%26spage%3D854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0612968b00005"><div class="reference"><strong class="refLabel"><a href="#jm0612968b00005" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-jm0612968b00005_1"><span><span class="NLM_string-ref">Tuthill, A.; Slawik, H.; O'Rahilly, S.; Finer, N. Psychiatric co-morbidities in patients attending specialist obesity services in the UK. <i>  Q. J. Med.:â </i><i>Monthly J. Assoc. Physicians</i><b>2006</b>, <i>99</i>, 317â325.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=A.+Tuthill&author=H.+Slawik&author=S.+O%27Rahilly&author=N.+Finer&title=Psychiatric+co-morbidities+in+patients+attending+specialist+obesity+services+in+the+UK.+Q.+J.+Med.%3A%E2%80%89+Monthly+J.+Assoc.+Physicians"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0612968b00005_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DTuthill%26aufirst%3DA.%26btitle%3DPsychiatric%2520co-morbidities%2520in%2520patients%2520attending%2520specialist%2520obesity%2520services%2520in%2520the%2520UK.%2520Q.%2520J.%2520Med.%253A%25E2%2580%2589%2520Monthly%2520J.%2520Assoc.%2520Physicians%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0612968b00006"><div class="reference"><strong class="refLabel"><a href="#jm0612968b00006" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-jm0612968b00006_1"><span><span class="NLM_string-ref">Vickers, S. P; Benwell, K. R.; Porter, R. H.; Bickerdike, M. J.; Kennett, G. A.; Dourish, C. T. Comparative effects of continuous infusion of mCPP, Ro 60-0175. and d-fenfluramine on food intake, water intake, body weight and locomotor activity in rats. <i>  Br. J. Pharmacol.</i><b>2000</b>, <i>130</i>, 1305â1314.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2000&pages=1314&author=S.+Vickers&author=K.+R.+Benwell&author=R.+H.+Porter&author=M.+J.+Bickerdike&author=G.+A.+Kennett&author=C.+T+Dourish&title=Comparative+effects+of+continuous+infusion+of+mCPP%2C+Ro+60-0175.+and+d-fenfluramine+on+food+intake%2C+water+intake%2C+body+weight+and+locomotor+activity+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0612968b00006_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVickers%26aufirst%3DS.%26atitle%3DComparative%2520effects%2520of%2520continuous%2520infusion%2520of%2520mCPP%252C%2520Ro%252060-0175.%2520and%2520d-fenfluramine%2520on%2520food%2520intake%252C%2520water%2520intake%252C%2520body%2520weight%2520and%2520locomotor%2520activity%2520in%2520rats%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2000%26volume%3D130%26spage%3D1314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0612968b00007"><div class="reference"><strong class="refLabel"><a href="#jm0612968b00007" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-jm0612968b00007_1"><span><span class="NLM_string-ref">Kennett, G. A.; Wood, M. D.; Bright, F.; Trail, B.; Riley, G.; Holland, V.; Avenell, K. Y.; Stean, T.; Upton, N.; Bromidge, S.; Forbes, I. T.; Brown, A. M.; Middlemiss, D. N.; Blackburn, T. P. SB 242084, a selective and brain penetrant 5-HT<sub>2C</sub> receptor antagonist. <i>  Neuropharmacology</i><b>1997</b>, <i>36</i>, 609â620.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1997&pages=620&author=G.+A.+Kennett&author=M.+D.+Wood&author=F.+Bright&author=B.+Trail&author=G.+Riley&author=V.+Holland&author=K.+Y.+Avenell&author=T.+Stean&author=N.+Upton&author=S.+Bromidge&author=I.+T.+Forbes&author=A.+M.+Brown&author=D.+N.+Middlemiss&author=T.+P.+Blackburn&title=a+selective+and+brain+penetrant+5-HT2C+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0612968b00007_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKennett%26aufirst%3DG.%2BA.%26atitle%3Da%2520selective%2520and%2520brain%2520penetrant%25205-HT2C%2520receptor%2520antagonist%26jtitle%3DNeuropharmacology%26date%3D1997%26volume%3D36%26spage%3D620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0612968b00008"><div class="reference"><strong class="refLabel"><a href="#jm0612968b00008" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-jm0612968b00008_1"><span><span class="NLM_string-ref">Tecott, L. H.; Sun, L. M.; Akana, S. F.; Strack, A. M.; Lowenstein, D. H.; Dallman, M. F.; Julius, D. Eating disorder and epilepsy in mice lacking 5-HT<sub>2C</sub> serotonin receptors. <i>  Nature</i><b>1995</b>, <i>374</i>, 542â546.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=374&publication_year=1995&pages=546&author=L.+H.+Tecott&author=L.+M.+Sun&author=S.+F.+Akana&author=A.+M.+Strack&author=D.+H.+Lowenstein&author=M.+F.+Dallman&author=D+Julius&title=Eating+disorder+and+epilepsy+in+mice+lacking+5-HT2C+serotonin+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0612968b00008_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTecott%26aufirst%3DL.%2BH.%26atitle%3DEating%2520disorder%2520and%2520epilepsy%2520in%2520mice%2520lacking%25205-HT2C%2520serotonin%2520receptors%26jtitle%3DNature%26date%3D1995%26volume%3D374%26spage%3D546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0612968b00009"><div class="reference"><strong class="refLabel"><a href="#jm0612968b00009" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-jm0612968b00009_1"><span><span class="NLM_string-ref">(a) Walsh, A. E.; Smith, K. A.; Oldman, A. D.; Williams, C.; Goodall, E. M.; Cowen, P. J. m-Chlorophenylpiperazine decreases food intake in a test meal. <i>  Psychopharmacology</i><b>1994</b>, <i>116</i> (1), 120â122.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=1994&pages=122&issue=1&author=A.+E.+Walsh&author=K.+A.+Smith&author=A.+D.+Oldman&author=C.+Williams&author=E.+M.+Goodall&author=P.+J+Cowen&title=m-Chlorophenylpiperazine+decreases+food+intake+in+a+test+meal"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0612968b00009_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWalsh%26aufirst%3DA.%2BE.%26atitle%3Dm-Chlorophenylpiperazine%2520decreases%2520food%2520intake%2520in%2520a%2520test%2520meal%26jtitle%3DPsychopharmacology%26date%3D1994%26volume%3D116%26issue%3D1%26spage%3D122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm0612968b00009_2"><span><span class="NLM_string-ref">(b) Sargent, P. A.; Sharpley, A. L.; Williams, C.; Goodall, E. M.; Cowen, P. J. 5-HT<sub>2C</sub> receptor activation decreases appetite and body weight in obese subjects. <i>  Psychopharmacology</i><b>1997</b>, <i>133</i>, 309â312.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=1997&pages=312&author=P.+A.+Sargent&author=A.+L.+Sharpley&author=C.+Williams&author=E.+M.+Goodall&author=P.+J.+Cowen&title=receptor+activation+decreases+appetite+and+body+weight+in+obese+subjects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0612968b00009_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSargent%26aufirst%3DP.%2BA.%26atitle%3Dreceptor%2520activation%2520decreases%2520appetite%2520and%2520body%2520weight%2520in%2520obese%2520subjects%26jtitle%3DPsychopharmacology%26date%3D1997%26volume%3D133%26spage%3D312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0612968b00010"><div class="reference"><div class="NLM_citation" id="rightTab-jm0612968b00010_1"><span><span class="NLM_string-ref">(a) Lacivita, E.; Leopoldo, M. Selective agents for serotonin2C (5-HT<sub>2C</sub>) receptor. <i>  Curr. Topics in Med. Chem.</i><b>2006</b>, <i>6</i> (18), 1927â1970.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=1970&issue=18&author=E.+Lacivita&author=M+Leopoldo&title=Selective+agents+for+serotonin2C+%285-HT2C%29+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0612968b00010_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLacivita%26aufirst%3DE.%26atitle%3DSelective%2520agents%2520for%2520serotonin2C%2520%25285-HT2C%2529%2520receptor%26jtitle%3DCurr.%2520Topics%2520in%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26issue%3D18%26spage%3D1970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm0612968b00010_2"><span><span class="NLM_string-ref">(b) Nilsson, B. M. 5 -Hydroxytryptamine 2C (5-HT<sub>2C</sub>) receptor agonists as potential antiobesity agents. <i>  J. Med. Chem.</i><b>2006</b>, <i>49</i>, 4023â4034.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4034&author=B.+M+Nilsson&title=5+-Hydroxytryptamine+2C+%285-HT2C%29+receptor+agonists+as+potential+antiobesity+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0612968b00010_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNilsson%26aufirst%3DB.%2BM%26atitle%3D5%2520-Hydroxytryptamine%25202C%2520%25285-HT2C%2529%2520receptor%2520agonists%2520as%2520potential%2520antiobesity%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm0612968b00010_3"><span><span class="NLM_string-ref">(c) Fitzgerald, L. W.; Ennis, M. D. 5-HT<sub>2C</sub> receptor modulators:â progress in development of new CNS medicines. <i>  Annu. Rep. Med. Chem.</i><b>2002</b>, <i>37</i>, 21â30.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2002&pages=30&author=L.+W.+Fitzgerald&author=M.+D.+Ennis&title=progress+in+development+of+new+CNS+medicines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0612968b00010_3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFitzgerald%26aufirst%3DL.%2BW.%26atitle%3Dprogress%2520in%2520development%2520of%2520new%2520CNS%2520medicines%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2002%26volume%3D37%26spage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0612968b00011"><div class="reference"><strong class="refLabel"><a href="#jm0612968b00011" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-jm0612968b00011_1"><span><span class="NLM_string-ref">(a) Fitzgerald, L. W.; Burn, T. C.; Brown, B. S.; Patterson, J. P.; Corjay, M. H.; Valentine, P. A.; Sun, J.-H.; Link, J. R.; Abbaszade, I.; Hollis, J. M.; Largent, B. L.; Hartig, P. R.; Hollis, G. F.; Meunier, P. C.; Robichaud, A. J.; Robertson, D. W. Possible role of valvular serotonin 5-HT2B receptors in the cardiopathy associated with fenfluramine. <i>  Mol. Pharmacol.</i><b>2000</b>, <i>57</i>, 75â81.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2000&pages=81&author=L.+W.+Fitzgerald&author=T.+C.+Burn&author=B.+S.+Brown&author=J.+P.+Patterson&author=M.+H.+Corjay&author=P.+A.+Valentine&author=J.-H.+Sun&author=J.+R.+Link&author=I.+Abbaszade&author=J.+M.+Hollis&author=B.+L.+Largent&author=P.+R.+Hartig&author=G.+F.+Hollis&author=P.+C.+Meunier&author=A.+J.+Robichaud&author=D.+W+Robertson&title=Possible+role+of+valvular+serotonin+5-HT2B+receptors+in+the+cardiopathy+associated+with+fenfluramine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0612968b00011_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFitzgerald%26aufirst%3DL.%2BW.%26atitle%3DPossible%2520role%2520of%2520valvular%2520serotonin%25205-HT2B%2520receptors%2520in%2520the%2520cardiopathy%2520associated%2520with%2520fenfluramine%26jtitle%3DMol.%2520Pharmacol.%26date%3D2000%26volume%3D57%26spage%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm0612968b00011_2"><span><span class="NLM_string-ref">(b) Rothman, R. B.; Baumann, M. H.; Savage, J. E.; Rauser, L.; McBride, A.; Hufeisen, S. J.; Roth, B. L. Evidence for possible involvement of 5-HT<sub>2B</sub> receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications. <i>  Circulation</i><b>2000</b>, <i>102</i>, 2836â2841.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2000&pages=2841&author=R.+B.+Rothman&author=M.+H.+Baumann&author=J.+E.+Savage&author=L.+Rauser&author=A.+McBride&author=S.+J.+Hufeisen&author=B.+L+Roth&title=Evidence+for+possible+involvement+of+5-HT2B+receptors+in+the+cardiac+valvulopathy+associated+with+fenfluramine+and+other+serotonergic+medications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0612968b00011_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRothman%26aufirst%3DR.%2BB.%26atitle%3DEvidence%2520for%2520possible%2520involvement%2520of%25205-HT2B%2520receptors%2520in%2520the%2520cardiac%2520valvulopathy%2520associated%2520with%2520fenfluramine%2520and%2520other%2520serotonergic%2520medications%26jtitle%3DCirculation%26date%3D2000%26volume%3D102%26spage%3D2841" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm0612968b00011_3"><span><span class="NLM_string-ref">(c) Xu, J.; Jian, B.; Chu, R.; Lu, Z.; Li, Q.; Dunlop, J.; Rosenzweig-Lipson, S.; McGonigle, P.; Levy, R. J.; Liang, B. Serotonin mechanisms in heart valve disease II:â The 5-HT2 receptor and its signaling pathway in aortic valve interstitial cells. <i>  Am. J. Pathol.</i><b>2002</b>, <i>161</i>, 2209â2218.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=161&publication_year=2002&pages=2218&author=J.+Xu&author=B.+Jian&author=R.+Chu&author=Z.+Lu&author=Q.+Li&author=J.+Dunlop&author=S.+Rosenzweig-Lipson&author=P.+McGonigle&author=R.+J.+Levy&author=B+Liang&title=Serotonin+mechanisms+in+heart+valve+disease+II%3A%E2%80%89+The+5-HT2+receptor+and+its+signaling+pathway+in+aortic+valve+interstitial+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0612968b00011_3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DJ.%26atitle%3DSerotonin%2520mechanisms%2520in%2520heart%2520valve%2520disease%2520II%253A%25E2%2580%2589%2520The%25205-HT2%2520receptor%2520and%2520its%2520signaling%2520pathway%2520in%2520aortic%2520valve%2520interstitial%2520cells%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2002%26volume%3D161%26spage%3D2218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0612968b00012"><div class="reference"><strong class="refLabel"><a href="#jm0612968b00012" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-jm0612968b00012_1"><span><span class="NLM_string-ref">(a) Robichaud, A. J.; Chen, W.; McClung, C.; McClung, C.; Clark, D.; Deng, W.; Brondyke-Calvello, E.; Mitchell, I. S.; Lee, T.; Rajagopalan, P.; Fitzgerald, L. W.; Conklin, D. S.; McElroy, J. F.; Rohrbach, K. W.; Miller, K. J.; Largent, B. L.; Robertson, D. W. Synthesis and biological evaluation of novel, selective 5-HT2C receptor agonists for the treatment of obesity. <i>  Abstracts of Papers</i>; 221st American Chemical Society National Meeting, San Diego, CA, American Chemical Society:â Washington, DC, 2001, MEDI-105.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&author=A.+J.+Robichaud&author=W.+Chen&author=C.+McClung&author=C.+McClung&author=D.+Clark&author=W.+Deng&author=E.+Brondyke-Calvello&author=I.+S.+Mitchell&author=T.+Lee&author=P.+Rajagopalan&author=L.+W.+Fitzgerald&author=D.+S.+Conklin&author=J.+F.+McElroy&author=K.+W.+Rohrbach&author=K.+J.+Miller&author=B.+L.+Largent&author=D.+W.+Robertson&title=Synthesis+and+biological+evaluation+of+novel%2C+selective+5-HT2C+receptor+agonists+for+the+treatment+of+obesity.+Abstracts+of+Papers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0612968b00012_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DRobichaud%26aufirst%3DA.%2BJ.%26btitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520novel%252C%2520selective%25205-HT2C%2520receptor%2520agonists%2520for%2520the%2520treatment%2520of%2520obesity.%2520Abstracts%2520of%2520Papers%26pub%3DAmerican%2520Chemical%2520Society%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm0612968b00012_2"><span><span class="NLM_string-ref">(b) Lee, T.; Robichaud, A. J.; Chen, W.; Lu, Y.; Dowdell, S.; Boyle, K. E.; Mitchell, I. S.; Fevig, J. M.; Wexler, R. R.; Miller, K. J.; Largent, B. L.; Rohrbach, K. W.; Devenny, J. J.; McElroy, J. F. Synthesis and biological evaluation of novel, selective 5-HT<sub>2C</sub> receptor agonists for obesity. <i>  Abstracts of Papers</i>; 229th American Chemical Society National Meeting, San Diego, CA; American Chemical Society:â Washington, DC, 2005; MEDI-283.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=T.+Lee&author=A.+J.+Robichaud&author=W.+Chen&author=Y.+Lu&author=S.+Dowdell&author=K.+E.+Boyle&author=I.+S.+Mitchell&author=J.+M.+Fevig&author=R.+R.+Wexler&author=K.+J.+Miller&author=B.+L.+Largent&author=K.+W.+Rohrbach&author=J.+J.+Devenny&author=J.+F.+McElroy&title=Synthesis+and+biological+evaluation+of+novel%2C+selective+5-HT2C+receptor+agonists+for+obesity.+Abstracts+of+Papers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0612968b00012_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DT.%26btitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520novel%252C%2520selective%25205-HT2C%2520receptor%2520agonists%2520for%2520obesity.%2520Abstracts%2520of%2520Papers%26pub%3DAmerican%2520Chemical%2520Society%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0612968b00013"><div class="reference"><strong class="refLabel"><a href="#jm0612968b00013" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-jm0612968b00013_1"><span><span class="NLM_string-ref">Richter, H. G. F.; Adams, D. R.; Benardeau, A.; Bickerdike, M. J.; Bentley, J. M.; Blench, T. J.; Cliffe, I. A.; Dourish, C.; Hebeisen, P.; Kennett, G. A.; Knight, A. R.; Malcolm, C. S.; Mattei, P.; Misra, A.; Mizrahi, J.; Monck, N. J. T.; Plancher, J.-M.; Roever, S.; Roffey, J. R. A.; Taylor, S.; Vickers, S. P. Synthesis and biological evaluation of novel hexahydro-pyrido[3â,2â:4,5]pyrrolo[1,2-a]pyrazines as potent and selective 5-HT<sub>2C</sub> receptor agonists. <i>  Bioorg. Med. Chem. Lett.</i><b>2006</b>, <i>16</i>, 1207â1211.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=1211&author=H.+G.+F.+Richter&author=D.+R.+Adams&author=A.+Benardeau&author=M.+J.+Bickerdike&author=J.+M.+Bentley&author=T.+J.+Blench&author=I.+A.+Cliffe&author=C.+Dourish&author=P.+Hebeisen&author=G.+A.+Kennett&author=A.+R.+Knight&author=C.+S.+Malcolm&author=P.+Mattei&author=A.+Misra&author=J.+Mizrahi&author=N.+J.+T.+Monck&author=J.-M.+Plancher&author=S.+Roever&author=J.+R.+A.+Roffey&author=S.+Taylor&author=S.+P+Vickers&title=Synthesis+and+biological+evaluation+of+novel+hexahydro-pyrido%5B3%E2%80%98%2C2%E2%80%98%3A4%2C5%5Dpyrrolo%5B1%2C2-a%5Dpyrazines+as+potent+and+selective+5-HT2C+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0612968b00013_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRichter%26aufirst%3DH.%2BG.%2BF.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520novel%2520hexahydro-pyrido%255B3%25E2%2580%2598%252C2%25E2%2580%2598%253A4%252C5%255Dpyrrolo%255B1%252C2-a%255Dpyrazines%2520as%2520potent%2520and%2520selective%25205-HT2C%2520receptor%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D1211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0612968b00014"><div class="reference"><strong class="refLabel"><a href="#jm0612968b00014" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-jm0612968b00014_1"><span><span class="NLM_string-ref">Welch, W. M. Synthesis of the 1,2,3,4-tetrahydropyrazino[2,1-<i>a</i>]isoindol-6(2<i>H</i>)-one ring system. <i>  J. Org. </i><i>Chem.</i><b>1982</b>, <i>47</i>, 886â888.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1982&pages=888&author=W.+M+Welch&title=Synthesis+of+the+1%2C2%2C3%2C4-tetrahydropyrazino%5B2%2C1-a%5Disoindol-6%282H%29-one+ring+system"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0612968b00014_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWelch%26aufirst%3DW.%2BM%26atitle%3DSynthesis%2520of%2520the%25201%252C2%252C3%252C4-tetrahydropyrazino%255B2%252C1-a%255Disoindol-6%25282H%2529-one%2520ring%2520system%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1982%26volume%3D47%26spage%3D888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0612968b00015"><div class="reference"><strong class="refLabel"><a href="#jm0612968b00015" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-jm0612968b00015_1"><span><span class="NLM_string-ref">Absolute stereochemistry was determined from the (<i>S</i>)-10-camphorsulfamide of compound <b>30</b> and correlated to all other compounds by chiral HPLC retention times. Crystallographic data (excluding structure factors) for compound <b>30</b> have been deposited with the Cambridge Crystallographic Data Centre as supplementary publication number CCDC 632659. Copies of the data can be obtained free of charge upon application to CCDC, 12 Union Road, Cambridge CB21EZ, UK (Fax:â (+44)1223-336-033. E-mail:â <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="452120352a362c3105">[emailÂ protected]</a> ccdc.cam.ac.uk).</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Absolute+stereochemistry+was+determined+from+the+%28S%29-10-camphorsulfamide+of+compound+30+and+correlated+to+all+other+compounds+by+chiral+HPLC+retention+times.+Crystallographic+data+%28excluding+structure+factors%29+for+compound+30+have+been+deposited+with+the+Cambridge+Crystallographic+Data+Centre+as+supplementary+publication+number+CCDC+632659.+Copies+of+the+data+can+be+obtained+free+of+charge+upon+application+to+CCDC%2C+12+Union+Road%2C+Cambridge+CB21EZ%2C+UK+%28Fax%3A%E2%80%89+%28%2B44%291223-336-033.+E-mail%3A%E2%80%89+deposit%40+ccdc.cam.ac.uk%29.+Absolute+stereochemistry+was+determined+from+the+%28S%29-10-camphorsulfamide+of+compound+30+and+correlated+to+all+other+compounds+by+chiral+HPLC+retention+times.+Crystallographic+data+%28excluding+structure+factors%29+for+compound+30+have+been+deposited+with+the+Cambridge+Crystallographic+Data+Centre+as+supplementary+publication+number+CCDC+632659.+Copies+of+the+data+can+be+obtained+free+of+charge+upon+application+to+CCDC%2C+12+Union+Road%2C+Cambridge+CB21EZ%2C+UK+%28Fax%3A%E2%80%89+%28%2B44%291223-336-033.+E-mail%3A%E2%80%89+deposit%40+ccdc.cam.ac.uk%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0612968b00015_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dother%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0612968b00016"><div class="reference"><strong class="refLabel"><a href="#jm0612968b00016" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-jm0612968b00016_1"><span><span class="NLM_string-ref">Bromidge, S. M.; Dabbs, S.; Davies, D. T.; Davies, S.; Duckworth, D. M.; Forbes, I. T.; Gaster, L. M.; Ham, P.; Jones, G. E.; King, F. D.; Mulholland, K. R.; Saunders, D. V.; Wyman, P. A.; Blaney, F. E.; Clarke, S. E.; Blackburn, T. P.; Holland, V.; Kennett, G. A.; Lightowler, S.; Middlemiss, D. N.; Trail, B.; Riley, G. J.; Wood, M. D. Biarylcarbamoylindolines Are Novel and Selective 5-HT2C Receptor Inverse Agonists:â Identification of 5-Methyl-1-[[2-[(2-methyl-3-pyridyl)oxy]-5-pyridyl]carbamoyl]-6-trifluoromethylindoline (SB-243213) as a Potential Antidepressant/Anxiolytic Agent. <i>  J. Med. Chem.</i><b>2000</b>, <i>43</i>, 1123â1134.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=1134&author=S.+M.+Bromidge&author=S.+Dabbs&author=D.+T.+Davies&author=S.+Davies&author=D.+M.+Duckworth&author=I.+T.+Forbes&author=L.+M.+Gaster&author=P.+Ham&author=G.+E.+Jones&author=F.+D.+King&author=K.+R.+Mulholland&author=D.+V.+Saunders&author=P.+A.+Wyman&author=F.+E.+Blaney&author=S.+E.+Clarke&author=T.+P.+Blackburn&author=V.+Holland&author=G.+A.+Kennett&author=S.+Lightowler&author=D.+N.+Middlemiss&author=B.+Trail&author=G.+J.+Riley&author=M.+D+Wood&title=Biarylcarbamoylindolines+Are+Novel+and+Selective+5-HT2C+Receptor+Inverse+Agonists%3A%E2%80%89+Identification+of+5-Methyl-1-%5B%5B2-%5B%282-methyl-3-pyridyl%29oxy%5D-5-pyridyl%5Dcarbamoyl%5D-6-trifluoromethylindoline+%28SB-243213%29+as+a+Potential+Antidepressant%2FAnxiolytic+Agent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0612968b00016_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBromidge%26aufirst%3DS.%2BM.%26atitle%3DBiarylcarbamoylindolines%2520Are%2520Novel%2520and%2520Selective%25205-HT2C%2520Receptor%2520Inverse%2520Agonists%253A%25E2%2580%2589%2520Identification%2520of%25205-Methyl-1-%255B%255B2-%255B%25282-methyl-3-pyridyl%2529oxy%255D-5-pyridyl%255Dcarbamoyl%255D-6-trifluoromethylindoline%2520%2528SB-243213%2529%2520as%2520a%2520Potential%2520Antidepressant%252FAnxiolytic%2520Agent%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D1134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0612968b00017"><div class="reference"><strong class="refLabel"><a href="#jm0612968b00017" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-jm0612968b00017_1"><span><span class="NLM_string-ref">Alongi, M.; Minetto, G.; Taddei, M. New pyrrole-based amino acids for the synthesis of peptidomimetic constrained scaffolds. <i>  Tetrahedron Lett.</i><b>2005</b>, <i>46</i>, 7069â7072.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2005&pages=7072&author=M.+Alongi&author=G.+Minetto&author=M+Taddei&title=New+pyrrole-based+amino+acids+for+the+synthesis+of+peptidomimetic+constrained+scaffolds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0612968b00017_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAlongi%26aufirst%3DM.%26atitle%3DNew%2520pyrrole-based%2520amino%2520acids%2520for%2520the%2520synthesis%2520of%2520peptidomimetic%2520constrained%2520scaffolds%26jtitle%3DTetrahedron%2520Lett.%26date%3D2005%26volume%3D46%26spage%3D7072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0612968b00018"><div class="reference"><strong class="refLabel"><a href="#jm0612968b00018" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-jm0612968b00018_1"><span><span class="NLM_string-ref">Pittelkow, M.; Lewinsky, R.; Christensen, J. B. Selective synthesis of carbamate protected polyamines using alkyl phenyl carbonates. <i>  Synthesis</i><b>2002</b>, 2195â2202.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2195&publication_year=2002&pages=2202&author=M.+Pittelkow&author=R.+Lewinsky&author=J.+B+Christensen&title=Selective+synthesis+of+carbamate+protected+polyamines+using+alkyl+phenyl+carbonates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0612968b00018_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPittelkow%26aufirst%3DM.%26atitle%3DSelective%2520synthesis%2520of%2520carbamate%2520protected%2520polyamines%2520using%2520alkyl%2520phenyl%2520carbonates%26jtitle%3DSynthesis%26date%3D2002%26volume%3D2195%26spage%3D2202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0612968b00019"><div class="reference"><strong class="refLabel"><a href="#jm0612968b00019" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-jm0612968b00019_1"><span><span class="NLM_string-ref">Short, J. H. Antiemetic and antipsychotic agents. U.S. Patent 4 470 977, 1984.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1984&author=J.+H.+Short&title=Antiemetic+and+antipsychotic+agents.+U.S.+Patent+4+470+977"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0612968b00019_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DShort%26aufirst%3DJ.%2BH.%26btitle%3DAntiemetic%2520and%2520antipsychotic%2520agents.%2520U.S.%2520Patent%25204%2520470%2520977%26date%3D1984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm0612968b00020"><div class="reference"><div class="NLM_citation" id="rightTab-jm0612968b00020_1"><span><span class="NLM_string-ref">Fitzgerald, L. W.; Conklin, D. S.; Krause, C. M.; Marshall, A. P.; Patterson, J. P.; Tran, D. P.; Iyer, G.; Kostich, W. A.; Largent, B. L.; Hartig, P. R. High-affinity agonist binding correlates with efficacy (intrinsic activity) at the human serotonin 5-HT<sub>2A</sub> and 5-HT<sub>2C</sub> receptors:â evidence favoring the ternary complex and two-state models of agonist action. <i>  J. </i><i>Neurochem.</i><b>1999</b>, <i>72</i>, 2127â2134.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1999&pages=2134&author=L.+W.+Fitzgerald&author=D.+S.+Conklin&author=C.+M.+Krause&author=A.+P.+Marshall&author=J.+P.+Patterson&author=D.+P.+Tran&author=G.+Iyer&author=W.+A.+Kostich&author=B.+L.+Largent&author=P.+R+Hartig&title=High-affinity+agonist+binding+correlates+with+efficacy+%28intrinsic+activity%29+at+the+human+serotonin+5-HT2A+and+5-HT2C+receptors%3A%E2%80%89+evidence+favoring+the+ternary+complex+and+two-state+models+of+agonist+action"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm0612968b00020_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFitzgerald%26aufirst%3DL.%2BW.%26atitle%3DHigh-affinity%2520agonist%2520binding%2520correlates%2520with%2520efficacy%2520%2528intrinsic%2520activity%2529%2520at%2520the%2520human%2520serotonin%25205-HT2A%2520and%25205-HT2C%2520receptors%253A%25E2%2580%2589%2520evidence%2520favoring%2520the%2520ternary%2520complex%2520and%2520two-state%2520models%2520of%2520agonist%2520action%26jtitle%3DJ.%2520Neurochem.%26date%3D1999%26volume%3D72%26spage%3D2134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="NLM_notes" id="rightTab-"><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24"><a href="/doi/suppl/10.1021%2Fjm0612968">Supporting Information Available</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76721" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76721" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Table of combustion analysis and X-ray crystallographic data. This material is available free of charge via the Internet at <a class="ext-link" href="http://pubs.acs.org" target="_blank">http://pubs.acs.org</a>. </div></div></div><div class="article_supporting-info" id=""><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm0612968/suppl_file/jm0612968si20070109_081041.pdf">jm0612968si20070109_081041.pdf (40.62 kb)</a></li></ul></div></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm0612968&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Fjm0612968%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2007.50.issue-6%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm0612968" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                191KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679980804d833d18","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
